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ABSTRACT 
Malondialdehyde (MDA) is a mutagenic and carcinogenic product of lipid peroxidation 
which has also been found at elevated levels in smokers. MDA reacts with nucleic acid 
bases to form pyrimidopurinone DNA adducts, of which 3-(2-deoxy-β-D-erythro-
pentofuranosyl)pyrimidol[1,2-α]purin-10(3H)-one (M1dG) is the most abundant and has 
been linked to smoking. Mutations in the TP53 tumour suppressor gene are associated 
with half of all cancers. This research applied a multidisciplinary approach to investigate 
the toxic effects of MDA on the human lung fibroblasts MRC5, which have an intact p53 
response, and their SV40 transformed counterpart, MRC5 SV2, which have a 
sequestered p53 response. 
Both cell lines were treated with MDA (0-1000 µM) for 24 and 48 h and subjected to a 
variety of analyses to examine cell proliferation, cell viability, cellular and nuclear 
morphology, apoptosis, p53 protein expression, DNA topography and M1dG adduct 
detection. For the first time, mutation sequencing of the 5’ untranslated region (UTR) of 
the TP53 gene in response to MDA treatment was carried out. 
The main findings were that both cell lines showed reduced proliferation and viability 
with increasing concentrations of MDA, the cell surface and nuclear morphology were 
altered, and levels of apoptosis and p53 protein expression appeared to increase. A 
LC-MS-MS method for detection of M1dG adducts was developed and adducts were 
detected in CT-DNA treated with MDA in a dose-dependent manner. DNA appeared to 
become more fragmented with increasing MDA concentration, and the number of 
mutations in the 5’ UTR region of the TP53 gene also increased. The majority of 
mutations observed were insertions, compared to lung cancer mutation data where the 
majority were G to T transversions. This was unexpected, suggesting that tobacco smoke 
compounds have a different role in mutagenesis than endogenous lipid peroxidation. 
Thus, MDA has been found to have a clear effect on human lung fibroblasts at both the 
cellular and DNA level. 
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CHAPTER 1 
INTRODUCTION 
1.1. Cancer Incidence 
Cancer is a diverse group of diseases with similar characteristics, of which there are over 
200 types. One in three people will develop cancer at some point in their lives (CRUK, 
2014). There is variation in cancer risk between countries, particularly between the 
developed and developing world, for each type of cancer, suggesting that lifestyle and 
diet play an important role in the aetiology of the disease (CRUK, 2011). When migrant 
populations are studied, the cancer rates reflect those of the new local population, 
rather than the country of origin, often within a single generation (Shuker and Benford, 
1997). For example, breast cancer rates increased in female Italian and Polish migrants 
in Australia to Australian levels compared to the country of origin (Nelson, 2006). Thus, 
it would appear that there is a link between cancer and lifestyle. 
There have been 14 major lifestyle, dietary and environmental risk factors associated 
with cancer: tobacco, alcohol, diet (red meat, fruit and vegetables, salt and fibre), 
obesity, lack of exercise, occupation, infections, radiation (ionising and solar), hormones 
and reproductive history. These factors were responsible for 42.7% of cancers in 2010 
in the UK, with the greatest risk factor being tobacco smoke exposure which was the 
cause of 19.4% of new cancer cases (Parkin et al., 2011). Tobacco smoking causes 
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cancers of the lung, larynx, pharynx, oesophagus, stomach, liver, kidney, pancreas, 
paranasal sinuses, oral cavity, bladder, ureter, cervix, bone marrow, colon, rectum and 
ovary (Ezzati et al.,2005; Gallus et al., 2003; Hannan et al., 2009; Jordan et al., 2006). Of 
the cases of lung cancer in the UK in 2010, 86% were due to exposure to tobacco smoke 
and of these 97.4% were due to smoking (Parkin et al., 2011). Tobacco smoking has been 
linked with atherosclerosis, mutagenesis and cancer of the respiratory tract and lungs. 
More than 60 carcinogens are present in tobacco smoke (Pleasance et al., 2010), 
including polyaromatic hydrocarbons, aromatic amines, aldehydes, catechols and 
butadiene (Arif et al., 2006). It is known that changes to DNA result in the formation of 
cancer. These changes to DNA may be brought about by exposure to sources of oxidative 
stress, which may be endogenous, such as malondialdehyde (MDA) formation, or 
exogenous, such as exposure to tobacco smoke carcinogens. 
Of the 20,000 protein-coding genes of the human genome, ~140 have been identified 
that promote tumorigenesis, primarily tumour suppressor genes and oncogenes. 
Common adult tumours, such as breast and colon, have an average of 33 – 66 genes 
which contain non-synonymous somatic mutations. However, other tumour types, 
including lung and melanoma, where mutagens are involved e.g. tobacco smoke 
constituents and UV light, have these mutations in around 200 genes. Moreover, there 
are up to ten times more non-synonymous somatic mutations in lung carcinomas from 
smokers than from non-smokers. Of the somatic mutations found in tumour cells, only 
a small number (2 – 8) play a major role in tumourigenesis (Vogelstein et al., 2013). 
However, almost every type of human cancer exhibits DNA damage in one specific gene, 
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the tumour suppressor TP53, with mutation rates varying from 10-100% for different 
cancer types (Rivlin et al., 2011).  
Many factors are associated with cancer and the main reasons identified for further 
study of the influence of MDA are: the wide range of lifestyle factors linked to MDA and 
its association with cancer incidence; the need for sensitive and robust methods of 
analysis of DNA adducts resulting from MDA exposure; and to expand the knowledge of 
the mechanisms of cancer initiation. This chapter will consider research to date, 
methods and analysis, the cell lines utilised and specific regions of DNA that were 
studied. 
1.2. Development of Cancer 
Cancer develops progressively from initial abnormal cell growth and proliferation in a 
particular tissue, to invasion of the surrounding tissue and then metastasis. Six acquired 
functional capabilities of cancer cells have been described, as shown in Figure 1 
(Hanahan and Weinberg, 2000). Genome instability resulting from the loss of function 
of tumour suppressor genes and other ‘caretaker’ genes enables pre-malignant cells to 
acquire these six capabilities. Genome instability can arise from a number of factors such 
as DNA damage, replication errors, chromosomal rearrangements and DNA repair 
deficiency. This instability can arise from chemical attack from endogenous and 
exogenous sources. 
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Figure 1. The six acquired functional capabilities of cancer cells (derived from 
Hanahan and Weinberg, 2000). 
The initial stages of cancer are often induced by chemical attack to give DNA adducts, 
and various other types of DNA damage, that may subsequently lead to mutations. The 
accumulation of mutations in a number of key regulatory genes may result in cancer, of 
which endogenous DNA damage, a consequence of normal metabolism, is a significant 
cause. Additionally, exogenous DNA damage from ionising radiation, UV light and 
chemical agents such as those found in tobacco smoke, are also significant contributors 
(Jackson, 2009). The inherent chemical instability of DNA under physiological conditions, 
replication of sites containing DNA adducts and errors in the cellular DNA repair, 
replication and maintenance machinery contribute to DNA mutations (Niedernhofer et 
al., 2003).  
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Genotoxic oxidizing agents, such as reactive oxygen species (ROS) may cause protein 
oxidation, protein degradation and lipid peroxidation. In addition, DNA damage is also 
caused by ROS as DNA strand-breaks, DNA cross-links with proteins and DNA adducts. 
The presence of ROS can directly activate the intrinsic apoptotic pathway of the cell or 
indirectly by ROS-induced DNA damage leading to activation of p53. The extrinsic 
apoptotic pathway can also be activated by ROS by activation of upstream kinases. ROS 
may cause mutagenesis and then alteration of the apoptosis pathway. This may lead to 
carcinogenic cells that are apoptosis resistant (Chen and Shi, 2002). 
1.3. The TP53 Tumour Suppressor Gene  
TP53 was discovered over 30 years ago and is located on chromosome 17p13.1. and has 
11 exons. It has been found to be a major tumour suppressor gene, where mutations in 
the gene can promote tumorigenesis. p53 plays a key role in a number of cellular 
pathways (Figure 2), including the DNA damage repair pathway, apoptosis , cell cycle 
arrest and cellular senescence (Hainaut and Hollstein, 2000). 
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Figure 2. p53 signalling pathways in response to DNA damage. (Adapted from 
SABiosciences.com (2015)). 
The structure was determined of the core domain of p53 tumour suppressor protein 
with a DNA binding site by x-ray crystallography (2.2 Å resolution), which consisted of 
three core domain units (Figure 3) and a 21 base pair (bp) DNA fragment in an 
asymmetric unit. Each of the three core domains are similar in structure with four and 
five β strands sandwiching two antiparallel β sheets. At one end of this sandwich is a 
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loop-sheet-helix motif and two large loops. The two loops are held together by a zinc 
atom with one histidine residue and three cysteine residues acting as ligands. The loop-
sheet-helix motif and one of the large loops are involved in binding to both the major 
and minor grooves of DNA (Cho et al., 1994). 
 
Figure 3. p53 core domain. Image from the RCSB PDB (Wang, 2007) 
Apoptosis and cellular senescence are mechanisms by which p53 acts as a tumour 
suppressor (Levine and Oren, 2009). p53 controls the expression of over 100 genes 
(Nikoshkov and Hurd, 2006). It is induced rapidly to high levels in response to cellular 
stress in order to prevent propagation of DNA damage (Moll and Petrenko, 2003). The 
TP53 gene is expressed constitutively at the basal level in almost all cell types and has a 
rapid turnover. To maintain p53 expression at a basal level, a negative regulator is 
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required. p53 promotes transcription of the Mdm-2 gene, an ubiquitin ligase which 
attaches ubiquitin molecules to p53, labelling it for degradation, thus keeping p53 levels 
low. p53 is induced in response to DNA damaging agents such as oxidizing agents, 
irradiation, carcinogenic and cytotoxic compounds. Damage such as DNA strand breaks 
e.g. by irradiation, or DNA adduct formation by alkylating agents induce p53, as do other 
non-DNA damaging cellular stress factors such as hypothermia and hypoxia (Hainaut and 
Hollstein, 2000). When DNA damage is detected, p53 is phosphorylated which stabilises 
it and allows levels to rise (Dagan Feng and Zaytoon, 2006). p53 has a short half-life of 
5-30 min in normal cells (Moll and Petrenko, 2003), however this can be prolonged due 
to missense mutations in the TP53 gene (Cherneva et al., 2009). Reconstitution of a 
mutant TP53 gene to wild type TP53 in a tumour cell line may lead to growth arrest at 
both G1 and G2/M phases of the cell cycle, thus apoptosis and cellular senescence are 
mechanisms by which p53 acts as a tumour suppressor (Levine and Oren, 2009).  
A number of human genes have been identified that undergo alternative splicing, 
whereby different transcripts are generated by different combinations of exons or 
segments of exons, and has an important role in gene regulation, linking cell signalling 
and splice control. Human p53 alternative splice variants have been identified 
(Nikoshkov and Hurd, 2006), transcription of which are controlled by two promoters, P1 
and P2, the latter is an alternative intragenic promoter (Wei et al., 2012). At least twelve 
different p53 protein isoforms have been identified (including p53 (α, β and γ), Δ40p53 
(α, β and γ), Δ133p53 (α, β and γ) and Δ160p53 (α, β and γ)), a number of which are 
shown in Figure 4, and of which the central DNA-binding domain is conserved (Courtois 
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et al., 2004; Wei et al., 2012). These are produced by alternative splicing, use of 
alternative promoters and alternative initiation and translation of the p53 gene.  
 
Figure 4. TP53 isoforms: exons 1 – 11 and introns 6 and 9 are shown as boxes 
with promoters P1 (for p53 and Δ40p53 initiation of transcription) and P2 (for Δ 133p53 
initiation of transcription) and alternative start codons (ATG) for translation start sites. 
No splicing of intron 2 occurs in Δ40p53 transcripts. TP53 α transcripts have normal 
splicing of exons with intron 9 fully spliced. TP53 β and γ transcripts have alternative 
splicing of intron 9. (Adapted from Wei et al (2012)). 
The different isoforms differentially regulate gene expression in response to cellular 
stresses and are important for regulation of cell fate (Surget et al., 2014). Alterations of 
some p53 isoforms have been associated with cancer, for example, p53β overexpression 
has been found in renal cell carcinoma, melanoma cell lines, and associated with tumour 
progression, whereas reduced expression has been found in breast cancer (Hu et al., 
2014). p53 isoforms have been found to have abnormal expression in cancers, including 
colon, ovarian and lung (Surget et al., 2014). 
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1.4. Apoptosis 
The cell number in multicellular organisms and tissues is highly regulated, maintaining 
the balance between cell division and programmed cell death (apoptosis). The apoptotic 
pathway involves the caspase family of proteases which cleave specific proteins, at 
aspartic acid residues, in the nucleus and cytoplasm. Procaspases, the inactive 
precursors of caspases, are activated by cleavage by other caspases, resulting in a 
proteolytic caspase cascade. The cascade is activated by an intra or extracellular death 
signal and is self-amplifying and irreversible. Adaptor proteins aggregate procaspases. 
An external activation signal is the Fas ligand on the surface of killer lymphocytes which 
binds to a Fas receptor on the cell surface, recruiting adaptor proteins and initiating a 
caspase cascade. An internal signal is the release of cytochrome c from mitochondria 
into the cytosol which binds and activates the adaptor protein Apaf-1 (Alberts et al., 
2002). Damage to DNA may activate the apoptotic signalling pathway (Ji et al., 1998), 
requiring p53 to transcribe Bcl-2 genes, initiating the release of cytochrome c into the 
cytosol. The Bcl-2 gene family regulates procaspase activation, some of which inhibit 
apoptosis and others promote procaspase activation. The IAP (inhibitor of apoptosis) 
gene family act by binding to either procaspases, preventing activation, or to caspases, 
to inhibit activity.   
Mdm-2 is a p53 negative regulator. DNA damage leads to a rapid increase in p53 due to 
inactivation of Mdm-2/p53 interaction. p53 activation leads to reversible cell cycle 
arrest and induction of DNA repair mechanisms to apoptosis or senescence (loss of 
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proliferative capacity). p53 transactivates genes that induce apoptosis e.g. Fas and Bax 
and genes that induce cell cycle arrest e.g. CDKN1A (Enge et al., 2009). 
Apoptotic pathway defects can contribute to a number of diseases such as cancer. For 
example, overexpression of Bcl-2, upregulation of Bcl-xL, inactivation of Bax, and 
mutations in upstream and downstream components of the p53 pathway e.g. Mdm-2, 
ARF and Bax may all lead to tumorigenesis (Lowe and Lin, 2000). 
1.5. Reactive Oxygen Species 
ROS are species such as superoxide (O2-), hydrogen peroxide (H2O2), hypochlorous acid 
(HClO), hydroxyl (•OH), hydroperoxyl (HO2•), alkoxyl (RO•) and peroxyl radicals (ROO•). 
The •OH free radical is a highly reactive oxidant and can attack most biomolecules 
(Gutteridge, 1995).  
Molecular oxygen is reduced when utilised for aerobic oxidation of carbon and hydrogen 
rich foods to produce heat and energy for life (Scheme 1). Two of the intermediates 
formed by reduction of oxygen are free radicals plus H2O2, which readily mixes with 
water and diffuses rapidly across cell membranes. It can form highly reactive free 
radicals in the presence of the transition metal ions. Catalase and glutathione peroxidise 
remove unwanted H2O2 from the cells (Gutteridge, 1995). 
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O2 + e- + H+  HO2•  (1) 
 HO2•  H+ + O2-  (2) 
O2- + 2H+ + e-   H2O2  (3) 
H2O2 + e-   OH- + •OH (4) 
•OH + e- + H+  H2O  (5) 
Superoxide dismutase catalyses: 
2O2- + 2H+  H2O2 + O2 (6)  
Scheme 1. The reduction of molecular oxygen by the stepwise addition of free 
electrons (equations 1-5). The enzyme superoxide dismutase catalyses the 
dismutation reaction of free radical superoxide in aqueous solution to hydrogen 
peroxide and oxygen (equation 6). (Adapted from Gutteridge (1995)). 
The Fenton reaction describes the reaction between iron salts (Fe2+ and Fe3+) and H2O2. 
The hydroxyl radicals produced go on to react with other molecules (Scheme 2) (Ayala 
et al., 2014).  
Fe2+ + H2O2  Fe3+ + OH- + •OH 
Fe3+ + H2O2  Fe2+ + HO2• + H+ 
 
Scheme 2. The Fenton reaction (adapted from Gutteridge (1995)). 
In addition to ROS, there are reactive nitrogen species (RNS). NO• (nitric oxide) is a weak 
reducing agent and NO2• (nitrogen dioxide) is a powerful oxidising agent. NO• can react 
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with superoxide to produce peroxynitrite (ONOO-) which is a powerful oxidant 
(Gutteridge, 1995). Hence, there is a vast source of radicals within the body.  
1.6. Oxidative Stress 
Oxidative DNA damage has been associated with the pathogenesis of a number of 
different diseases, including cancer and aging. Oxidative stress is the result of a cellular 
imbalance in antioxidants and pro-oxidants, where free radicals are produced in excess 
of normal cellular metabolic levels following xenobiotic exposure or radiation. Free 
radicals, such as ROS and RNS, interact and modify biomolecules (Cooke et al., 2008). A 
free radical is an atom, molecule or ion that contains one or more unpaired valence 
electrons (Gutteridge, 1995). Polyphenolic compounds such as flavinoids, isoflavinoids, 
anthocyanins and catechins, along with other compounds such as carotenoids and 
vitamins A, C and E, are found in fruits and vegetables and a diet rich in these has been 
associated with reduced cancer risk. It has been proposed that these compounds act as 
antioxidants and thereby reduce oxidative damage and thus cancer risk (Hwang and 
Bowen, 2007). There is a link between chronic inflammation and the aetiology of cancer. 
Reactive oxidants, derived from superoxide anions and nitric oxide, are generated by 
the inflammatory response (Marnett, 2012). 
DNA damage can be formed endogenously such as DNA adduct formation produced by 
metabolic activation of a carcinogen, or exogenously such as DNA strand breaks and 
oxygen-nitrogen adducts produced by direct attack by ROS and RNS. Point mutations 
resulting from oxidative stress may lead to carcinogenesis, particularly when the DNA 
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damage involves the activation of oncogenes or the loss of tumour suppressor genes. 
Damage to the sugars in DNA can also occur in addition to modification of the nucleic 
acid bases. The action of the enzymes DNA ligase and DNA polymerase can be blocked 
by deoxyribose fragments (Hwang and Bowen, 2007).  
Endogenous sources of oxidative stress include immune reactions, transition metal 
mediated oxidation, the mitochondrial respiratory chain and enzymatic reactions. 
Exogenous sources include chemicals and toxins such as tobacco smoke, ionizing and 
non-ionising radiation and air pollution. Tobacco smoke contains a large number of gas 
(1015) and tar (1014) phase oxidants, including free radicals in a single puff (Pryor and 
Stone, 1993). 
1.7. Malondialdehyde  
MDA (Scheme 3) is an example of an endogenous source of oxidative stress, as it is a 
product of lipid peroxidation. It has been detected a low levels in biological samples 
from healthy individuals (0 – 47.2 μM) and at increased levels in samples subjected to 
oxidative stress (Esterbauer et al., 1991; Nielsen et al., 1997; Tug et al., 2005). The 
numerous reactive chemicals in the tar and smoke from tobacco cause oxidative stress 
and lipid peroxidation, leading to an increase in MDA formation (Atasayar et al., 2004). 
It has also been found that there was an increase in plasma MDA in individuals who 
smoked tobacco (Montano et al., 2010). 
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Scheme 3. Tautomer β-hydroxyacrolein (in trans form) in equilibrium with MDA 
(adapted from Esterbauer et al. (1991)). 
MDA exists in both its free state and also in complex with other biomolecules bound via 
SH and NH2 groups (Cighetti et al., 2002). Despite MDA having a low reactivity when 
present as an enolate ion at neutral pH, it can still react with nucleosides. MDA has been 
shown to induce frame shift mutations and base pair substitutions, in addition to 
formation of interstrand cross links in DNA. DNA-protein cross-links between DNA and 
histone proteins have also been reportedly mediated by MDA (del Rio et al., 2005). MDA 
adducts with proteins and phospholipids have been identified (Agarwal and Draper, 
1992). MDA reacts with bovine serum albumin (Takagi et al., 2005), a key component in 
cell culture media, to form a protein adduct (He et al., 2011). Adduction to proteins may 
result in denaturation due to alterations in the secondary and tertiary structure. MDA 
inhibited contraction of collagen in fibroblast cells when treated in vitro, and inhibited 
cell proliferation by interaction with serum proteins (Rittie et al., 2002). Protein adducts 
can be formed by exposure of amine groups to MDA and monofunctional aldehydes, 
which are found in tobacco smoke (Freeman et al., 2005). 
MDA is hygroscopic when in the crystallised sodium salt form and only has a short 
storage time. In solution, at neutral and alkaline pH, the enolate anion is predominant. 
In acidic conditions (pH <4.5), MDA exists as the tautomeric undissociated enol form as 
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β-hydroxyacrolein (Scheme 3) in equilibrium with the dicarbonyl form. The C=C double 
bond is mainly cis and the cyclic chelate form is favoured due to intramolecular H bonds, 
although two cis-enols can form a dimeric complex (Esterbauer et al., 1991). At 
physiological pH MDA exists as an enolate ion and has relatively low reactivity, with 
reactivity increasing as pH decreases. MDA is electrophilic and is strongly reactive 
towards nucleophiles, such as the basic amino acids histidine, arginine and lysine (Ayala 
et al., 2014). MDA slowly condenses in aqueous solution under physiological conditions 
to form polymeric products 2-(3’-oxo-1’-propenyl)malondialdehyde and 2,4-
dihydroxymethylene-3-(2,2-dimethoxyethyl)glutaraldehyde (Gomez-Sanchez et al., 
1993), however, although they are mutagenic, their formation is thermodynamically 
unfavourable under these conditions (Riggins et al., 2004). 
1.8. Formation of Malondialdehyde 
MDA, widely used as a biomarker of oxidative stress, is the most abundant mutagenic 
and carcinogenic compound generated by lipid peroxiation, reacting with 
deoxynucleosides to produce DNA adducts (Chaudhary et al., 1994). Of the biomolecular 
targets for oxidative stress, lipids are the more abundant and result in a number of 
secondary metabolites, primarily aldehydes, which can interact with biomolecules to 
exacerbate the oxidative damage. Two main hypotheses have been described regarding 
the formation of MDA in vivo: a radical based scheme whereby polyunsaturated fatty 
acids (PUFAs) form carbon-centred radicals on reaction with oxidising agents and 
peroxyl radicals are formed when the carbon-centred radicals react with O2 (Scheme 4) 
(Marnett, 1999). 
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Scheme 4. Schematic of the pathways of lipid peroxidation (adapted from Marnett 
(1999)). 
If the peroxyl radical is at one end of the fatty acid carbon chain, relatively stable 
hydroperoxides are formed. Initiation of a radical chain reaction can occur if the 
molecule that reduces the peroxyl radical to a hydroperoxide is another fatty acid e.g. 
in phospholipid membranes. A cyclic peroxide is produced if the peroxyl radical is within 
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the fatty acid carbon chain, this can either form a peroxyl radical in the presence of O2 
and be reduced to a hydroperoxide, or it can form a bicyclic peroxide after a second 
cyclisation event. In the presence of O2, the bicyclic peroxide is reduced to form an 
intermediate compound for the production of MDA and isoprostanes. An alternative 
method is shown in Scheme 5 and involves the formation of successive hydroperoxides 
and β cleavage of the fatty acid chain (Esterbauer et al., 1991). MDA is subsequently 
produced by β scission of the hydroperoxyaldehyde or by a hydroxyl radical reacting 
with the final acrolein radical (del Rio et al., 2005). Other pathways of MDA formation 
have also been proposed that are less well understood, such as generation by 
prostaglandin biosynthesis (Marnett, 2002) and non-enzymatic pathways (Onyango and 
Baba, 2010). Overall, this shows that the mechanisms are not fully understood.  However, 
it is known that MDA is present in the human body in variable amounts depending upon 
a number of factors. Moreover, it reacts with cellular components to cause damage that 
leads to long-term effects, including cancer. 
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Scheme 5. Two pathways for the peroxidation of PUFAs and the formation of MDA 
(adapted from Esterbauer et al. (1991)). 
1.9. Formation and Repair of the M1dG Adduct 
Endogenous and exogenous DNA adducts have been implicated in cancer (Chaudhary et 
al., 1994). Damage to DNA by genotoxic oxidizing agents can be mutational, i.e. 
sequence changes/insertions/deletions, or non-mutational, e.g. telomere shortening. 
Direct interaction of ROS with DNA bases can lead to DNA adduct formation and DNA 
modification, as can the interaction of ROS with proteins and lipids forming DNA reactive 
intermediates e.g. by lipid peroxidation. An example of a DNA adduct formed by direct 
MDA 
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modification of a base is 8-oxo-7,8-dihydro-2’-deoxyguanosine (8-oxo-dG), whereas 
those produced by a DNA reactive electrophilic intermediate include 1,N6-etheno-2’-
deoxyadenosine (N6EtA) and 3-(2-deoxy-β-D-erythro-pentofuranosyl)pyrimidol[1,2-
α]purin-10(3H)-one (M1dG) (Cooke et al., 2008).  
 
MDA reacts with nucleic acid bases e.g. deoxyguanosine to form pyrimidopurinone DNA 
adducts, of which M1dG is the most abundant, with levels detected in rat liver in the 
region of 5000 adducts per cell (Marnett, 1999). M1dG has been linked to a high fat diet 
(Moore et al., 2008) and to smoking (Lykkesfeldt et al., 2004). Elevated levels of M1dG 
were associated with a diet high in meat (Lewin et al., 2006), alcohol and saturated fatty 
acids, whereas reduced levels were associated with a diet rich in fruit, vegetables,  
wholegrains and PUFAs (Leuratti et al., 2002). A decrease in urinary and plasma MDA 
was observed following consumption of polyphenol-rich spices, compared with a 
negative control, suggesting possible health benefits (Li et al., 2010). Although, no 
association, or inverse association, was found between intake of fruits, vegetables, 
carotenoids and vitamins and bladder cancer incidence in tobacco smokers (Michaud et 
al., 2002). Bronchial mucosa levels of MDA-DNA adducts, including M1dG, were found 
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to be higher in smokers than non-smokers, and adduct levels were increased in lung 
cancer cases, but only for smokers (Munnia et al., 2006).  
 
Scheme 6. Formation of DNA adduct M1dG from MDA and deoxyguanosine 
(adapted from Marnett (1999)). 
Research has suggested that  the main source of M1dG formation was by reaction of 
MDA from lipid peroxidation with DNA (Scheme 6) (Lykkesfeldt et al., 2004). Although, 
other research has suggested that an alternative route of M1dG formation is via reaction 
of base propenals with DNA (Sharma and Farmer, 2004; Zhou et al., 2005). Base 
propenals e.g. adenine-N1-propenal are some of the products of direct oxidative DNA 
damage, for example from attack by hydroxyl radicals, and are structural analogues of 
MDA (Dedon et al., 1998) (Scheme 7). It has been demonstrated that adenine propenal 
had a higher reactivity with DNA than MDA with regards to the formation of M1dG 
adducts, by treatment of DNA with both compounds directly and also with two oxidising 
agents known to produce base propenals (Dedon et al., 1998). It was suggested that 
base propenals are a biologically important source of M1dG adducts, perhaps due to 
their proximity to DNA i.e. generated in the DNA, whereas MDA is generated by lipid 
peroxidation and must migrate to the DNA. However, plasma MDA levels are 
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significantly elevated in subjects exposed to oxidative stress, such as smoking, and M1dG 
adduct levels were also increased in smokers with and without lung cancer, which 
suggests that M1dG adduct formation via reaction of MDA with DNA is a biologically 
relevant pathway particularly in smokers (Lykkesfeldt et al., 2004; Munnia et al., 2006; 
Montano et al., 2010).  
 
Scheme 7. Mechanism for the formation of M1dG adduct from reaction of 
deoxyguanosine with adenine-N1-propenal (adapted from Dedon et al. (1998)). 
In basic solution, M1dG is subject to hydrolytic ring-opening (Scheme 8) by addition of a 
hydroxide ion to C8 of the exocyclic ring, breaking the C8-C9 bond (Knutson and Marnett, 
2010). At physiological pH, the ring-closed M1dG is the major form present (Mao et al., 
1999). Ring closure is biphasic, N2-(3-oxo-1-propenyl)-deoxyguanosine (N2OPdG) is 
protonated to 8-hydroxy-6,7-propeno-deoxyguanosine followed by acid catalysis to 
M1dG (Riggins et al., 2004). The ring closed form is five times more mutagenic than the 
ring open form, although this is difficult to determine in vivo as the two forms exist in 
equilibrium (Fink et al., 1997). 
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Scheme 8. M1dG exists in equilibrium with its ring-open form, N2-(3-oxo-1-
propenyl)-deoxyguanosine (adapted from VanderVeen et al. (2003)). 
The M1dG adduct is a substrate of nucleotide excision repair (NER) pathway (Marnett, 
1999) and has been found to metabolise to 6-oxo-M1dG  for excretion in urine (Ottender 
et al., 2006), although some M1dG is also excreted in urine (Hoberg et al., 2004). Further 
oxidation of 6-oxo-M1dG to 2,6-oxo-M1dG has also been shown to occur in rat liver 
extracts (Knutson et al., 2007). When M1dG was injected into rodents, the metabolite 6-
oxo-M1dG, produced by oxidation of M1dG, was also excreted in faeces (Ottender et al., 
2006; Knutson et al., 2007). M1dG and 6-oxo-M1dG, from rat urine and faeces samples, 
were quantified by immunoaffinity chromatography and liquid chromatography-mass 
spectrometry (LC-MS) and only 6-oxo-M1dG was detected (Akingbade et al., 2012). 
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1.10.  Analytical Methods Applied to Detection of 
Malondialdehyde and the M1dG Adduct  
1.10.1.  Lipid Peroxidation by TBARS 
The traditional measurement of lipid peroxidation is measurement of MDA by the 
thiobarbituric acid reactive substances (TBARS) assay. MDA reacts with thiobarbituric 
acid (TBA) by condensation at low pH and increased temperature by nucleophilic 
addition to produce a red coloured product which can easily be assessed by 
spectrophotometry (Janero, 1990), as shown in Scheme 9. The red MDA-TBA product is 
formed by a 2:1 reaction of TBA with MDA and quantified by UV-vis spectrophotometry 
at 532 nm (Badcock et al., 1997). 
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Scheme 9. Reaction of 2-thiobarbituric acid with MDA to produce a fluorescent red 
chromophore with absorbance maxima 532 nm (adapted from Atasayar et al. (2004)). 
The TBARS assay has often been criticised for overestimation of MDA content due to 
reaction of TBA with other, non-MDA, exogenous and endogenous compounds found in 
biological specimens such as bile pigments, some proteins and carbohydrates and other 
aldehydes such as hexanal (Oates and Van der Kraak, 2003). Additionally, the 
temperature required for derivatisation of MDA by TBA is high and may cause 
artefactual reactions (Atasayar et al., 2004) by the decomposition of lipid peroxides 
(Seljeskog et al., 2006). However, the assay is simple, rapid and reliable.  
1.10.2.  Methods of M1dG DNA Adduct Detection 
Assessment of lipid peroxidation induced DNA damage needs to be both sensitive and 
specific. DNA damage derived from endogenous processes can occur at detectable levels 
in human DNA, including M1dG adducts. A number of methods can be used for the 
detection and analysis of the M1dG DNA adduct. 
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1.10.2.1. Immunoslot Blot Assay 
The immunoslot blot (ISB) assay can be used to detect and quantify DNA adducts with 
the use of antibodies. The assay involves fragmentation and denaturation of the DNA 
sample, followed by immobilisation of the DNA on nitrocellulose. The membrane is then 
incubated with a primary adduct-specific antibody followed by a secondary antibody 
with an attached enzyme e.g. horseradish peroxidase, and detection and quantification 
of the DNA adduct by chemiluminescence (Leuratti et al., 1998).  
Several groups have used an ISB assay to assess lifestyle effects on M1dG levels. Mean 
levels of M1dG were found to be 4.3 ± 3 per 107 bases in men and 4.6 ± 2.9 per 107 bases 
in women, using only 1 µg colorectal DNA, with an inverse association of M1dG adduct 
levels with fruit and vegetable intake and a positive association with meat and alcohol 
intake (Leuratti et al., 2002). Higher levels of M1dG adducts were found in human oral 
mucosa DNA from smokers versus non-smokers, analysed by ISB (Zhang et al., 2002). 
Mice infected with Helicobacter hepaticus were found to have increased levels of M1dG 
adduct (40.7 – 52.5 per 108 nucleotides) in their liver DNA compared to the control group 
(30.1 – 37.5 per 108 nuceotides), analysed by ISB using 1 µg DNA (Singh et al., 2001).  
ISB is one of the most sensitive assays for M1dG adduct detection, requiring 1-200 µg 
DNA, to measure adducts in very small sample volumes, however, antibodies are 
required, one of which exists for M1dG (Leuratti et al., 1998). It has good relative 
selectivity with an antibody raised against a specific DNA adduct, although there is a risk 
of cross-reactivity with similar-structured DNA adducts. The technique is robust, easy to 
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perform and has a higher sample throughput than 32P-postlabelling (Phillips et al., 2000; 
Himmelstein et al., 2009). 
1.10.2.2. 32P-postlabelling 
32P-postlabelling involves four steps: DNA digestion using enzymes; purification of the 
adduct by solid phase extraction (SPE), immunoaffinity or high performance liquid 
chromatography (HPLC); labelling of adduct with 32P; and chromatographic separation 
by thin layer chromatography (TLC) or HPLC followed by detection of 32P decay (Phillips 
et al., 2000).  
M1dG has been found in healthy human tissues by  32P-postlabelling followed by reverse 
phase HPLC: 3.0 ± 1.3 adducts/107 nucleotides in breast tissue and 2.6 ± 1.2 adducts/107 
nucleotides in white blood cells were detected and required 10 µg DNA (Vaca et al., 
1995). The effect of formaldehyde exposure on M1dG adduct levels in human leukocyte 
DNA was analysed by 32P-postlabelling, requiring only 1-2 µg DNA. A significant increase 
was found in pathology workers exposed to air formaldehyde (5.7 ± 1.3 M1dG adducts 
per 108 nucletides) versus the negative control group (2.4 ± 0.3 M1dG adducts per 108 
nucleotides)(Bono et al., 2010). The levels of M1dG adducts in workers and nearby 
residents, who had been exposed to air pollution from a Thai petrochemical industrial 
estate, were measured by 32P-postlabelling, again using only 1-2 µg leukocyte DNA. A 
significant increase was found in workers (6.0 ± 0.5 M1dG adducts per 108 nucletides) 
compared to nearby residents (3.7 ± 0.4 M1dG adducts per 108 nucletides) who had 
significantly higher levels than a negative control group (2.9 ± 0.4 M1dG adducts per 108 
nucleotides) (Peluso et al., 2010). 
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32P-postlabelling is a sensitive method of DNA adduct detection, requiring only 1-10 µg 
DNA, and can be used to detect a wide range of adducts, although the method is more 
sensitive for aromatic adducts (1-100 in 109 nucleotides) than non-aromatic adducts (1 
in 105 to 106 nucleotides) (Phillips et al., 2000). However, the major drawback of this 
technique is that it requires the use of a radioactive substance. It also has limited 
specificity, low sample throughput compared to ISB and often adduct standards are 
required (Himmelstein et al., 2009). 
1.10.2.3. HPLC with Fluorescence Detection  
HPLC is a separation method whereby a mixture is pumped under pressure through a 
column packed with a solid adsorbant phase. Different detectors can be coupled to the 
HPLC for detection and analysis of the fractions eluting from the column.  
Reverse-phase HPLC with fluorescence detection (FLD) was used to identify the 
presence of M1dG adducts in hydrolysed DNA, using synthetic M1dG as an internal 
standard, however, the peaks for the sample and synthetic M1dG could not be separated 
(Agarwal and Draper, 1992). Increased benzo[α]pyrene diolepoxide (BPDE)-DNA levels 
were detected by HPLC-FLD in DNA from human subjects exposed to high levels of 
polycyclic aromatic hydrocarbons (PAHs), including benzo[α]pyrene (Pavanello et al., 
1999).  
HPLC-FLD is a simple, inexpensive, robust technique, requiring a moderate amount of 
sample (20-100 µg DNA), however, it can only be used for detection of fluorescent 
adducts and is unlikely to detect adducts at biological levels (Himmelstein et al., 2009). 
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1.10.2.4. Detection of M1dG Adducts by Mass Spectrometry  
DNA adducts may also be detected by mass spectrometry (MS). The basic principle of 
MS involves sample ionisation by electron bombardment, ion separation, according to 
the mass/charge ratio (m/z), by acceleration and deflection using an electric or magnetic 
field and the detection of ions by e.g. electron multiplier detection.  Two or more mass 
spectrometers may be coupled for tandem MS (MS-MS), whereby the ion of interest is 
further fragmented into daughter ion fragments (de Hoffmann and Stroobant, 2007). 
The presence of M1dG in human liver cells was investigated by derivatising cellular M1dG 
with pentafluorobenzyl (PFB) and analysing with gas chromatography-electron capture 
negative chemical ionisation mass spectrometry. The cellular M1dG was quantified by 
using selective ion monitoring relative to a dideuterated M1dG-PFB internal standard. 
The average value of M1dG adducts was 9 per 107 bases, i.e. 5400 per cell but required 
a large amount (9.3 mg) of DNA (Chaudhary et al., 1994).  
M1dG is repaired by the NER pathway and can be detected in urine. The levels of free 
M1dG in the urine would be a useful biomarker for lipid peroxidation and MDA exposure 
in vivo that may be implicated in cancer associated with lifestyle and diet (Marnett, 
2002). Human urinary M1dG was measured using immune-extraction purification using 
an M1dG antibody, followed by chemical reduction with sodium borohydride and liquid 
chromatography- atmospheric pressure chemical ionisation tandem mass spectrometry 
(LC-APCI-MS-MS). [13C,15N2]-M1dG was used as an internal standard and attomole 
sensitivity was achieved. The average excretion rate, in 25 µl aliquots urine, over 24 
hours, of M1dG was found to be 12 ± 3.8 fmol kg-1 total body weight (Hoberg et al., 2004). 
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M1dG was quantified in urine and faeces to evaluate DNA damage by LC-MS analysis at 
levels of approximately 12 fmol/kg/day (Marnett, 2012). The 5,6-dihydro derivative of 
M1dG was analysed by LC-nanospray ionization (NSI)-high resolution tandem MS (HRMS-
MS) using 200 µg DNA. Levels of M1dG were detected in human leukocyte DNA at 0.132 
– 275 fmol/mg DNA or 0.004 – 9.15 adducts per 108 nucleotides, with smokers having 
slightly higher, although not significantly higher, levels than non-smokers (Ma et al., 
2015).  
LC-MS and LC-MS-MS methods of DNA adduct detection have high chemical specificity, 
giving detailed structural information, particularly tandem MS methods. They have a 
high level of accuracy, particularly in multiple reaction monitoring (MRM) or single ion 
monitoring (SIM) modes and have high sample throughput depending on the 
instrumentation. Moreover, they do not require the use of antibodies or radioactive 
substances. However, they require expensive, specialised equipment, which are not 
always available in the standard laboratory, they often require the use of internal 
standards and they require larger sample amounts than ISB or 32P-postlabelling (10-
100 µg DNA) (Phillips et al., 2000; Himmelstein et al., 2009). 
Thus, a number of methods exist for the measurement of M1dG, however, some require 
the use of tissues which can be invasive and not suitable for bio-monitoring. These 
techniques also show overall damage rather than specific damage at sites relevant to 
cancer. 
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1.10.3.  Cell Proliferation and Viability Assays 
Cell proliferation and cell viability are useful measurements for the susceptibility of a 
cell culture to external conditions. In vitro assays can be used as models for in vivo cell 
populations and their reactions to, for example, therapeutic or cytotoxic agents. There 
are a range of techniques that measure cell proliferation and viability. Cell proliferation 
is important in multi-cellular organisms and failure of regulation of normal cell turnover 
is characteristic of a number of diseases such as cancer and AIDS. Cell proliferation is a 
measure of the actively dividing cells in a sample (Evan and Vousden, 2001; Macallan et 
al., 1998).  
DNA labelling with stable isotope-labelled glucose was used to measure DNA synthesis 
and thus cell proliferation (as this is relatively specific for cell division). [6.6-2H2]-labelled 
glucose was administered to rats in vivo and after a set time genomic DNA was extracted 
from isolated intestinal epithelial cells, hydrolysed to deoxyribonucleosides, of which 
trimethylsilyl derivatives were synthesized and analysed using gas chromatography-MS 
(GC-MS). The relative abundance of the isotope in DNA is a measure of the rate of DNA 
replication i.e. cell proliferation. This method has advantages over the similar tritiated 
thymidine method as it does not use radioisotopes and can therefore be carried out in 
vivo in humans. An indirect measure of cell proliferation is to quantify molecules that 
regulate the cell cycle. This can be done directly using Western Blots or enzyme linked 
immunosorbent assay (ELISA), or by measuring their activity e.g. cyclin-dependent 
kinase assay (Macallan et al., 1998). 
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Cell viability is a measure of the number of living cells, although it does not distinguish 
between those actively dividing and the quiescent which cell proliferation does 
distinguish. The 3-[4,5 dimethylthiazol-2yl]-2,5-diphenyl-tetrazolium bromide (MTT) 
assay measures the metabolic activity of the cell population, where viable cells 
metabolise MTT to a coloured formazan product, which can be quantified by UV-vis 
spectrophotometry (VanMeerloo et al., 2011).  
There is a second type of cell viability assay, the dye-exclusion assay. This involves the 
exclusion of a dye from a healthy cell due to maintenance of the integrity of the cell 
membrane thus staining only dead, non-viable cells. Trypan blue is one such dye that 
can be utilised to ascertain cell viability. Cells in late apoptosis and early necrosis exhibit 
a loss of membrane integrity and are able to take up trypan dye and stain the cell blue. 
In contrast, cells with intact membranes exclude trypan blue. Cells with intact and 
disrupted membranes can therefore be distinguished, although cells in early apoptosis 
will still have an intact membrane and also exclude trypan blue (Siddique et al., 2009). 
The trypan blue assay was compared with an assay using acridine orange and propidium 
iodide fluorescent dyes, which stain both viable and non-viable cells. The acridine 
orange and propidium iodide assay were found to have more readability and stability 
than the trypan blue assay (Mascotti et al., 2000). 
An assay used for the assessment of chromosome breakage and loss is the micronucleus 
assay. Chromosomal loss or non-disjunction are events associated with aging and cancer, 
due to spindle or centromere defects. Dividing cells containing chromosomal breaks and 
chromosomes that are unable to travel to the spindle poles during mitosis, often express 
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micronuclei which are much smaller than the main nucleus. The micronucleus assay is a 
method of staining and scoring these micronuclei to assess the level of DNA damage. 
Fluorescent stains such as 4’,6-diamidino-2-phenylindole (DAPI) can be used (Fenech, 
2000). Micronuclei can be used as biomarkers of cancer risk for which a non-invasive 
method using exfoliated epithelial cells can be used (Nersesyan et al., 2006). 
1.11.  MRC5 and MRC5 SV2 Lung Fibroblast Cells  
Human and other mammalian cell lines are used in in vitro studies to determine the 
genotoxic and carcinogenic effects of various compounds, for example, to study 
formation of M1dG adducts in response to MDA levels (Sapkota et al., 2014). Fibroblast 
cells are commonly used for in vitro cell culture as they are relatively easy to maintain 
over time. 
Stromal tissue, comprised of mesenchymal cells and extra cellular matrix (ECM), is one 
of the fundamental features of vertebrates and is required to provide the connective, 
structural support for the functional parenchymal cells of an organ. Fibroblasts are the 
principal cells of the stroma and synthesise the majority of ECM in connective tissue and 
also are involved in wound healing (Tug et al., 2005). Fibroblasts are identified by their 
spindle-shaped morphology and, although they are one of the more accessible and 
amenable mammalian cell types for in vitro tissue culture (adhere readily to plastic), 
they are poorly defined in terms of molecular expression in different tissue types (Chang 
et al., 2002). Fibroblasts from different tissue types were characterised from their 
transcriptional patterns and it was found that fibroblasts from each site had distinct and 
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characteristic gene expression profiles and should be considered as separate, functional 
cell types (Chang et al., 2002). Thus, tissue-specific fibroblast cell lines should be used 
for in vitro cytotoxicity studies, for example lung fibroblasts would be used to assess the 
effects of tobacco smoking on the lungs. MRC5 cells are an example of a human lung 
fibroblast cell line. 
MRC5 SV2 cells are a transformed version of the MRC5 human lung fibroblast cell line 
(Huschtscha and Holliday, 1983). MRC5 SV2 cells have a sequestered p53 protein, 
resulting from the transfection of MRC5 cells with simian virus SV40 and are thus 
immortalised (Zhu and Gooderham, 2002). MRC5 cells were transformed with the SV40 
virus to give the MRC5 SV2 cell line, whereby the viral DNA was integrated into the cell 
DNA at a random integration site. The viral large T-antigen gene is expressed in 
transformed cells and this complexes with the p53 protein, an interaction which blocks 
p53 dependent gene expression by preventing association with target promoters. This 
T-antigen binding also stabilises the p53 protein, allowing accumulation in cells (Pipas, 
2009). 
Non-transformed human lung fibroblasts, when cultured in vitro, have a limited lifespan. 
In contrast, MRC5 SV2 does not senesce, and following 5 years of continuous sub-culture 
(passage 650) growth did not slow down, suggesting this cell line has the potential for 
infinite growth. Additionally, MRC5 SV2 does not exhibit contact inhibition, continuing 
to grow in confluent culture. Further properties of this cell line include an epithelial 
morphology, no tumorigenicity, and the ability to grow in methionine-free media, like 
non-transformed MRC5 cells, whereas other transformed cell lines require methionine 
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for growth (Huschtscha and Holliday, 1983). It was found that MRC5 SV2 cells are able 
to produce infectious SV40 viral progeny with the ability to infect both simian and 
human cells, a concern as SV40 is an oncogenic virus and MRC5 SV2 cells are widely used 
in research laboratories (Morelli et al., 2004). 
Previous studies have used MRC5 SV2 cells to study the effects of benzo(α)pyrene (Zhu 
and Gooderham, 2002) and MRC5 cells to study the effects of H2O2 (Caldini et al., 1998). 
Thus these cells may be useful in determining the effects of MDA in lung cells. 
1.12.  Imaging Techniques 
The cytotoxic effects of various compounds on the cellular morphology and subcellular 
structure may be examined by microscopy, of which there are numerous types. The light 
microscope (LM) has a maximum resolving power of 200 nm, limited by the wavelength 
of illumination. Larger subcellular structures, such as the nucleus, can be visualized, 
whereas, smaller features within the cell or on the cellular surface, such as the 
cytoskeletal filaments and microvilli cannot be visualized. Sample preparation is simple 
and low cost. Live cells can be viewed in situ using the inverted LM (Lodish et al., 2000). 
Cell shrinkage and pyknosis have been observed under the LM, as an indicator of the 
early stages of apoptosis, which is often a consequence of treatment with cytotoxic 
compounds (Elmore, 2007). Hence, the LM is a useful tool for preliminary identification 
of cytotoxicity. 
Additional features, such as fluorescence, may be used in conjunction with microscopy, 
such as epiflourescence microscopy or with the more complex confocal microscope. The 
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specimen is illuminated with light of a specific wavelength which is absorbed by 
fluorophores, causing them to emit light of longer wavelengths. The excitation light is 
separated from the emitted fluorescence using an emission filter. Fluorescence 
microscopy has numerous applications, such as immunofluorescence, whereby 
antibodies labelled with fluorescent dyes bind to target molecules enabling their 
detection by fluorescence microscopy (Lodish et al., 2000). Unless molecules 
autofluoresce, they must be labelled with a fluorescent dye and either fixed or living 
cells can be imaged, for example, overexpression of p53 in a number of sinonasal 
squamous cell carcinoma cell lines was observed using immunofluorescence with a 
fluorescently labelled anti-p53 antibody (García-Inclán et al., 2014). However, 
fluorescence fades over time, photobleaching may occur and fixatives may cause 
artefact formation. The confocal microscope is typically used with fluorescence. It has 
better resolution than regular fluorescence as it uses point illumination, so little 
photobleaching occurs, and allows 3-D reconstruction of whole, or parts of a specimen 
(Wilson and Bacic, 2012; Watkins and St Croix, 2013).  
Cell surface morphology has historically been examined by electron microscopy (EM), 
which has the capacity to give detailed images of the cell surface e.g. membrane 
blebbing during apoptosis (Elmore, 2007). However, EM is very expensive and sample 
preparation is lengthy and fixation and coating procedures may cause artefact formation 
(Goodhew et al., 2001; Wilson and Bacic, 2012). The atomic force microscope (AFM) is 
advantageous over EM techniques, as sample preparation is minimal. The AFM allows 
3-D images of the surface topography of biological samples in liquid or gas over a large 
temperature range (Binnig et al., 1986). The high resolution attained by AFM allows 
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imaging of biological molecules e.g. DNA and proteins and small ligands in the absence 
of stains, shadows and labels (Lyubchenko, 2011), allowing structure and function of 
biological samples to be maintained (Billingsley et al., 2012). For example, altered 
cellular shape and morphology was observed in cells treated with different actin poisons, 
such as phalloidin (Lazaro-Dieguez and Egea, 2007). DNA damage was observed by AFM 
upon interaction of DNA with cisplatin, in a dose dependent manner (Liu et al., 2010), 
and DNA adducts formed due to BPDE treatment were observed by AFM as 30° bends 
in the DNA structure (Pietrasanta et al., 2000). Thus, AFM is a useful tool for examining 
the cytotoxic effects of compounds at both the cellular and molecular level. Resolution 
is in the subnanometer scale, in comparison to the optical microscopy which is in the 
micrometer scale, and in addition to imaging the sample, the mechanical properties e.g. 
surface stiffness, hardness, friction or elasticity can be measured (Alonso and Goldmann, 
2003). Hence, the AFM is a versatile tool for imaging cells and DNA, although it is 
expensive and is not a standard tool in biological laboratories. 
AFM uses a sharp tip attached to a flexible cantilever. The tip or the sample is mounted 
onto a piezoelectric scanner. A laser is reflected from the cantilever on to a position 
sensitive detector as the tip scans across the sample surface and the interactions 
between the tip and the sample are measured by the laser deflection. The data from the 
tip-sample interactions is constructed into a 3-D image of the sample. The tip scans in 
constant contact with the surface of the sample in contact mode, with the tip-surface 
force being maintained by the piezoelectric scanner. A voltage is applied to the tip 
causing it to oscillate across the sample surface in tapping mode, and the phase 
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difference and amplitude are measured to produce the data to produce the image 
(Figure 5) (Webb. et al., 2011).  
 
Figure 5. AFM principle: as the tip which is attached to the cantilever scans the 
sample surface, a laser beam is reflected off the back of the tip on to a photodiode 
detector which measures the deflection of the cantilever, allowing a 3-D image to be 
produced from the data (adapted from Billingsley et al. (2012)). 
The flexible cantilever consists of silicon or silicon nitride of 100-500 µm in length and 
0.5-5 µm in thickness. The tip is mounted on the end of the cantilever and is brought 
into contact with the sample surface, or taps the sample surface as it scans. An electric 
feedback circuit keeps the tip in constant contact with the sample surface, measuring 
the deflection of the cantilever tip as it scans the sample surface using a piezoelectric 
scanner. In tapping mode, the tip is oscillated vertically at the resonant frequency of the 
cantilever, and the distance the tip oscillates vertically as it scans the sample surface is 
measured to produce an image. Lateral shear forces, which can damage/deform the 
sample, are present in contact mode but are eliminated in tapping mode (Figure 6) 
(Alonso and Goldmann, 2003).  
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Figure 6. AFM modes: A) tapping mode and B) contact mode, showing the tips’ 
movement over the sample surface (adapted from Santos and Castanho (2004)).  
In order to image DNA by AFM, it needs to be adsorbed onto a mica surface by the 
sharing of counterions despite DNA and mica having similar, negative, surface charges. 
Cations are used to bind the negatively charged DNA molecules to the mica surface 
(Pastre et al., 2003). Mica is used as it is atomically flat and biologically compatible as a 
support surface (Figure 7) (Billingsley et al., 2012).  
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Figure 7. Divalent cations (M2+) in the DNA buffer allow the DNA to interact with 
the mica substrate to prevent the DNA sample from moving as a result of the motion 
of the tip. Interactions (blue arrows) between the DNA and mica substrate must be 
greater than the interaction between the DNA and the tip to prevent sample 
movement (adapted from Billingsley et al. (2012)). 
1.13.  Summary 
As levels of M1dG adducts have been found at increased levels in smokers, the human 
lung fibroblast strain MRC5 and its transformed counterpart, MRC5 SV2 were chosen for 
the initial stages of this research. Treatment with genotoxic agents such as MDA, may 
serve to mimic one of the effects of smoking on the cellular response of these cell lines. 
MRC5 SV2 cells have a sequestered p53 response, resulting from the transfection of 
MRC5 cells with SV40 and are thus immortalised (Zhu and Gooderham, 2002). The 
differences in cellular response of both cell lines to treatment with genotoxic agents may 
be attributed to the p53 response. 
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It is well established that MDA is mutagenic and carcinogenic. However, there is a 
discrepancy in whether it is responsible for M1dG adduct formation. The aim was to 
examine the mutation spectra in MRC5 and MRC5 SV2 cells and compare with known 
mutation spectra in order to establish if MDA is linked to lung cancer. In order to achieve 
this, sensitive methods of analysis needed to be developed. 
1.14.  Experimental Design 
Given the link between MDA, M1dG adduct formation and mutagenesis, and the link 
between TP53 damage and carcinogenesis, further research was required to provide an 
overall picture of the effect of MDA at the cellular and molecular levels. The research 
here, focusses on the effect of MDA on the human lung fibroblast MRC5 cell line and its 
SV40 transformed counterpart, MRC5 SV2, which has a sequestered p53 response. 
These cell lines were chosen as they are human lung cell lines and MDA, linked to cellular 
stress, may mimic the genotoxic effects of smoking and thus lung cancer. Additionally, 
the differing p53 responses of the two cell lines may allow comparison of the effect of 
MDA on the cellular responses of healthy cells versus transformed cells. 
Initially, as components in foetal bovine serum (FBS) (which contains growth 
supplements required for cell proliferation) have been found to interact with MDA 
(Rittie et al., 2002), it was necessary to determine the effect of omitting FBS from the 
cell media on cell proliferation. This was examined in order to determine whether this 
would have an effect on the assays utilized in this research. The effect of MDA on cell 
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proliferation in the absence of FBS was also examined to determine the upper limit of 
MDA concentration that could subsequently be used. 
A positive control was chosen to show that the cytotoxic effects of treatment with MDA 
were due to the oxidative stress caused by MDA and no other external cause. The ideal 
candidate for this was H2O2 as this is known to cause oxidative stress (Gutteridge, 1995) 
and has been shown to elicit a similar response to MDA. 
A number of cytotoxicity assays were carried out, in order to demonstrate the effects of 
MDA on the two cell lines, and to complement each other, to build an overall cytotoxicity 
profile for MDA on these cell lines. A MTT assay was carried out, as this is the most 
widely adopted assay for cell viability. The effect of MDA on cell morphology was carried 
out using two imaging techniques: inverted LM, to view the live cells in vitro, and AFM 
to view the cell surface morphology. Nuclear morphology was investigated using 
fluorescence microscopy, and also apoptosis and p53 protein expression by 
immunofluorescence. p53 expression was also determined by reverse transcription-
quantitative polymerase chain reaction (RT-qPCR) for comparison with p53 
immunofluorescence detection. 
Following characterisation of the effects of MDA at the cellular level, the effects of MDA 
were examined at the DNA level to determine whether the alterations observed would 
lead to mutagenesis or other outcomes. Initially, DNA adduct analysis was carried out to 
determine whether M1dG adducts could be detected in the genomic DNA extracted 
from cells treated with MDA. This was carried out by synthesis and purification of a M1G 
standard, to be used for quantitative analysis, followed by optimisation of a HPLC 
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separation method using this standard. Development and optimisation of LC-MS and LC-
MS-MS techniques for M1dG adduct analysis were carried out prior to analysis of DNA 
samples. 
The genomic DNA extracted from the MRC5 and MRC5 SV2 cells treated with MDA was 
examined using AFM, to visualise any obvious large scale changes to the DNA and 
fragmentation levels. A feasibility study using AFM was also carried out using M1dG 
antibodies to try and detect the presence of M1dG adducts on the DNA molecules.  
Finally, a section of the TP53 gene was amplified by PCR and sequenced to look for 
mutations. The segment of DNA chosen included the 5’ untranslated region (UTR), 
encompassing exon 1, of the TP53 gene, a region previously thought to have no or little 
biological functionality. A huge bias exists in the mutation data from the TP53 gene, 
where the majority of data is for the protein coding exons 2-11. Thus mutation 
sequencing of the 5’ UTR would make an important, novel, contribution to the TP53 
mutation database. An overview of the methods utilised in this research is shown in 
Figure 8.
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Figure 8. An overview of the methodology used in this research
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1.15.  Aims & Objectives 
The aim of this research was to determine the effect of treatment with MDA on human 
lung fibroblast cells, MRC5 and MRC5 SV2, which have an intact and a sequestered p53 
response respectively. This was achieved by: 
 Establishing the growth characteristics of both cell lines in response to treatment 
with and without FBS, and with and without MDA. 
 Determining the viability of the cell lines in response to treatment with MDA by 
MTT assay. 
 Assessment of DNA damage by staining the nuclei of both cell lines following 
treatment with MDA, to show changes in nuclear morphology. 
 Examination of cell morphology using LM and AFM following treatment of both 
cell lines with MDA. 
 Apoptosis detection in response to MDA treatment of cells by Annexin V assay 
and immunofluorescence. 
 p53 expression by immunofluorescence and RT-qPCR in response to treatment 
of cells with MDA. 
 Imaging of genomic DNA from cells treated with MDA by AFM to show DNA 
structural changes and fragmentation. 
 Development of methods to analyse M1dG adducts in cellular DNA.  
 PCR and mutation sequencing of residues 4640-5328 of the TP53 gene.  
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CHAPTER 2  
MATERIALS & METHODS  
The materials and equipment utilized for this research are listed in this chapter, along 
with detailed experimental procedures and protocols. 
2.1. Materials 
2.1.1. Reagents and Disposable Items 
The following materials were obtained from the following suppliers: 25% glutaraldehyde 
(EM grade) was purchased from Agar Scientific, Stansted (UK); sterile pipette tips, 0.2 µl 
thin-wall 8-tube strips and thin-wall tube (high profile) with an optical flat cap were from 
Appleton Woods, Birmingham (UK); sterile vented petri dishes were from BD Falcon, 
Oxford (UK); hyperladder II (included DNA loading buffer) was purchased from Bioline, 
London (UK); FBS was from Biowest, Nuaillé (France); TP53 primers (forward 
5’TCTGGGAGAAAACGTTAGGG3’ and reverse 5’ATCCCTCTAGCCAAGCTTCC3’), p53 
complementary DNA (cDNA) primers (forward 5’AGATGAAGCTCCCAGAATGC3’ and 
reverse 5’TCTTGCGGAGATTCTCTTCC3’) and glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) primers (forward 5’GGTGAAGGTCGGAGTCAACGG3’ and 
reverse 5’GGTCATGAGTCCTTCCACGAT3’) were purchased from Eurofins MWG Operon, 
Ebersberg (Germany); prolong gold anti fade, molecular-grade water and a purelink 
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messenger ribonucleic acid (mRNA) mini kit were from Life Technologies, Paisley (UK); 
mica was from Novascan Technologies, Ames, Iowa (USA); AC240 and TR400PSA AFM 
cantilevers were from Olympus, Southend-on-sea (UK); RNasin Plus RNase inhibitor, 
GoScript reverse transcriptase and GoTaq 2-step RT-qPCR system were purchased from 
Promega, Southampton (UK); random hexamers were from Qiagen, Manchester (UK); 
ethylenediaminetetraacetic acid (EDTA) 500 mM solution, 
tris(hydroxymethyl)aminomethane (tris) were from Severn Biotech, Kidderminster (UK); 
SPE Supelclean ENVI-18 Tubes, H2O2 (30%), glacial acetic acid, Cellomics p53 detection 
kit (included hoechst dye), nylon membrane filters (47 mm diameter, 0.2 µm pore), 
ethidium bromide, boric acid, deoxynucleotide (dNTP) mix, 11 mm clear glass crimp top 
HPLC vials and aluminium crimp caps, screw top fixed insert borosilicate glass clear 0.3 
ml HPLC vials and blue plastic screw caps were purchased from ThermoFisher, 
Loughborough (UK); methanol HiPerSolv and water HiPerSolv were from VWR 
International Ltd, Lutterworth (UK). 
Sterile items: serological pipettes (5 ml and 10 ml), universal tubes (25 ml), conical 
centrifuge tubes (15 ml), cell culture flasks (25 and 75 cm2), 8 chamber cell culture slides, 
tissue culture treated 96 well, 12 well and 6 well plates with lids, cover slips (15 mm2), 
glass microscope slides (75 x 25 x 1.1 mm) and glass pasteur pipettes, PCR tubes were 
purchased from Scientific Laboratory Supplies Ltd, Nottingham (UK). 
Dimethyl sulphoxide (DMSO), minimal essential medium Eagle (MEM), L-glutamine 
(200 mM), penicillin-streptomycin (10,000 units/ml penicillin and 10 mg/ml 
streptomycin), non-essential amino acids (NEAA), phosphate buffered saline (PBS), 
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trypan blue solution (0.4% w/v), trypsin/EDTA Solution (0.25%), thiazolyl blue 
tetrazolium bromide (MTT, 97.5%), 1,1,3,3-tetramethoxypropane (TMP, 6.01 M), 2-
thiobarbituric acid powder (TBA), concentrated hydrochloric acid (HCl), potassium 
hydroxide (KOH), potassium chloride (KCl), DAPI (10 mg/ml), 2,4-dinitrophenylhydrazine 
(DNP), phosphoric acid (85%), acetonitrile (HPLC-grade), methanol, 100% ethanol, calf 
thymus (CT) DNA, monobasic potassium dihydrogen phosphate (KH2PO4), dibasic 
potassium phosphate (K2HPO4), cytochalasin B, guanine, Reddymix PCR mastermix, 
GenElute mammalian genomic DNA mini prep kit, Annexin V-CY3 apoptosis detection 
kit, agarose, fluoromount, trizma hydrochloride, EDTA disodium salt dihydrate 
(EDTA.Na2.H2O), magnesium chloride hexahydrate (MgCl2.6H2O), 2-mercaptoethanol, 
araldite were purchased from Sigma-Aldrich, Gillingham (UK).  
The primary antibody to M1dG was a gift provided by Lawrence J. Marnett, Marnett 
Research Laboratory, Vanderbilt School of Medicine, Vanderbilt Univeristy, USA. 
The M1dG DNA standard was provided by Dr Sharon A. Moore, School of Pharmacy and 
Biomolecular Sciences, Liverpool John Moores Univesity and prepared as previously 
described (Leuratti et al., 1998). M1dG adduct levels in undiluted DNA were 21 pmol/µg 
DNA. 
2.1.2. Cell Lines and Cell Line Maintenance 
Cell lines were obtained from the European Collection of Animal Cell Cultures (ECACC), 
Porton Down, Salisbury, UK. MRC5 cells were adherent human lung fibroblasts, ECACC 
number 05090501, derived from normal human lung tissue of a 14 week old male, 
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requiring MEM supplemented with 10% FBS (v/v), 2 mM L-glutamine (with penicillin-
streptomycin) and 1% NEAA (complete media). Growth conditions were humidified 5% 
carbon dioxide (CO2)/95% air and 37°C. Cells were sub-cultured 1:3 to 1:6 when 70-80% 
confluent and seeding density was 2-4 x 10,000 cells/cm2. MRC5 SV2 cells, ECACC 
number 84100401, were derived from the parental cell line MRC5 by transformation 
with the SV40 virus. Culture medium and growth conditions required were the same as 
for MRC5 cells. Cells were sub-cultured 1:5 to 1:10 when 70-80% confluent and seeding 
density was 1-2 x 10,000 cells/cm2. 
2.2. Equipment 
Cell Culture: Grade II biological safety cabinet was from ESCO, Hatboro, Pennsylvania 
(USA); Spectramax 190 ROM absorbance microplate reader from Molecular Devices, 
Sunnyvale, California (USA); Cary eclipse fluorescence spectrophotometer was from 
Agilent Technologies, Wokingham (UK); 
Microscopy: The inverted optical microscope (CK2) was from Olympus, Southend-on-
sea (UK); the laser scanning confocal microscope (510 META) was from Zeiss, Cambridge 
(UK); haemocytometer from Sigma-Aldrich, Gillingham (UK); Lightsource monochrome 
CCD camera; molecular force probe 3D microscope (MFP-3D) was from Asylum Research, 
Santa Barbara, California (USA); 
PCR: Veriti 96 well thermal cycler and 7500 real time PCR system were from Applied 
Biosystems, Paisley (UK); electrophoresis system and power supply were from Fisher 
Scientific, Loughborough (UK); Gel Doc XR image analysis system from BioRad, Hemel 
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Hempstead (UK); Nanophotometer 7122 v1.3 from NanoDrop, Wilmington, Delaware 
(USA); 
Chromatography and Mass Spectrometry: Agilent 1200 series HPLC separations module 
with photodiode array detector (PDA), fluorescence detector (FLD), degasser, 
quaternary pump, column module and autosampler were from Agilent, Stockport (UK); 
Alliance Micromass liquid chromatography – time of flight – mass spectrometer (LC-MS), 
Waters 2695 separations module and a Waters 486 tunable absorbance detector were 
from Waters, Elstree (UK); Phenomenex Luna C18 250 mm x 4.6 mm HPLC column 
(Column A), Phenomenex Gemini NX 3u C18 110A 100 x 2.00 mm HPLC column (Column 
B), Phenomenex security guard cartridge guard column and A50-4288 4 mm L x 2.00 C18 
guard cartridge were from Waters, Elstree (UK). Waters 2690 HPLC separation module 
with a Waters 996 photodiode array detector and a Waters Micromass Quattro Premier 
Triple Quadrupole Mass Spectrometer (LC-MS-MS) were from Waters, Elstree (UK), 
operated by MassLynx v. 4.1 software. 
2.3. Methods 
All statistical analysis was carried out using Microsoft Excel 2007 software and results 
were significantly different if P < 0.05, unless otherwise stated. HPLC- grade water was 
used in all protocols unless otherwise stated.  
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2.3.1.  Synthesis of Malondialdehyde 
A 100 mM stock solution of MDA was prepared by acid hydrolysis of TMP (MR 220.31). 
A 166.4 µl aliquot of TMP was added to 4690 µl 0.1 M HCl and incubated at room 
temperature for 40 min. The solution was then neutralised by the addition of 4690 µl 
0.1M KOH and the volume made up to 10 ml with water.  
2.3.2.  Analysis of Malondialdehyde Standards by TBARS 
A 100 mM MDA stock solution was diluted with water to give standards in the range 
0-1000 µM MDA. TBARS reagent was prepared by dissolving 0.375 g TBA in 100 ml 
0.25 M HCl. A 0.125 ml aliquot of each standard was added to 1 ml TBARS reagent and 
incubated at 95°C for 10 min, followed by cooling to room temperature on ice. The 
samples were centrifuged at 2000 g for 10 min and the supernatant transferred to wells 
of a 96 well plate. The absorbance at 532 nm was read using a Spectramax 190 ROM 
plate reader and SoftMax Pro v5.2 software. 
2.3.3.  Analysis of Malondialdehyde Standards by HPLC 
A 100 mM MDA stock solution was diluted with water to give standards in the range 
0-20 mM MDA. Brady’s reagent was prepared by dissolving 0.26 g DNP in 100 ml 6M HCl 
(Vogel, 1956). The MDA standards were derivatised by adding 1 ml standard to 1 ml 
Brady’s reagent and incubating at room temperature for 15 min, 2 ml HPLC grade 
acetonitrile was added and 1 ml was transferred to a HPLC vial. The HPLC method was 
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as shown in Table 1. Column A (Section 2.2) was used with an Agilent HPLC separator 
module with PDA and FLD detectors. 
Table 1. HPLC method for DNP derivative analysis. Temperature 37°C, flow rate 
1 ml/min, sample volume 20 µl.   
Time (min) H2O    (%) Acetonitrile   (%) 0.1 M H3PO4   (%) 
0 80 10 10 
30 0 90 10 
30-35 0 90 10 
35-45 80 10 10 
2.3.4.  Routine Maintenance of Cells  
All cell culture was carried out under aseptic conditions in an ESCO grade II laminar flow 
cabinet. Cells were sub-cultured when 70-80% confluent by removal of the spent media, 
washing with PBS and addition of trypsin/EDTA. Complete media was added to 
neutralise the action of the trypsin. The cell suspension was centrifuged at 1500 rpm for 
5 min. The pellet was re-suspended in complete media. Cells were seeded into T-75 
flasks or re-suspended in freezing mixture (70% MEM, 20% FBS and 10% DMSO) and 
stored in liquid nitrogen at -196°C. Cells were grown in an incubator at 37°C with 5% CO2 
unless otherwise stated. 
Chapter 2 Materials and Methods 
  53  
2.3.5.  Effect of Foetal Bovine Serum and Malondialdehyde on Cell 
Proliferation 
Cell proliferation was determined for both cell lines in both the presence and absence 
of FBS. FBS-free media was prepared by addition of 1% NEAA and 2 mM L-glutamine 
(with penicillin-streptomycin) to MEM. Complete media was prepared as described in 
Section 2.1.2. Cells were suspended in both media and seeded at 1 x 104 cells per well 
of a 96 well plate. A viable cell count was carried out at 24 h intervals in triplicate by 
application of a 1:1 mixture of cell suspension:trypan blue to a haemocytometer. Cells 
stained blue were regarded as non-viable and were not counted. The growth of each 
cell line was also determined in the presence of MDA (0-1000 µM) diluted in FBS-free 
media. Mean cell number versus time was plotted, all data was shown as ± 1 SD from 
the mean, unless otherwise stated. The population doubling time (PDT) (h) was 
calculated from the log phase of growth as follows:  
 PDT =  t2− t1
3.32(log n2−log n1)
 
Where n1 = initial cell number at time t1 (h) and n2 = final cell number at time t2 (h). 
The growth rate (k) (h-1) was calculated by: 
 k =  
ln 2
PDT
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2.3.6.  Cell Viability using a MTT Assay 
The viability of both cell lines when treated with MDA (0-1000 µM) and positive control 
H2O2 (0-100 µM), diluted in FBS-free media, was assessed using an MTT assay. A 1 mg/ml 
MTT solution was prepared by dissolving 10 mg MTT in 1 ml PBS and then made up to 
10 ml with FBS-free media. Cells were seeded at 1 x 104 cells per well of 96 well plates 
and left to attach for 24 h. The media was removed and the cells were treated with each 
MDA solution in triplicate and incubated for 24, 48 or 72 h. The media was removed and 
MTT reagent was added to each well and incubated for 3 h. DMSO was added to each 
well, to solubilise the purple formazan product. MTT and DMSO were also added to 3 
cell-free wells to determine the background absorbance. The absorbance of each well 
was read using a Spectramax 190 ROM microplate reader at 540 nm. The mean 
absorbance and standard deviation were calculated for each MDA concentration and 
control, and the mean absorbance of the MTT-DMSO only wells was deducted. The 
mean % cell viability was calculated as follows. 
Mean % Cell Viability =  
Mean Absorbance Sample
Mean Absorbance Control
 x 100 % 
Data was normalized to the untreated (control) cells at 100% viability. Student’s t-test 
was used to compare each cell line treated with each concentration of MDA at each time 
period. 
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2.3.7.  In vitro Imaging of Cells  
Cells from each cell line were seeded at 1 x 104 cells /cm2 into 12 well plates and allowed 
to grow in complete media for 48 h. Cells were treated in triplicate with MDA 
(0-1000 µM) and H2O2 (50 µM) in FBS-free media and incubated for 24 h and 48 h. Light 
microscope images of live cells were captured after treatment using a Lightsource 
monochrome CCD camera coupled to an Olympus CK2 inverted optical microscope. 
2.3.8.  Effects of MDA on Nuclear Morphology 
Cells from each cell line were seeded at 1 x 104 cells /cm2 onto 8 chamber microscope 
slides and allowed to attach for 24 h. Cells were treated in triplicate with MDA 
(0-1000 µM) and H2O2  (50 µM) in FBS-free media and incubated for 24 h and 48 h. The 
media was removed from the wells. A 1 mg/ml cytochalasin B in DMSO solution was 
diluted 1.5:100 in complete media and was added to each well. Following 24 h 
incubation, the wells were removed from the chamber slides and the media discarded. 
The cells were washed in PBS and then fixed as follows: the microscope slides were 
placed in hypotonic solution (0.4% Na-citrate + 0.4% KCl in distilled water) containing 4% 
formaldehyde and incubated at 4°C for 8 min. The slides were removed from the 
solution and placed in hypotonic solution only. A fixative solution of 4:1 
methanol : glacial acetic acid was prepared. An equal volume of fixative was added very 
slowly to the hypotonic solution whilst gently shaking. Next, 50% of the 
hypotonic/fixative mixture was removed and an equal volume of fixative was then 
added slowly. The hypotonic/fixative mixture was removed and 100% fixative was added 
for at least 1 min. The fixative was removed and the slides were allowed to air dry. The 
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slides were incubated in DAPI (50 µg/ml in distilled water) for 15 min at room 
temperature and then washed (x5) in PBS. The slides were then viewed using a Zeiss 510 
META laser scanning confocal microscope (excitation 350 nm, emission 470 nm).  
The area of 10 nuclei from each cell line and each MDA treatment were measured using 
ImageJ software (Rasband, 1997). Student’s t-test was used to compare each cell line 
treated with each concentration of MDA at each time period. 
2.3.9.  Apoptosis Detection using Annexin V Fluorescent Assay 
Cells from each cell line were seeded at 1 x 104 cells /cm2 onto 15 mm coverslips placed 
in 12 well plates and allowed to attach for 24 h. Cells were treated in triplicate with MDA 
(0-1000 µM) and H2O2 (50 µM) in FBS-free media and incubated for 24 h and 48 h. The 
media was removed from the wells by aspiration and the cells were washed (x2) with 
PBS and the solution aspirated. Cell were stained using an Annexin V-CY3 apoptosis 
detection kit as follows. Cells were washed (x3) with binding buffer (10 mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), pH 7.5 containing 140 mM 
sodium chloride (NaCl) and 2.5 mM calcium chloride (CaCl2)), diluted 1:10 in deionized 
water, each time removing excess solution by blotting the edge of the coverslip with a 
tissue. Double staining solution (1 µg/ml annexin-Cy3.18 and 500 µM 6-
carboxyfluorescein diacetate in 1:10 dilution of binding buffer) was added to the 
coverslip to cover the cells, and the plate was incubated in the dark at room temperature 
for 10 min. Cells were washed (x5) in aliquots of 1:10 dilution of binding buffer. The 
coverslips were mounted onto microscope slides using ProLong gold anti-fade mounting 
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medium and the cells were imaged using a Zeiss 510 META laser scanning confocal 
microscope. 
2.3.10. p53 Expression using Immunofluorescence 
Cells from each cell line were seeded at 1 x 104 cells /cm2 onto 15 mm coverslips placed 
in 12 well plates. Cells were allowed to attach for 24 h. Cells were treated in triplicate 
with MDA (0-1000 µM) and H2O2 (50 µM) in FBS-free media and incubated for 24 h and 
48 h. The media was removed from the wells by aspiration and the cells were stained 
using a Cellomics p53 detection kit as follows: Fixation solution (4% paraformaldehyde 
in 1:10 dilution of wash buffer) was added to each well and incubated in a fume hood at 
room temperature for 15 min. The fixation solution was aspirated completely and 1:10 
diluted permeabilization buffer (in 1:10 diluted wash buffer) was added to each well and 
incubated for 15 min at room temperature. The permeabilization buffer was aspirated 
and the cells were washed (x2) with 1:10 diluted blocking buffer (in 1:10 diluted wash 
buffer). The blocking buffer was aspirated and further aliquots of diluted blocking buffer 
were added to each well and incubated for 15 min. The blocking buffer was aspirated 
and primary antibody solution (1:100 dilution of anti-p53 antibody in diluted blocking 
buffer) was added to each well and incubated for 1 h. The primary antibody solution was 
aspirated and the cells were washed (x2) with diluted blocking buffer. The blocking 
buffer was aspirated and staining solution (1:1000 hoechst dye and 1:100 DyLight 549 
goat anti-rabbit in diluted blocking buffer) was added to each well and incubated in the 
dark for 1 h. The staining solution was aspirated and the cells were washed (x2) in diluted 
wash buffer. The coverslips were removed from the 12 well plates and mounted onto 
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microscope slides using ProLong gold anti-fade mounting medium and the cells were 
imaged using a Zeiss 510 META laser scanning confocal microscope.  
2.3.11. p53 Expression using Reverse Transcription Quantitative 
Polymerase Chain Reaction 
TP53 gene expression was assessed by quantitative analysis of p53 mRNA using a GoTaq 
two-step reverse transcription-quantitative PCR (RT-qPCR) as follows: Cells from each 
cell line were seeded into T-75 flasks and allowed to grow until 70-80% confluent in 
complete media. Cells were treated in duplicate with MDA (0-100 µM) and H2O2 (50 µM) 
in FBS-free media and incubated for 24 h and 48 h. The growth media was removed and 
the cells were washed with PBS and trypsin/EDTA was added to detach the cells. 
Complete media was added to neutralise the action of the trypsin. The cell suspension 
was transferred to an RNase-free tube and centrifuged at 2000 x g for 5 min, the 
supernatant was discarded, leaving the pellet for mRNA extraction. 
2.3.11.1. mRNA Extraction and Purification 
mRNA was extracted and purified using a PureLink RNA mini kit, as follows: Lysis Buffer 
(containing 1% 2-mercaptoethanol) was added to the cell pellet and vortexed 
thoroughly to disperse the cells and they appeared lysed. The lysate was passed through 
a 21-gauge syringe needle (x10) to homogenise. Next, 70% ethanol was added to each 
sample and vortexed. The sample (including precipitate) was transferred to a spin 
cartridge and collection tube and centrifuged at 12000 x g for 15 s at room temperature, 
and the flow-through was discarded. This step was repeated until all of the sample was 
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used up. An aliquot of wash buffer I was added to the spin cartridge, centrifuged at 
12000 x g for 15 s at room temperature and the flow through and collection tube were 
discarded. The spin cartridge was transferred to a clean collection tube and wash buffer 
II (containing ethanol) was added and then centrifuged at 12000 x g for 15 s at room 
temperature, the flow through was discarded and this step was repeated. The spin 
cartridge was centrifuged for 1-2 min at 12000 x g to dry the membrane with bound RNA. 
The collection tube was discarded and the spin cartridge was inserted into a recovery 
tube. Finally, RNase-free water was added to the centre of the cartridge and incubated 
at room temperature for 1 min, then centrifuged at room temperature for 2 min at 
12000 x g and this step was then repeated. The purified RNA was stored at -80°C. 
2.3.11.2. Quantification of p53 by RT-qPCR 
The concentration of RNA in each sample was quantified using a NanoDrop 
spectrophotometer (absorbance at 260 nm) and then diluted with RNase-free water so 
that all samples contained the same concentration of RNA. Next, each RNA sample was 
added to a 50 µl PCR tube with random hexamers (final concentration 0.025 µg/µl 
random hexamers), each sample in triplicate. Two negative controls were also set up, 
one without an RNA template (replaced by RNase-free water) and one without reverse 
transcriptase (for later in the protocol) using any of the RNA samples. The sealed tubes 
were placed in a heat block at 70°C for 5 min to denature, followed by chilling to 4°C for 
5 min and centrifuging briefly to collect any condensation. The samples were held on ice. 
A reverse transcription master mix was prepared on ice as follows, adding the reagents 
in the following order, the volume per reaction was: 1.5 µl RNase-free water, 4 µl 
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GoScript reaction buffer, 2 µl MgCl2, 1 µl dNTP’s, 0.5 µl RNase inhibitor, 1 µl reverse 
transcriptase (the reaction without reverse transcriptase had 2.5 µl RNase-free water 
instead). The reaction mix was mixed thoroughly by inversion. 10 µl of the reverse 
transcription reaction mix was added to 10 µl RNA sample and the reverse transcriptase-
free reaction mix was added to the correct RNA sample. cDNA was synthesized in a 
thermal cycler, according to Table 2. The cDNA was stored on ice for immediate use, or 
at -20°C for later use.  
Table 2. Steps for the synthesis of cDNA by reverse transcriptase. 
Step Temperature (°C) Time 
Anneal 25 5 min 
Extend 42 1 h 
Inactivate 70 15 min 
Chill 4 Hold ∞ 
 
To quantify the TP53 cDNA by qPCR, two sets of cDNA primers were used. GAPDH was 
used as a reference gene, the primers for this were: forward 
5’GGTGAAGGTCGGAGTCAACGG3’ and reverse 5’GGTCATGAGTCCTTCCACGAT3’. The 
TP53 cDNA primers were: forward 5’AGATGAAGCTCCCAGAATGC3’ and reverse 
5’TCTTGCGGAGATTCTCTTCC3’. Primers were designed using Entrez Gene (Maglott et al., 
2010), Primer3 (Untergasser et al., 2012) and primer BLAST (Ye et al., 2012) 
bioinformatics and 1 µM stock solutions of each primer were prepared using RNase-free 
water and held on ice. 
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A qPCR reaction mix was prepared on ice, containing 10 µl GoTaq qPCR Master Mix 2X, 
4 µl RNase-free water and 1µl each of either TP53 forward and reverse cDNA primers or 
GAPDH forward and reverse cDNA primers. Each RNA sample was prepared in triplicate 
and 2 reactions were set up for each triplicate, one for TP53 and one for GAPDH, plus 2 
reactions for the template-free control (TP53 and GAPDH) and 2 reactions for the 
reverse transcriptase-free control (TP53 and GADPH). A 4 µl aliquot of RNA 
sample/control was added to a well of a 96 well qPCR reaction plate on ice and 16 µl 
qPCR reaction mix was added to each sample, to give a final volume of 20 µl. The 
reaction plate was centrifuged using a swinging-bucket centrifuge at low speed for 1 min. 
The real-time qPCR thermal cycler was programmed with SYBR as the detection dye and 
CXR as the reference dye. The cycling conditions are shown in Table 3. 
Table 3. Real-time qPCR thermal cycling conditions. 
Step Cycles Temperature (°C) Time 
GoTaq Hot Start 
Polymerase 
Activation 
1 95 2 min 
Denaturation 
Annealing/Extension 
40 95 
60 
15 s 
1 min 
Dissociation 1 60-95 - 
 
Expression of TP53 (target gene) relative to GAPDH (endogenous control gene) 
expression was calculated using the 2-ΔΔCt Comparative Cycle Threshold (Ct) method 
(Livak and Schmittgen, 2001). Samples were normalised to a RNA–free negative control 
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and referenced against GADPH. Student’s t-test was used to compare each cell line 
treated with each concentration of MDA at each time. 
2.3.11.3. Agarose Gel Electrophoresis 
Gel electrophoresis of the qPCR products was performed to check that the cDNA 
fragments were the correct size and that no DNA could be detected in the negative 
controls. Agarose gels (1%) were prepared as follows: Tris/Borate/EDTA (TBE) buffer was 
prepared with 10.8 g/l tris base, 5.5 g/l boric acid and 4 ml/l 0.5 M EDTA (pH 8). Next, 1 
g agarose was added to 100 ml TBE buffer and stirred on a magnetic stirrer at 100°C until 
the agarose dissolved. The solution was cooled to approximately 60°C and 3 µl ethidium 
bromide was added. The gel was cast, a horizontal gel comb was inserted and the gel 
was allowed to set for 60 min. The gel was then placed into the electrophoresis tank and 
just covered with TBE buffer. A marker was loaded into the first lane (HyperLadder II, 
500 – 2000bp) and 9 µl samples were loaded into the wells with 1 µl DNA loading buffer. 
The electrophoresis was carried out at 95 V for 45 min to 1 h. The gels were viewed with 
a gel imager and BioRad Quantity One software. 
2.3.12.  Effect of Malondialdehyde on DNA Sequence 
To assess whether MDA had an effect on the integrity of the DNA sequence, both cell 
lines were treated with MDA and H2O2 (positive control) for 48 h, DNA was extracted 
and purified and residues 4640-5328 of the TP53 gene were amplified by PCR and 
sequenced as follows: Cells from each cell line were seeded into T-75 flasks and allowed 
to grow until 70-80% confluent in complete media. Cells were treated in duplicate with 
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MDA (0-1000 µM) and H2O2 (0 - 100 µM) in FBS-free media and incubated for 48 h. The 
growth media was removed and the cells were washed with PBS and trypsin/EDTA was 
added to detach the cells. Complete media was added to neutralise the action of the 
trypsin. The cell suspension was transferred to a nuclease-free tube and centrifuged at 
2000 x g for 5 min, the supernatant was discarded, leaving the pellet for DNA extraction. 
The cell pellets were frozen at -80°C until required. 
2.3.12.1. DNA Extraction, Purification and Quantification 
Genomic DNA was extracted and purified using a GenElute Mammalian Genomic DNA 
Miniprep Kit as follows: The cell pellets were allowed to thaw and were then 
resuspended in Resuspension Solution. RNase A solution was added and incubated at 
room temperature for 2 min. Proteinase K solution (20 mg/ml) was added to each 
sample, followed by Lysis Solution C, the samples were vortexed thoroughly and 
incubated in a water bath at 70 °C for 10 min to lyse the cells. 
The columns were prepared by adding Column Preparation Solution to each pre-
assembled GenElute Miniprep Binding Column and centrifuged at 12000 x g for 1 min 
and the flow through was discarded. Next, 100% ethanol was added to the cell lysates 
and mixed thoroughly by vortexing for 15 s. The cell lysates were transferred to the 
binding columns using wide bore pipette tips to prevent DNA shearing. The columns 
were centrifuged at 6500 X g for 1 min and the flow through and collection tube were 
discarded. The column was placed in a new 2 ml collection tube. 
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Wash Solution Concentrate was diluted 1:5 with 100% ethanol. The diluted Wash 
Solution was added to the binding columns and centrifuged at 6500 x g for 1 min. The 
collection tube and flow through were discarded and the binding column was placed in 
a new collection tube. Another aliquot of diluted Wash Solution was added to the 
binding columns and centrifuged at maximum speed for 3 min to dry the columns and 
remove residual ethanol. The collection tube and flow through were discarded and the 
binding columns were placed in new collection tubes. 
To elute the DNA, Elution Solution (10 mM Tris-HCl, 0.5 mM EDTA, pH 9.0) was added to 
the centre of the binding columns, incubated at room temperature for 5 min and 
centrifuged for 1 min at 6500 x g. This step was repeated and the DNA was quantified 
using a NanoDrop spectrophotometer (260 nm absorbance). The DNA solutions were 
stored at -20°C until required. 
2.3.12.2. Polymerase Chain Reaction of TP53 Gene 
The following TP53 primers were used for PCR. The forward primer 
5’TCTGGGAGAAAACGTTAGGG3’ and reverse primer 5’ATCCCTCTAGCCAAGCTTCC3’ 
flank residues 4640-5328 of the human TP53 gene (GenBank Accession Number 
NG_017013). Primers were designed using Ensembl (Flicek et al., 2012), Primer3 
(Untergasser et al., 2012) and BLAST (Madden, 2002) bioinformatics. PCR was carried 
out on the genomic DNA samples as follows. 
DNA samples in aliquots of 5 µl were added to 50 µl PCR tubes and a negative control of 
5 µl molecular grade water was also prepared. A reaction master mix was prepared, 
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containing 25 µl ReddyMix PCR Mastermix, 0.5 µl each of forward and reverse primers, 
19 µl molecular grade water for each DNA sample. A 45 µl aliquot of reaction master mix 
was added to each DNA sample and the negative control and the tubes were sealed and 
placed in a thermal cycler. The PCR cycle is shown in Table 4. The PCR products were 
stored at -20°C until required. 
Table 4. PCR cycle conditions for amplification of TP53 DNA fragment. 
Step Temperature (°C) Time Number Cycles 
Hot Start 95 3 min 1 
Denaturation 
Annealing 
Extension 
95 
57 
72 
30 s 
1 min 
40 s 
 
40 
Final Extension 72 5 min 1 
Hold 4 ∞ 1 
 
2.3.12.3. Agarose Gel Electrophoresis 
Gel electrophoresis of the PCR products was performed to check that the DNA fragments 
were the correct size and that no DNA could be detected in the negative controls. 
Agarose gels (1%) were prepared as described in Section 2.3.11.3. A marker was loaded 
into the first lane (HyperLadder II, 500 – 2000bp) and samples were loaded into the wells. 
The electrophoresis was carried out at 100 V for 30 minutes. The gels were viewed with 
a gel imager and BioRad Quantity One software. 
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2.3.12.4. Mutation Sequencing 
Sanger DNA sequencing was carried out on the non-purified PCR products (using the 
same primers as in Section 2.3.12.2) by Beckman Coulter Genomics, UK, by double 
stranded primer walking using an ABI Prism 3730XL DNA sequencer.  
The DNA sequences were analysed and processed using CLC Main Workbench 6 
software (CLCBIO, 2014). A consensus sequence combining both the forward and 
reverse sequences from each sample was created. The consensus sequence was then 
aligned to the TP53 reference sequence and any unknown nucleotides were assigned. 
Conflicts between the TP53 reference sequence and the sample consensus sequence 
were identified and duplicate sample sequences were merged to include all possible 
mutations for that sample. A multiple alignment for each cell line was carried out, 
referenced to the TP53 reference sequence. Each sample sequence was converted to 
the corresponding amino acid sequence and a multiple alignment of the amino acid 
sequence for each sample and cell line was carried out. The secondary structure of the 
amino acid sequence was also shown, to indicate if any mutations had any effect on the 
protein structure. Using the amino acid sequences, protein hydrophobicity was plotted 
and protein charge versus pH was plotted to show the effect any mutations had on the 
protein properties. 
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2.3.13.  Imaging using Atomic Force Microscopy 
2.3.13.1. Cell Surface Morphology 
Cells from each cell line were seeded at 1 x 104 cells /cm2 onto 25 mm coverslips placed 
in 6 well plates and allowed to attach for 24 h. Cells were treated in triplicate with MDA 
(0-1000 µM) and H2O2 (50 µM) in FBS-free media and incubated for 24 h and 48 h. The 
media was removed from the wells by aspiration and the cells were washed twice with 
PBS and the solution aspirated. Cells were fixed in 2.5% glutaraldehyde in PBS for 20 min. 
They were then washed (x6) in excess PBS followed by a final wash in molecular grade 
water. Cells were allowed to air-dry in the fume cupboard, covered enough to prevent 
settling of dust. The cell surface was imaged using a Molecular Force Probe 3D AFM in 
contact mode using an Olympus AFM V-shaped TR400PSA cantilever (spring constant 
0.02-0.08 N/m, imaged at a rate of 1 Hz) and Argyle software. Integral and proportional 
gains were optimised empirically whilst scanning. 
2.3.13.2. Effect of Malondialdehyde on DNA Topography 
DNA molecules can be imaged using AFM. The DNA samples imaged were the PCR 
products produced in Section 2.3.12.2. To prepare the DNA samples for imaging, 
microscope slides with mica discs were prepared as follows. A mica disc was fixed to a 
clean, plain glass microscope slide with araldite and allowed to dry for 24 h in a covered 
petri dish. The top layer of mica was then removed using either a razor blade or sellotape. 
Tris/EDTA (TE) buffer was prepared by dissolving 0.4728 g Tris HCl in 10 ml HPLC-grade 
water, 0.1017 g EDTA.Na2.H2O in 10 ml HPLC-grade water and 0.6010 g MgCl2.6H2O in 
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10 ml HPLC-grade water. The three solutions were then mixed together to make TE 
buffer. DNA samples were diluted in TE buffer to 2 ng/µl and 10 µl was applied to the 
prepared mica. The sample was left on the mica for 1 min in a covered petri dish (to 
prevent settling of dust and contamination). The solution was then carefully washed 
from the mica with HPLC-grade water and excess water blotted from the edge of the 
disc with tissue. The DNA was left to dry on the mica for 10 min and once dry was imaged 
using an Asylum Research MFP-3D microscope in tapping mode with an Olympus AC240 
V tipped AFM cantilever (resonant frequency 72 kHz, spring constant 2 N/m, imaged at 
a rate of 1 Hz with a free-air amplitude of 0.5 V and a damping amplitude of 0.3 V) and 
Argyle software. Integral and proportional gains were optimised empirically whilst 
scanning. 
2.3.13.3. Use of M1dG Antibodies to Locate MDA-Induced Mutations by AFM 
M1dG primary antibodies (supplied by Marnett, L) were used to locate M1dG adducts on 
the DNA strands using AFM.  The antibodies were diluted to 10 ng/µl in TE buffer and 
were added to the DNA samples as follows: 5 µl of 10 ng/µl DNA solution, 13 µl TE buffer 
and 2 µl of 10 ng/µl antibody were added to a microfuge tube and placed on a rocker 
for 30 min at room temperature to allow the antibodies to bind to any adducts. Next, 
10 µl of the DNA-antibody solution was applied to a mica disc as previously described in 
Section 2.3.13.1. The DNA-antibody solution was left to attach to the mica for 5 min and 
then washed with HPLC-grade water. The edge of the mica was blotted with tissue to 
remove excess water and the mica was allowed to dry for 10 min. Once, dry, the DNA-
antibody sample was imaged using an Asylum Research MFP-3D microscope in tapping 
mode with an Olympus AC240 V-shaped AFM cantilever (resonant frequency 72 kHz, 
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spring constant 2 N/m, imaged at a rate of 1 Hz with a free-air amplitude of 0.5 V and a 
damping amplitude of 0.3 V) and Argyle software. Integral and proportional gains were 
optimised empirically whilst scanning. 
2.3.14. Chromatography and Mass Spectroscopy Method 
Development for Adduct Analysis 
The development of a method of analysis of M1G adducts in DNA samples by LC-MS-MS 
is detailed in this section. Initially a HPLC method was developed, followed by a MS 
method and finally fine-tuning of the LC-MS-MS method prior to sample analysis. Two 
HPLC columns with a guard cartridge were used for method development. A standard 
C18 - bonded silica 250 mm x 4.6 mm column for reverse phase HPLC (Column A) was 
used initially for detection and qualitative analysis of M1G, followed by a 100 x 2.00 mm 
narrower column (Column B) for quantitative analysis.  
2.3.14.1. High Performance Liquid Chromatography 
A crude pyrimido[1,2-a]purin-10(3H)-one (M1G) sample, made by reacting 100 mM MDA 
with 1 ml 6.6 mM guanine for 1 h in an incubator shaker, was used to develop a method 
of detection by HPLC and then optimized using a pure M1G standard (Section 2.3.15) to 
give the greatest sensitivity for detection. Three different buffers were chosen that were 
volatile enough to also be used for MS (Table 5). Six HPLC methods were used in 
combination with the three buffer choices in Table 5, shown in Table 6. 
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Table 5. Mobile phases for each buffer choice for HPLC method development. 
Buffer Mobile Phase 1 Mobile Phase 2 
A – Acetic Acid 
0.1 % Acetic Acid in 
methanol 
0.1 % Acetic Acid in 
Water 
B – Formic Acid 
0.1% Formic Acid in 
Methanol 
0.1% Formic Acid in 
Water 
C – Ammonium Formate Methanol 
50 mM Ammonium 
Formate (pH 5.4) 
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Table 6. HPLC methods for development of M1G detection method. 
Method Time (min) 
Mobile Phase 1 
(%) 
Mobile Phase 2 
(%) 
i 
0 10 90 
20 90 10 
30 90 10 
32 10 90 
40 10 90 
ii 
0 100 0 
20 0 100 
25 0 100 
28 100 0 
40 100 0 
iii 
0 25 75 
20 25 75 
iv 
0 25 75 
20 25 75 
30 100 0 
31 25 75 
40 25 75 
v 
0 10 90 
20 10 90 
30 100 0 
31 10 90 
40 10 90 
vi 
0 20 80 
20 20 80 
30 100 0 
31 20 80 
40 20 80 
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HPLC methods were carried out on an Agilent HPLC separation module with PDA (signal 
254 nm, reference 500 nm) and FLD (excitation 360 nm and emission 500 nm) detectors. 
The photomultiplier tube gain setting was set at the highest level of 18 using Agilent 
software. A needle wash using 100% methanol was used between draws. Two HPLC 
columns, A and B, were also used, the sample flow rates were 0.5 ml/min and 0.2 ml/min 
respectively. The column temperature was maintained at 25 °C and the sample volume 
was 20 µl for each sample. Three different flow rates were tested for the narrower HPLC 
column B: 0.1 ml/min, 0.15 ml/min and 0.2 ml/min to determine the optimum flow rate.  
The different methods were tested using the following samples: 1 mg/ml guanine in 1 M 
HCl, 1 mg/ml adenine in 1 M HCl, both diluted to 1:10 and 1:100, and a pure M1G 
standard (Section 2.3.15), diluted 1:10 to 1:106 in mobile phase 2 to 200 µl in low volume 
HPLC vials. A M1dG DNA standard with known concentration of M1dG (21 pmol M1dG/µg 
DNA, 3 mg/ml DNA) was hydrolysed as in Section 2.3.16 and was used to validate the 
HPLC method. Standard curves of pure M1G standard (0 – 53.4 µM) versus peak area 
and guanine (0 – 66 µM) versus peak area were plotted to assess the purity of the M1G 
standard. 
The peak resolutions (Rs) of the guanine and M1dG peaks of the M1dG DNA standard for 
columns A and B were calculated and compared using the following equation, where 
retention time (t), peak width (w) and baseline resolution Rs > 1.5. 
Rs =  
1.18(tB − tA)
(W0.5A + W0.5B)
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2.3.14.2. Liquid Chromatography – Mass Spectrometry  
 An Alliance LC-MS was used to develop a method for detection of M1G adducts by MS. 
The same samples, columns and HPLC conditions were used as in Section 2.3.14.1., with 
the UV absorbance set at 260 nm. The same mobile phases were used as in Table 5, with 
HPLC Method (iii) from Table 6, plus an additional method shown in Table 7. 
Table 7. LC method for development of M1G detection method. 
Time (min) Mobile Phase 1 (%) Mobile Phase 2 (%) 
0 
5 
20 
30 
32 
40 
2 
2 
98 
98 
2 
2 
98 
98 
2 
2 
98 
98 
 
Direct infusion of the crude M1G sample (Section 2.3.14.1) was used to determine the 
optimum cone voltage for detection of M1G by MS. The MS was performed in positive 
ion (ES+) mode with the lockspray removed, with a total ion current (TIC) scan of m/z 75 
to m/z 190 and reconstructed ion chromatogram (RIC) of m/z 188. The column 
temperature was maintained at 25 °C. The cone voltage was set at 50 V. Guanine and 
the pure M1G standard, diluted 1:100 in 50 mM ammonium formate (pH 5.4) buffer, 
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were analysed by LC-MS using the optimized MS conditions using method C(iii) (Section 
2.3.14.1.) and column B. 
2.3.14.3. Triple Quadrupole Mass Spectrometry  
Based on the development of the HPLC and LC-MS methods, the optimum method was 
used to fine tune the HPLC and MS methods and begin method development for 
LC-MS-MS. The HPLC method used was C(iii) (Section 2.3.14.1.). Column B was used and 
this was maintained at 25 °C. The sample flow rate was 0.2 ml/min with sample injection 
volume 10 µl, and UV absorbance at 254 nm. Different run times were tested, from 
8 min to 15 min. The final run time of 10 min was chosen, with a blank run in between 
each sample to remove any residual sample from the column.  
Direct infusion of the pure M1G standard was used to determine the optimum collision 
energy for analysis. Two MS-MS methods were used in conjunction: 1) a products of m/z 
188 scan in ES+ mode, scanning from m/z 75 to m/z 190, with 10 min data collection, 
0.5 s scan time, 0.1 s inter-scan delay, 28 eV collision energy and 50 V cone voltage; 2) a 
MRM scan of 2 mass pairs, with 10 min data collection in ES+ mode, as shown in Table 8. 
Table 8. MRM parameters for MS-MS scan 
Precursor m/z Product m/z Dwell (s) Cone (V) Collision 
Energy (eV) 
188 79 0.05 50 28 
188 106 0.05 50 28 
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A full scan was also set up in MS mode of m/z 145 to 300 in ES+ mode, scan duration 
0.5 s, inter-scan delay 0.1 s and cone voltage 50 V. The data was processed from the TICs 
produced by the products of m/z 188 scan and the full scan to give RICs and mass spectra.  
The same samples were used as in Section 2.3.14.1 to test the parameters and develop 
the optimum method for M1G detection by LC-MS-MS. Different flow rates were tested, 
including 0.1 ml/min, 0.125 ml/min, 0.15 ml/min, 0.175 ml/min and 0.2 ml/min. Flow 
rate 0.15 ml/min was chosen for sample analysis. 
2.3.15.  Preparation of Standards 
2.3.15.1. Synthesis of Pyrimido[1,2-a]purin-10(3H)-one Standard 
A procedure adapted from Singh et al. (2001) was used produce M1G. A number of 
different conditions were tried in order to optimize the method to produce the greatest 
yield of M1G crystals, including reaction of guanine with either MDA, as prepared in 
Section 2.3.1., or TMP directly and variations in the temperature used and length of 
reaction. The optimized method was as follows: 0.66 mmoles guanine was added to 
10 ml 1M HCl in a conical flask and heated on a hot plate to dissolve. The solution was 
then cooled, but not lower than 40 °C as the guanine precipitated. Next, 3 equivalents 
of TMP (2 mmoles) were very slowly added to the reaction mix and the flask was covered 
in foil and allowed to react for 2 h at 40 °C in a shaker incubator. 
The reaction mix was filtered using filter paper and the yellow M1G crystals were then 
washed with 0.1 M HCl to remove any impurities. The crystals were then rinsed with 
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water and allowed to dry overnight in a fume hood covered with a funnel to prevent 
contamination. The crude M1G crystals were collected and weighed. 
2.3.15.2. Purification of Pyrimido[1,2-a]purin-10(3H)-one Standard 
M1G crystal solubility was found to be pH dependent, increasing in basic conditions. 
However, a neutral or slightly acidic solution was required in order to prevent hydrolytic 
ring-opening of the M1G. Combinations of KOH with HCl and ammonia with formic acid 
were used to dissolve the M1G crystals, with differing final pHs. These solutions were 
analysed by HPLC to identify the acid/alkali combination and pH that gave the largest 
peak for the ring-closed form of M1G, which was formic acid/ammonia at pH 5.  
To purify the M1G crystals, 10.0 mg M1G crystals were dissolved in 1 ml concentrated 
ammonia solution and then diluted 1:10 in water. The pH was adjusted with 
concentrated formic acid to approximately pH 5, using litmus paper to check pH. 
A SPE cartridge was conditioned with 2 ml methanol followed by 2 ml 50 mM 
ammonium formate buffer (pH 5.4), taking care not to allow the column to dry out. All 
of the M1G solution was added to the SPE cartridge and fractions of approximately 
250 µl were collected, cooled immediately, labelled and frozen at -20°C. Next, 1 ml 
aliquots of the following were added to the SPE cartridge – 50 mM ammonium formate 
(pH 5.4) with an increasing % of methanol in 5 % increments from 0 – 100 %. 
Fractions were analysed by HPLC using method C(iv) as detailed in Section 2.3.14.1, using 
column B. Fractions with M1G peaks were identified, combined, and freeze-dried 
overnight. The freeze-dried crystals were then weighed. 
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The M1G crystals were dissolved in 1 ml concentrated ammonia solution and then 
diluted 1:10 in water. The pH was adjusted with concentrated formic acid to 
approximately pH 5. The SPE was repeated as above for additional purification. 
2.3.16.  Treatment of DNA with Malondialdehyde 
CT-DNA was dissolved in 0.1 M KH2PO4 buffer (1.35 g/l KH2PO4 in water) at 60 °C to 
5 mg/ml. DNA from MRC5 (51.5 µg/ml) and MRC5 SV2 (86.0 µg/ml) cells untreated with 
MDA or H2O2 (negative controls), from Section 2.3.12.1., were treated post-DNA 
extraction as follows: A 100 mM stock solution of MDA was prepared as in Section 2.3.1. 
Aliquots of 100 µl DNA were reacted with MDA (0 – 50 mM) and H2O2 (100 µM), to give 
a final volume of 500 µl, in triplicate for 5 days in the dark at 37 °C in a shaker incubator. 
All DNA samples extracted from MRC5 and MRC5 SV2 cells treated with MDA and H2O2 
in Section 2.3.12.1., the concentrations of which are shown in Table 9 (previously 
quantified by Nanodrop spectrophotometry (absorbance 260 nm)), were then 
precipitated and hydrolysed for LC-MS-MS analysis. 
A 500 µl aliquot of the DNA sample (500 µg CT-DNA samples, 5.15 µg MRC5 and 8.6 µg 
MRC5 SV2 DNA samples treated post-extraction, and 1.75 µg MRC5 and 24.5 µg MRC5 
SV2 DNA samples from treated cells) was added to 500 µl cold isopropanol and 
centrifuged for 10 min at 12,000 x g. The supernatant was removed and 500 µl cold 100% 
ethanol was added to wash the pellet and then centrifuged at 12,000 x g for 10 min. The 
supernatant was removed and 500 µl cold 70% ethanol was added to wash the pellet 
and then centrifuged for 10 min at 12,000 x g. The supernatant was removed and the 
pellet was re-suspended in 500 µl 0.1 M formic acid and then incubated for 1 h at 70 °C 
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in a water bath. The samples were then dried overnight at 40 °C in a centrifugal dryer. 
The dried DNA samples were then re-suspended in 100 µl 0.01 M formic acid and 
sonicated for 20 min to re-dissolve ready for analysis. 
Table 9. DNA concentrations of MRC5 and MRC5 SV2 DNA from cells treated 
with MDA and H2O2 used for LC-MS-MS analysis. 
MDA Treatment (µM) 
DNA Concentration (µg/ml) 
MRC 5 MRC 5 SV2 
0  17.0 49.0 
10 25.5 29.5 
50 13.5 39.0 
100 13.0 30.0 
200 24.0 37.5 
500 16.5 14.5 
1000 20.0 47.0 
50 H2O2 37.0 3.5 
100 H2O2 12.0 4.5 
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2.3.17.  DNA Adduct Analysis by Triple Quadrupole Mass 
Spectrometry 
2.3.17.1. Analysis of Pyrimido[1,2-a]purin-10(3H)-one Standard 
A series of M1G standards was made using the purified M1G crystals (Section 2.3.15.2.). 
0.1 mg M1G crystals were dissolved in 500 µl 50 mM ammonium formate buffer (pH 5.4), 
sonicated for 20 min and then made up to 1 ml with more buffer, to give a 0.1 mg/ml 
solution. The standard was diluted 1:10 – 1: 106 in buffer. 
Standard curves of peak intensity versus M1G concentration were prepared using the 
series of pure M1G standards, for each of the products of m/z 188 ions and the MRM 
scan produced from analysis by LC-MS-MS using the method optimized in Section 
2.3.14.3. The M1dG DNA standard with a known concentration of adduct (21 pmol/µg 
DNA) was analysed by the same method and the standard curves were used to compare 
the amount M1G detected for each product of m/z 188 ion and by the MRM scan with 
the known amount, to ascertain the accuracy of the method. 
The limit of detection (LOD) and limit of quantification (LOQ) were determined using the 
calibration line method. A standard curve of peak intensity versus M1G concentration 
was plotted for 1:1000 to 1:15000 dilutions of the pure M1G standard, as prepared and 
analysed as above, for products of m/z 188 ions (m/z 79 and m/z 106) and the MRM 
scan. LOD was calculated using the following equation: 
LOD =  
Standard Error of Regression Line
Gradient
 × 3.3 
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The LOQ was calculated using the following equation: 
LOQ =  
Standard Error of Regression Line
Gradient
 × 10 
Peak precision for the peak with the M1G concentration closest to the LOQ was 
determined by calculating the % relative standard deviation (RSD), with good precision 
< 0.5%, as follows: 
% RSD =  
SD
Mean
 × 100 
To determine if guanine had an effect on the level of detection of M1G adducts by LC-
MS-MS, the 1:200 diluted M1G standard was spiked with 10 µl, 20 µl, 50 µl and 100 µl 
1 mg/ml solution of guanine and analysed by LC-MS-MS as previously. To determine 
whether the expected m/z was correct for each sample, a full scan of m/z 145 –300 was 
carried out on 0.1 mg/ml guanine, 0.1 mg/ml adenine, 1:10 and 1:100 dilutions of the 
M1dG DNA standard (diluted as above) and the M1G standards. 
2.3.17.2. Analysis of DNA Samples 
The hydrolysed CT-DNA and the MRC5 and MRC5 SV2 DNA samples treated post 
extraction with MDA and H2O2 (Section 2.3.16) and the MRC5 and MRC5 SV2 cell 
samples (Section 2.3.12.1) were each transferred into low volume HPLC vials and freeze 
dried overnight. The samples were then each dissolved in 100 µl 50 mM ammonium 
formate buffer (pH 5.4) in the low volume vials and then analysed by LC-MS-MS using 
the method developed in Section 2.3.14.3 for both the products of m/z 188 and the 
MRM scans.  
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CHAPTER 3  
CELLULAR EFFECTS OF 
MALONDIALDEHYDE 
The purpose of this chapter is to present the results from a number of assays where the 
effects of MDA are shown at the cellular level using an in vitro model. The MDA 
standards used in the assays were checked by the TBARS assay and HPLC with DNP 
derivatisation prior to treatment of MRC5 and MRC5 SV2 cells. Components in FBS (a 
widely used serum-supplement in in vitro cell culture of eukaryotic cells) have been 
found to interact with MDA (Rittie et al., 2002). As FBS contains growth supplements 
that cells require for proliferation, the effect of omitting FBS from the cell media was 
examined in order to determine whether this would have an effect on the assays utilized 
in this research. The effects of MDA on cell viability, cellular morphology, nuclear 
morphology, apoptosis and p53 protein expression are presented here. 
In all assays involving MRC5 and MRC5 SV2 cells, cells were initially grown in complete 
media and subsequently treated with MDA (0 – 1000 µM), or untreated as a negative 
control, in FBS-free media for 24 and 48 h, unless otherwise stated. H2O2 (0-100 µM), 
known to induce oxidative stress at sub-lethal doses, was used as the positive control to 
verify that the effects observed were due to the effect of MDA on the cells (Caldini et 
al., 1998), the data for which is not always shown. Where confocal microscopy was used, 
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the detector gain was kept constant to show that differences in fluorescent intensity 
was due to the experimental rather than instrumental parameters. 
3.1. Verification of Malondialdehyde Concentrations  
MDA was synthesised by acid hydrolysis of TMP, as shown in Scheme 10.  
 
Scheme 10. Hydrolysis of TMP to form MDA  
A TBARS assay to confirm the MDA concentration of MDA standards was carried out. 
This was then verified by reacting MDA with an acidified solution of DNP (Brady’s 
reagent) to form MDA-DNP derivatives, which were then analysed by HPLC. In order to 
determine the concentration of MDA present in solutions, a TBARS assay of MDA 
standards (Section 2.3.2.) was carried out (Figure 9). The linear regression had a R2 value 
close to 1 indicating good linearity, however, above 1000 µM the linear regression lost 
linearity, indicating the upper limit of detection of MDA by this assay.  
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Figure 9. Standard curve of 0-1000 µM MDA measured using a TBARS assay, 
absorbance measured at 532nm.  
The concentrations of MDA standards were verified by DNP derivatisation and HPLC 
(Section 2.3.3.), the derivatisation reaction is shown in Scheme 11.  
 
Scheme 11. DNP derivitisation of MDA to form 1-(2,4-dinitrophenyl)pyrazole (MDA-
DNP) (adapted from Ekstrom et al. (1988)).  
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Figure 10. HPLC chromatograms of MDA analysis using derivatisation with Brady’s 
reagent: A) blank showing the peak for Brady’s reagent at 15.255  min; B) 1 mM MDA 
showing an additional peak at 19.423 min for the MDA-DNP derivative; C) 10 mM MDA 
showing only the MDA-DNP peak at 19.430  min.  
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The HPLC chromatograms are shown in Figure 10, where for 0 mM MDA the single peak 
represents Brady’s reagent and at 1 mM MDA shows an additional peak that represents 
the MDA-DNP derivative (19.4 min). At 10 mM MDA, the Brady’s reagent peak is present 
as a very small peak, however, the MDA-DNP peak is present (19.4 min) as a large peak, 
indicating that the MDA concentrations were at the upper limit for this assay, as above 
10 mM the Brady’s reagent is saturated and there is little further increase in peak area. 
This can also be seen in the calibration curve, as shown in Figure 11. The calibration 
curve had good linearity with a R2 value close to 1. However, the calibration curve loses 
linearity above 8 mM MDA, where the R2 value decreases indicating the upper limit of 
the assay due to Brady’s reagent saturation. Analysis of MDA by HPLC with DNP 
derivatisation allows for a wider range of MDA concentrations to be analysed, up to 
8 mM MDA, compared to 900 µM MDA by TBARS assay, with improved sensitivity and 
selectivity. 
 
Figure 11.    Standard curve of 0-8 mM MDA by DNP-derivatisation, analysed by HPLC 
at 350 nm. 
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A possible small peak at retention time 14.1 min at 10 mM MDA was observed in Figure 
10. However, concentrations at this level were not used for treatment of cells. Most 
importantly, as the aim of this work was to ensure that the product of TMP hydrolysis 
was MDA, no other peaks were observed at any of the lower MDA concentrations 
analysed indicating that the only aldehyde that results from TMP hydrolysis is MDA. It 
has been suggested that MDA may polymerise at high concentrations, and in older 
solutions (Gutteridge et al., 1977; Janero, 1990). However, as the concentration range 
of MDA (0 – 1000 µM) used for treatment of MRC5 and MRC5 SV2 cells and subsequent 
assays in this chapter was relatively low, it is unlikely that polymerisation of MDA would 
occur at these concentrations.  
The TBARS assay had lower specificity and overestimated the MDA content compared 
to HPLC detection of the same MDA-TBA samples (Lykkesfeldt, 2001). Interfering 
chromagens are mostly eliminated by measurement of MDA-TBA by high performance 
liquid chromatography (HPLC). However the red product can stain the HPLC equipment 
and HPLC is less practical as it is less readily available as an analytical technique than 
TBARS (Badcock et al., 1997). The traditional MDA-TBA spectrophotometric assay was 
compared to detection of MDA-TBA and MDA-DNP by HPLC in fish, which has high levels 
of PUFA and therefore highly susceptible to lipid peroxidation. The MDA-DNP method 
gave the greater accuracy and specificity than the MDA-TBA methods, however it had a 
relatively high limit of detection and lower reproducibility at lower MDA concentrations 
(Mendes et al., 2009).  
Chapter 3 Cellular Effects of Malondialdehyde 
  87  
The TBARS test has low specificity for MDA as other lipid peroxidation products are also 
TBA positive e.g. monofunctional aldehydes, it is therefore considered to be a general 
indicator of lipid peroxidation rather than a specific test for MDA (Janero, 1990). 
Different analytical techniques for the quantification of MDA were compared (Fenaille 
et al., 2001). MDA derivatisation with TBA, using both visible spectrophotometry and 
HPLC led to an overestimate of MDA content due to the elevation of temperature 
required which may have catalysed artefactual MDA formation. The DNP derivative of 
MDA measured by HPLC-UV and the phenylhydrazone derivative of MDA, measured by 
GC-MS gave lower MDA levels. However, the TBARS test is widely used as it is simple 
and can be a useful tool for MDA detection if further methods of verification are used, 
such as DNP derivatisation. The HPLC analysis verified that a single aldehyde was formed 
from TMP hydrolysis, and that quantitative hydrolysis occurred to give the required 
concentration of MDA for treatment of cells.  
3.2. Effect of Foetal Bovine Serum and Malondialdehyde on Cell 
Growth and Viability 
Mammalian cells, used in in vitro studies, are cultured in basic media which contains a 
number of different nutrients. The media can be supplemented according to the growth 
requirements of a particular cell line. Amino acids, antibiotics and FBS are examples of 
media supplements. Although FBS is ill-defined, it provides nutrients, macromolecular 
proteins and other compounds necessary for cell growth, such as hormones. It can also 
act as a buffer for the culture medium and it contains a high content of embryonic 
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growth factors. It possesses these properties as it is harvested from foetuses. Cell 
proliferation and growth of the foetus requires specific growth factors and nutrients 
which are present in the serum. Cells from solid tissues e.g. fibroblasts and epithelial 
cells are adherent and require a surface for the cells to attach and proliferate, whereas 
other cells can grow in suspension e.g. blood cells. Adherent cells need to be detached 
from the surface of their container when they reach a particular level of confluence 
(depending on the requirements of the particular cell line) and subcultured/passaged. 
The adhesion mechanisms of the cell are Ca2+ dependent and the enzyme trypsin is used 
(often with chelating agent EDTA) to digest the proteins from the cell surface that allow 
adhesion (Butler, 2004). MRC5 and MRC5 SV2 are adherent cell lines and hence growth 
in FBS-free media needed to be investigated to ensure adequate growth. 
To characterize cell proliferation and viability, the two cell lines were grown in both 
complete media and FBS-free media under standard conditions, as described in Section 
2.3.5. Cell proliferation was measured by viable cell count. MRC5 cells were observed to 
grow more slowly (k = 0.052 h-1) than their transformed counterpart MRC5 SV2 
(k = 0.072 h-1) in complete media and the growth rate decreases for both cell lines when 
grown without FBS (k = 0.044 h-1 MRC5 and 0.052 h-1 MRC5 SV2 respectively), as seen in 
Figure 12.  
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Figure 12.  Growth of A) MRC5 and B) MRC5 SV2 mean cell number versus time, in 
complete and FBS-free media, error bars indicate ± 1SD from the mean (number of 
replicates n = 3).  
The mean cell number of MRC5 and MRC5 SV2 cells were compared at each time point 
when grown with and without FBS by Student’s t-test, as shown in Table 10. A significant 
difference was observed between cells grown with and without FBS over time, apart 
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from MRC5 cells after 24 h. This experiment was repeated in triplicate, giving consistent, 
repeatable results.  
Table 10. Statistical analysis of the mean cell number of MRC5 and MRC5 SV2 cells 
grown in complete versus FBS free media for 24 and 48 h, by Student’s t-test: P values 
for significance (*). 
P Values for Complete vs FBS Free Media 
MRC5 24 h 0.801 
MRC5 48 h 1.2 x 10-4 * 
MRC5 SV2 24 h 0.041 * 
MRC5 SV2 48 h 1.71 x 10-8 * 
 
These results indicate that FBS is an important growth supplement for the proliferation 
of both cell lines and without FBS, and taking the large error bars in Figure 12 into 
account, it appears that cells were no longer proliferating at 48 h. However, cells were 
found to be sufficiently viable up to 48 h without FBS present in the media, indicating 
that FBS-free media would be suitable for further assays. 
To compare the effects of MDA on cell viability, both cell lines were treated with MDA 
(0-1000 µM). Cell viability was measure by viable cell count and the cell number was 
normalised to the respective negative controls. Figure 13 shows that after 24 h 
treatment, there was an increase in cell viability for both MRC5 and MRC5 SV2 cells 
when treated with 10 µM MDA compared with the negative control. Cell viability then 
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decreased to a greater extent for MRC5 SV2 cells than MRC5 cells when treated with 
100 µM MDA and 1000 µM.  
 
Figure 13. Viability of MRC5 and MRC5 SV2 cell lines following treatment with 
MDA (0-1000 µM) for A) 24 h and B) 48 h (1000 μM MDA > 0.5% in B), normalised to 
the negative control, error bars indicate ± 1SD from the mean (n = 12). 
The mean cell number of MRC5 and MRC5 SV2 cells were compared with each other at 
each MDA concentration (0-1000 µM) and each time point by Student’s t-test, as show 
in Table 11. Significant differences were observed at 24 h between the negative controls 
and when treated with 1000 µM MDA, which confirms the differences in growth 
between the two cell lines. 
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Table 11. Comparison of the mean cell numbers of MRC5 and MRC5 SV2 cells 
treated with MDA (0-1000 µM) by Student’s t-test: P values for significance (*). 
MDA Concentration 
(µM) 
24 h 48 h 
0 0.024 * 2.17 x 10-5 * 
10 0.107 0.006 * 
100 0.231 0.401 
1000 0.001 * n/a 
 
After 48 h treatment with 10 µM MDA, cell viability remained slightly higher than the 
negative control for MRC5 and MRC5 SV2 cells, and these values were lower than their 
respective values following 24 h treatment. When treated with 100 µM MDA for 48 h, 
cell viability for both cell lines was reduced compared with 10 µM MDA and the negative 
control, but also with 100 µM MDA for 24 h. No viable cells remained following 
treatment with 1000 µM MDA for 48 h. Significant differences in mean cell number 
between the two cell lines were observed at 48 h between the negative controls and 
when treated with 10 µM MDA (Table 11). This experiment was repeated in triplicate, 
giving consistent, repeatable results. 
The growth rate of MRC5 cells was found to be slower than the growth rate of MRC5 
SV2 cells, both with and without FBS, and the growth rate of both cell lines is reduced in 
FBS-free media. Although the removal of FBS from the media reduced the growth rate 
of both cell lines, cells were still found to be viable up to 48 h, hence a maximum of 48 h 
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treatment times were used throughout this study. FBS-free media was used for 
treatment of cells with MDA as MDA is known to bind to bovine serum albumin (BSA) 
(Takagi et al., 2005) in vivo, a major component of FBS (Rittie et al., 2002). The formation 
of MDA-BSA adducts would effectively reduce the dose of MDA in the treatment 
solution, and therefore the MDA concentration would not be known, thus FBS-free 
media was used throughout the study. 
The viability of both cell lines were compared when treated with different 
concentrations of MDA (Figure 13). Treatment with a relatively low MDA concentration 
(10 µM) appeared to induce (or failed to inhibit) the growth in both cell lines compared 
to the negative control (cells grown in FBS-free media). The same trend has been 
observed with other cell lines treated with different chemicals, for example, in LL24 
human lung fibroblast cells treated with relatively low concentrations of benzene, 
enhanced cell proliferation was observed (Giuliano et al., 2009) and it was suggested 
that treatment with relatively low doses caused a defect in cell cycle control, allowing 
cell proliferation. Increased cell proliferation was observed in MRC5 cells and A549 
human adenocarcinoma cells treated with relatively low doses of the cigarette smoke 
products, pyrazine, 2-ethlpyridine and 3-ethylpyridine, whereas higher doses were 
inhibitory (Liu et al., 2015).  
At higher MDA concentrations (100-1000 µM), the cell viability of both cell lines 
gradually decreased to zero after 48 h incubation, suggesting that higher MDA 
concentrations have an adverse effect on cell viability, which was also observed by 
(Giuliano et al., 2009), although in different cell lines. 
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Cells were counted using a dye-exclusion assay, involving the exclusion of trypan blue 
from healthy cells due to maintenance of the integrity of the cell membrane, thus 
staining only dead, non-viable cells. Cells in late apoptosis and early necrosis exhibit a 
loss of membrane integrity and are able to take up trypan blue. In contrast, cells with 
intact membranes exclude trypan blue and are therefore not stained blue. Cells with 
intact and disrupted membranes can therefore be distinguished and excluded from the 
cell count, although cells in early apoptosis will still have some membrane integrity and 
also exclude trypan blue (Siddique et al., 2009). Therefore the cells counted as healthy 
and viable in these assays may be greater than expected due to early apoptotic cells 
being counted as well as viable cells, although the cell counts are relative to each other 
as the same procedure was used for each cell line and MDA treatment. 
3.3. Cell Viability using a MTT Assay 
The colormetric MTT assay is used as a measure of metabolic activity of a cell population. 
The assay was developed to measure cell proliferation, cell activation and cytotoxicity 
rapidly, precisely and without the use of radioisotopes (Mosmann, 1983). The principle 
behind the MTT assay is to add a substrate to a cell culture which is metabolised by living 
cells to produce a different coloured product which can be quantified by 
spectrophotometry. Any dead cells and the medium in which the cells are growing do 
not account for any change in colour/absorbance as they do not process the substrate. 
MTT is a tetrazolium salt which has a tetrazolium ring. Active mitochondria (i.e. living 
cells) cleave the ring producing the coloured product. The formation of the coloured 
product is therefore directly related to mitochondrial activity and can be used to 
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measure cell viability. MTT is yellow in colour and is reduced by mitochondria to give a 
purple product, a formazan. The reaction is shown in Scheme 12. 
 
Scheme 12. The reaction of MTT to the purple formazan product, catalysed by 
mitochondrial reductase. 
The mitochondrial reductase enzyme that converts the MTT to the formazan product is 
only active in active mitochondria. Suitable solvents, such as DMSO, are used to 
solubilise the insoluble formazan into a coloured solution whose absorbance is 
quantified using spectrophotometry (Mosmann, 1983). 
The effect of MDA (0-1000 µM), and positive control H2O2 (0-100 µM), on the viability 
of MRC5 and MRC5 SV2 cells was assessed by MTT assay and the mean percentage cell 
viability calculated and normalised to the negative control (Section 2.3.6.). Only data for 
0-450 µM MDA was recorded as above this concentration range the cell viability was 
very low and results were inconsistent, perhaps due to decreased cell numbers and 
assay sensitivity. Figure 14 shows the mean percentage viability of MRC5 and MRC5 SV2 
cells treated with MDA for 24 and 48 h. After 24 h, the viability of MRC5 cells increases 
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when treated with 25 µM MDA and then decreases with increasing MDA concentration, 
although viability appears to increase when treated with 400 µM and 450 µM MDA. The 
viability decreases further after treatment with MDA for 48 h, compared with the 
respective treatments after 24 h, although there was some fluctuation in the percentage 
viability of cells treated with 100 µM to 450 µM MDA rather than a gradual decrease in 
viability. After 24 h, the viability of MRC5 SV2 cells increased when treated with 25 µM 
MDA and then remained at approximately 100% (the same as for the untreated cells to 
which the data were normalised) for 50-100 µM MDA but then decreased gradually. 
After 48 h, the viability of MRC5 SV2 cells decreased much more steeply than for 24 h, 
although there was still an increase in viability following treatment with 25 µM MDA, 
however, this was lower than after 24 h. Treatment of both cell lines with the positive 
control (H2O2) also showed a similar dose dependent decrease in cell viability, but to a 
greater extent than MDA (data not shown). 
The percentage viability of MRC5 and MRC5 SV2 cells were compared with one another 
for each MDA concentration (0-450 µM) at each time point by Student’s t-test, P values 
are shown in Table 12. For 24 h, the viability of the two cell lines were significantly 
different for each concentration of MDA. After 48 h, there was a significant difference 
in the viability of the two cell lines for each MDA concentration apart from 350 µM MDA. 
These assays were repeated (n = 4) giving consistent results. 
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Figure 14. Viability of A) MRC5 and B) MRC5 SV2 cells treated with MDA (0-450 µM) 
over 24-48 h, normalised to the negative control, error bars indicate ± 1SD from the 
mean.  
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Table 12.    Comparison of the viability of MRC5 and MRC5 SV2 cells treated with 0-
450 µM MDA by Student’s t-test: P values for significance (*) 
MDA 
Concentration 
(µM) 24 h 48 h 
25 0.0028 * 0.0133 * 
50 0.00020 * 0.00022 * 
100 0.00098   * 0.00040 * 
150 0.00029  * 0.00020  * 
200 0.00001  * 0.00025  * 
250 0.00021  * 0.00196  * 
300 0.00034  * 0.00682  * 
350 0.00072  * 0.08172 
400 0.00015  * 0.01439  * 
450 0.00017  * 0.01628  * 
 
MDA appeared to have less of an effect on MRC5 SV2 cells than MRC5 cells at 
concentrations below 250 µM MDA. In general, the viability decreased after 24 h and 
then decreased further after 48 h for both cell lines, but to a greater extent with MRC5 
cells. When treated with 25 µM MDA, the viability of both cell lines did not follow the 
trend and increased to greater than the viability of the untreated controls to which the 
data was normalised. At higher MDA concentrations (50-450 µM), the profile of cell 
viability of MRC5 was very different to that of the MRC5 SV2 cells. The viability of MRC5 
cells decreased after 24 h for all concentrations, and decreased further after 48 h. The 
viability of MRC5 SV2 cells decreased to a much lesser extent than for MRC5 cells after 
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both time periods for concentrations up to 300 µM MDA, but to a greater extent than 
MRC5 after 24 h, above 300 µM MDA.  
When compared to the initial cell viability assay in Section 3.2., where a viable cell count 
was used to assess viability in response to MDA treatment, the cell viability of both cell 
lines was generally lower when assessed by the MTT assay. This was due to the inclusion 
of all cells with an intact cell membrane which may or may not have been viable using 
the viable cell count, whereas the MTT assay measures mitochondrial activity as a 
measure of viability. 
H2O2 is often chosen as a positive control in cell toxicity assays as it is known to induce 
cytotoxic effects and DNA damage and induce oxidative stress at sub-lethal doses 
(Caldini et al., 1998). It is an intermediate molecule formed from dismutation of 
superoxide anions by superoxide dismutase. The positive control in this assay (H2O2) had 
a greater effect on both cell lines than MDA, with cell viability decreasing with increasing 
H2O2 concentration (0-100 µM). This effect was also seen in rat cortical neurons, where 
treatment with MDA and H2O2 produced a significant dose dependent decrease in cell 
viability using the MTT assay. The effect of H2O2 was more severe than MDA, suggesting 
that they have different damaging effects on the cell (Cheng et al., 2011). 
MRC5 cells, which have an intact p53 response, appear to be more susceptible to MDA 
than their transformed counterpart, MRC5 SV2 cells, which have a sequestered p53 
response (Huschtscha and Holliday, 1983). The TP53 gene acts in response to DNA 
damage by triggering apoptosis and cellular senescence. Lack of p53 response in MRC5 
SV2 cells may allow cells with DNA damage, which would normally apoptose, to continue 
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to proliferate. MRC5 SV2 cells appear to be less sensitive to MDA than MRC5 cells, 
perhaps due to the altered p53 response of MRC5 SV2 cells, e.g. allowing cells to 
continue to be metabolically active despite DNA damage which would normally trigger 
apoptosis. Other non-transformed human cell lines have been shown to respond to 
MDA in a similar manner to MRC5 cells. The effects of MDA on human bone marrow 
mesenchymal stem cells was assessed by flow cytometry and MTT assay (Guolin et al., 
2006) and it was found that increasing concentrations of MDA (up to 1 mM) decreased 
the cell count, increased the population doubling time, decreased cell viability and 
triggered apoptosis. The flow cytometry also revealed that the percentage of cells in the 
G2/M and S phases of mitosis increased with increased MDA concentration, suggesting 
MDA may trigger cell proliferation during oxidative stress, even though the rate of 
apoptosis also increased. As discussed in Section 3.2, enhanced proliferation was 
observed in cells subjected to low doses of chemical (Giuliano et al., 2009; Liu et al., 
2015). This hermetic dose response, with contradictory low dose stimulation but high 
dose inhibition was described when levels of ROS, lipid peroxidation, heat shock proteins 
and glutathione peroxidase (the latter two being indicators of damage response) were 
measured in human embryo lung fibroblasts following treatment with sodium arsenite 
(Yang et al., 2007). Cell proliferation was induced in response to low doses without 
cytotoxicity, but was inhibited at high doses, along with increased ROS, lipid 
peroxidation and cellular damage. This induction of cellular proliferation was also 
observed in the MTT assay (25 µM MDA) for both MRC5 and MRC5 SV2 cells, the viability 
increased in the initial 24 h of treatment with MDA, although this may also be due to 
cell proliferation before the MDA has had time to act.  
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The MTT assay relies on the mitochondrial reductase enzyme to catalyse the production 
of the formazan product, however, the enzyme may be altered by the test compound 
which may result in false negative or positive results, although this would depend upon 
the mechanism by which the test compound acts. A combination of assays, including 
microscopy to observe cell morphology, is therefore required to confirm the effect of 
the test compound on the cell (Hamid et al., 2004). 
3.4. In vitro Imaging of Cells 
MRC5 and MRC5 SV2 cells are morphologically different from one another, MRC5 cells 
appear more elongated with finger-like projections, typical of fibroblast cells (Alberts et 
al., 2002), whereas MRC5 SV2 cells are smaller and more rounded, typical of epithelial 
cells, as shown in Figure 15 and Figure 16, which may be due to their differing p53 
responses.  
Both cell lines were imaged using an inverted optical microscope to assess the effect of 
treatment with MDA and H2O2 on cell morphology, as described in Section 2.3.7. MRC5 
cells treated for 24 h and 48 h are shown in Figure 15. MRC5 SV2 cells treated for 24 h 
and 48 h are shown in Figure 16. Overall, MRC5 cells appeared to be fibroblastic with 
multiple filopodia compared to the MRC5 SV2 cells, which appeared to display an 
epithelial morphology, as expected. As previously observed in Section 3.2, MRC5 SV2 
cells grow more densely than their MRC5 counterparts, which can also be seen in Figure 
15 and Figure 16. As the concentration of MDA increased, the number of cells decreased 
for both cell lines, which was also observed in Section 3.2. There was a noticeable 
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decrease in cell density between the positive control (50 µM H2O2) and negative control 
(no treatment) for both cell lines and both time periods.  
It can be seen from Figure 15 and Figure 16 that when treated with MDA, both cell lines 
started to detach from their substrate (as indicated by dark/light round structures in the 
images). Cell detachment appeared to increase with increasing MDA concentration and 
exposure time, indicating loss of cell viability as previously observed in Sections 3.2 and 
3.3. Similar results were observed when cells were treated with H2O2 (positive control). 
The images shown in Figure 15 and Figure 16 are representative of a number of images 
(n = 6) taken for each cell line and treatment, the observations were thus repeatable. 
MRC5 SV2 cells have a sequestered p53 response, due to transformation of the wild type 
cells, MRC5, with the SV40 virus (Huschtscha and Holliday, 1983). It has not been 
documented as to why there is a difference in cell size and shape between the two cell 
lines, however, it may be assumed that the differences in morphology are due to the 
sequestration of p53 in MRC5 SV2 cells compared to the wild type p53 in MRC5 cells. A 
possible explanation for the difference may be the effect sequestration of the p53 
protein has on the cytoskeleton.  
The cytoskeleton is a network of protein fibres including microfilaments (actin), 
microtubules and intermediate filaments, that, along with cell surface receptors and the 
extracellular matrix, determine the morphology of the cell. Contractile stress fibres are 
the main actin-containing cytoskeletal structures, and give the cell tension and shape. 
Microtubules are involved in cell-substrate adhesion and aid cell elongation and 
filopodia maintenance. Intermediate filaments provide the main structure for overall 
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cell shape (Mermelstein et al., 2003; Lazaro-Dieguez and Egea, 2007). The TP53 gene 
coordinates many cellular responses and with regards to the cytoskeleton, actin 
regulators RhoC (which is involved in rearrangement of the actin cytoskeleton) and LIM 
kinase 2 (which inactivates filamentous actin) have been found to be direct TP53 target 
genes. Treatment of cells expressing wild type p53 with cisplatin led to an increase in 
RhoC and Lim kinase 2 expression, but not in cells expressing mutant p53 (Croft et al., 
2011). 
The morphology of the cell may be affected by treatment with carcinogenic and 
mutagenic compounds. Actin poisons, e.g. phalloidin, have been shown to have an effect 
on the cytoskeleton organisation and thus the shape of the cell (Lazaro-Dieguez and 
Egea, 2007). MRC5 cells treated with cigarette smoke compounds exhibited altered cell 
morphology with increased cell rounding, shape irregularity in a dose dependent 
manner (Liu et al., 2015), as also observed here. The carbonyl group of MDA has been 
found to react with nucleophilic groups of proteins, such as cysteine, lysine, arginine and 
histidine residues, to form protein adducts (Pamplona, 2011). MDA is known to modify 
β-actin, γ-actin, α-tubulin and β-tubulin (Zarkovic et al., 2013), which are involved in the 
maintenance and integrity of the cytoskeleton and thus cell morphology. 
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Figure 15. Light microscope images of MRC5 cells following treatment for 24 h (A-
D) and 48 h (E-H) with MDA: A & E) 0 µM MDA; B & F) 100 µM MDA; C & G) 1000 µM 
MDA and D & H) 50 µM H2O2. Arrows indicate cell detachment as light/dark round 
structures. Magnification x20, n=6, all images are representative of each sample. 
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Figure 16. Light microscope images of MRC5 SV2 cells following treatment for 24 h 
(A-D) and 48 h (E-H) with MDA: A & E) 0 µM MDA; B & F) 100 µM MDA; C & G) 1000 µM 
MDA and D & H) 50 µM H2O2. Arrows indicate cell detachment as light/dark round 
structures. Magnification x20, n=6, all images are representative of each sample. 
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Whilst inverted light microscopy allowed imaging of live cells in vitro, without using 
fixation techniques which may alter the cellular conformation, the low magnification of 
the light microscope limits the amount of information obtainable from these images. 
The morphological differences between the two cell lines have been shown, but other 
than reduction in cell density and an increase in cell detachment, no other changes could 
be detected, hence the requirement to use more advanced imaging techniques to 
investigate the effects of MDA on MRC5 and MRC5 SV2 cells. 
3.5. Cell Surface Morphology by Atomic Force Microscopy 
AFM imaging of the cell surface was used at it allows much more cellular surface detail 
to be shown compared with the light microscope. Firstly, the magnification and 
resolution are much greater than the light microscope. Secondly, the AFM tip also scans 
the surface of the cell enabling the morphology of the cell surface to be mapped. 
Following treatment with MDA for 24 h, the cells were fixed in glutaraldehyde, air-dried 
and then imaged by AFM to look for differences in cell surface morphology, as described 
in Section 2.3.13.1. Only images of cells treated with 0-200 µM MDA and after 24 h were 
captured due to the reduced cell density observed at higher MDA concentrations making 
AFM imaging difficult, as cells were harder to locate. All images shown are 
representative of a number of images (n = 10) taken for each cell line and treatment. 
MRC5 and MRC5 SV2 cells treated with MDA are shown in Figure 17. Untreated MRC5 
and MRC5 SV2 cells both appeared to have a smoother, more rounded surface, with 
defined boundaries. AFM images of MRC5 and MRC5 SV2 cells treated with MDA show 
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increasing irregularity of the cell morphology and the cell surfaces seemed to become 
more ‘pitted’ with increasing concentrations of MDA, indicating possible damage to the 
cell membrane and cytoskeleton. Different actin poisons (e.g. phalloidin, which binds to, 
and stabilises dynamic actin microfilaments, preventing depolymerisation (Prentki et al., 
1979)), had an effect on the actin cytoskeleton and on cellular shape, with the surface 
of cells becoming more pitted and with blebbing (protrusion or bulging of the plasma 
membrane) (Lazaro-Dieguez and Egea, 2007), as observed here. MDA has a high 
capability of interacting with a number of biomolecules, forming adducts with both DNA 
and proteins including cytoskeletal proteins, enzymes, carrier proteins and 
mitochondrial proteins. These adducts may form secondary DNA or protein crosslinks, 
which may alter the biochemical nature of these biomolecules (Ayala et al., 2014), and 
thus make alterations to the cell morphology. 
MRC5 cells treated with cigarette smoke compounds, had increased cell rounding, 
altered cell morphology and shape irregularity with increased doses of the chemicals 
(Liu et al., 2015), as also observed here. Whilst there was an obvious change in the cell 
surface characteristics of the MRC5 and MRC5 SV2 cells here, the cells were fixed and 
air-dried and so their appearance when imaged by AFM would be altered compared to 
that in vitro. AFM was used to image the morphology of developing tumour cells and it 
was pointed out that the drying procedure when preparing the cells for AFM imaging 
may have caused some flattening of the nanostructure of the cells’ surface and thus 
there may have been an increase in the cell surface roughness as a result (Tomankova 
et al., 2007). The different fixatives available for cultured cells in air for AFM were 
investigated, ideally looking for a fixative that preserved fibroblast cells in a similar state 
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as in vitro without generating any artefacts such as coating, crystals, debris etc, to 
preserve the topography of the cell surface (Moloney et al., 2004). Glutaraldehyde, as 
used here, was assessed as a good fixative, with no artefact formation, however, 
paraformaldehyde would have been a better choice as fibroblast morphology was 
conserved to a greater degree. A difference in cell surface morphology was observed 
between untreated cells and those treated with 100 µM MDA, so although the fixative 
may have had an effect, MDA has a clear effect on cell surface morphology. 
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Figure 17. AFM images of MRC5 (A-C) and MRC5 SV2 (D-F) cells treated for 24 h with MDA: A &D) 0 µM, B & E) 100 µM, C & F) 200 µM. 
n = 10, all images were representatives of each sample.
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3.6. Effects of MDA on Nuclear Morphology 
In order to determine the effect of treatment of MRC5 and MRC5 SV2 cells with MDA 
on nuclear morphology and nuclear size, a variation of the micronucleus assay was 
carried out. Chromosomal mutation is an important event in carcinogenesis and this 
method measures both chromosomal breakage and loss. Chromosomal loss or non-
disjunction are events associated with ageing and cancer, due to spindle or centromere 
defects. Dividing cells containing chromosomal breaks and chromosomes that are 
unable to travel to the spindle poles during mitosis, often express micronuclei which are 
much smaller than the main nucleus. The micronucleus assay involves treating cultured 
cells with a test compound and then inhibiting cytokinesis by using cytochalasin B, which 
is a microfilament assembly inhibitor, ensuring that all cells are in the bi-nucleated stage 
of the cell cycle as micronuclei are only expressed in cells that have completed nuclear 
division (Fenech, 2000). The micronucleus assay is a method of staining and scoring 
these micronuclei to assess the level of DNA damage. Fluorescent stains such as DAPI 
are used (Fenech, 2000).  
Here, the protocol for the micronucleus assay was followed, to ensure that the cells 
were in the same stage of the cell cycle, although the aim was primarily to examine the 
effect that treatment of MRC5 and MRC5 SV2 cells with MDA had on nuclear 
morphology, rather than quantification of micronuclei (Section 2.3.8.). Fluorescent 
images of MRC5 and MRC5 SV2 cells treated with MDA and the nuclei stained with DAPI 
are shown in Figure 18 (only images for 0-200 µM MDA are shown as location of cells 
due to decreased cell density became more difficult at higher concentrations, and all 
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images are representative of each sample (n = 12)). The morphology of the nuclei were 
examined and as the concentration of MDA increased, the nuclei of both cell lines 
became more irregular in shape and what appear to be micronuclei were observed in 
cells treated with 100 and 200 µM MDA. Little effect was observed on the nuclear 
morphology of cells treated with 10-50 µM MDA. The number of possible micronuclei 
observed appeared to increase with increasing MDA concentration, although small blue 
spots can also be seen in the negative controls, albeit to a lesser extent. 
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Figure 18. DAPI stain of the nuclei of MRC5 (A-D) and MRC5 SV2 (E-H) cells following treatment with MDA: A & E) 0 µM, B & F) 50 µM, C 
& G) 100 µM and D & H) 200 µM. The scale bars represent 20 µM. The green arrows indicate possible nuclei. (n = 12). 
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The mean area of the nuclei of MRC5 and MRC5 SV2 cells treated with MDA and H2O2 
for 24 and 48 h were measured, using ImageJ software (Rasband, 1997), following 
staining with DAPI, to quantify the changes observed in Figure 18. Figure 19 shows the 
mean nuclear area of untreated MRC5 cells remained similar over 24 and 48 h. The area 
increased continually after 24 h treatment with increased MDA concentrations. After 
48 h treatment with 50 µM MDA, the nuclear area increased more than after only 24 h 
and increased to a lesser extent after 200 µM MDA after 48 h than 24 h. The nuclear 
area of MRC5 SV2 cells increased following treatment with increasing MDA 
concentration for 24 h compared with the untreated control. After 48 h, the nuclear 
area increased further, with the largest nuclear area observed in cells treated with 
100 µM MDA. Treatment with the positive control (50 µM H2O2, data not shown) for 
both cell lines showed an increase in nuclear area from 24 h to 48h. 
Single factor ANOVA was used to assess the variance in nuclear area for treatments of 
0-200 µM MDA at each time point for each cell line. A significant difference in nuclear 
area measurements were reported if F > Fcrit and P < 0.05. For both cell lines, for 24 h 
and 48 h treatment with 0-200 µM MDA, the results were all significantly different, as 
shown in Table 13, although significance was greater at 24 h than 48 h. 
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Figure 19. Area of nuclei of A) MRC5 and B) MRC5 SV2 cells treated with MDA (0-
200 µM) over 24-48 h, error bars indicate ± 1SD from the mean, n=10. 
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Table 13. Comparison of the effect of treatment with 0-200 µM MDA for 24 h and 
48 h on nuclear area of MRC5 and MRC5 SV2 cells by single factor ANOVA. P and F 
values for significance (*). 
  MRC5 MRC5 SV2 
ANOVA 24 h 48 h 24 h 48 h 
Fcrit 2.589 2.584 2.626 2.782 
F value 5.534 * 3.042 * 12.17 * 7.574 * 
P value 0.001 * 0.027 * 2.06x10-6 * 3.02x10-4 * 
 
The increase in the nuclear area observed in both cell lines treated with MDA compared 
to the negative control indicates that there had possibly been some reorganisation of 
the cytoskeleton, which may cause the cells to spread out and flatten, which would 
make the nucleus appear to be larger than it would have otherwise, or there was an 
increase in the volume of the nucleus. 3-D imaging and measurement of the nuclear 
volume would be required to confirm changes to nuclear size. 
 In human primary diploid fibroblasts that had senesced following treatment with H2O2, 
the cell morphology was altered, becoming enlarged, flattened and more rounded, with 
an increase in the size of the nucleus, whereas in apoptotic cells, the cells contracted 
and detached (Bladier et al., 1997). As the significance of treatment with MDA on 
nuclear area was lower after 48 h than 24 h, this perhaps indicates that cells were 
starting to become apoptotic and beginning to contract. The possible damage to the 
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cytoskeleton as a result of MDA treatment was also observed in Section 3.5., where the 
cell surface morphology was imaged by AFM. 
The nuclear volume is determined by cytoplasmic factors rather than DNA content and 
the nuclear-cytoplasmic (karyoplasmic) ratio remains constant for particular cell types 
and organisms (Huber and Gerace, 2007). Abnormal nuclear shape and disturbances in 
the ratio have been associated with some cancers (Webster et al., 2009). The nuclear 
envelope is a double lipid bilayer, of which the outer layer is connected to the 
endoplasmic reticulum of the cytoplasm and the inner layer which is connected to the 
nuclear components and is lined by the nuclear lamina, a network of proteins including 
intermediate filaments (mainly nuclear lamins). The size and shape of the nucleus is 
influenced by the nuclear lamina (Huber and Gerace, 2007). The cytoskeleton consists 
of microtubules, actin microfilaments and intermediate filaments and gives the cell its 
shape and mechanical stability. The cytoskeleton is connected via nuclear envelope 
bridges to the nuclear surface and may also influence the size and shape of the nucleus 
(Starr and Fridolfsson, 2010). Thus damage to the cytoskeleton may alter the volume of 
the nucleus. 
Quantification of micronuclei formed by exposure of both cell lines to different 
concentrations of MDA would be required to determine the level of DNA damage 
induced. Micronuclei can be used as biomarkers of cancer risk for which a non-invasive 
method using exfoliated epithelial cells can be used. The oral mucosa cells of non-
smokers were compared with those of heavy smokers using a variety of DNA specific 
stains e.g. DAPI and non-specific stains e.g. Giemsa.  There were significantly elevated 
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numbers of micronuclei found using the non-specific Giemsa stain but not using the DNA 
specific stains. However, there was an increased number of nuclear anomalies, mainly 
keratin bodies, which could be misinterpreted as micronuclei when using the Giemsa 
stain. It was concluded that micronuclei induction is not found in oral mucosa cells 
exposed to cigarette smoke, however the use of a more specific dye such as DAPI may 
have shown otherwise (Nersesyan et al., 2006), as was used in this study. The 
micronucleus assay was used with Feulgen fast-green staining to examine the difference 
in micronuclei frequency in exfoliated buccal mucosa cells from non-smokers, smokers 
who had smoked for more than 10 years and smoker who had been smoking for less 
than 10 years. They found that there was a significant difference between the non-
smokers and the two groups of smokers but not between the two groups of smokers 
(Naderi et al., 2012). The data was pooled from a number of studies looking into the 
effect of smoking on micronuclei frequency and re-analysed, it was found that for 
smokers in general, there was no significant increase in micronuclei, however for those 
who smoked ≥30 cigarettes per day, there was a significant increase in micronuclei 
frequency (Fenech and Bonassi, 2011). As these studies used oral mucosa cells, there is 
no direct comparison with the lung fibroblast cells used in this study, and although 
smoking may not show a significant increase in micronuclei in oral mucosa cells, there 
may be a difference in lower respiratory tract cells, which will require further analysis.  
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3.7. Apoptosis Detection using an Annexin V Fluorescent Assay 
Apoptosis is programmed cell death whereby cells initiate apoptotic signalling in 
response to stress (Alberts et al., 2002). Morphological changes occur to the cell during 
apoptosis including chromatin condensation, nuclear fragmentation, membrane 
blebbing, collapse of the cytoskeleton and cell shrinkage. Defects in the apoptotic 
pathway may lead to uncontrolled cell proliferation and cancer (Lowe and Lin, 2000). 
An immunofluorescence detection kit was used to detect apoptosis in MRC5 and MRC5 
SV2 cells treated with MDA for 24 – 48 h, as described in Section 2.3.9. The assay 
involved two fluorescent dyes: Annexin V binds to phosphatidyl serine (a cell surface 
signal for phagocytosis (Verhoven et al., 1995)) in cells that are necrotic, observed as red 
fluorescence, 6-carboxyfluorescein diacetate hydrolyses in viable cells to 6-
carboxyfluorescein, observed as green fluorescence, and both green and red 
fluorescence may be observed in cells that are at an early stage of apoptosis. An increase 
in the amount of cells fluorescing red was observed in both cell lines after 24 and 48 h 
treatment with increasing concentrations of MDA, although the intensity of red was 
slightly less in MRC5 SV2 cells than MRC5 cells (Figure 20 and Figure 21, all images are 
representative of each sample, n = 6). Both cell lines show a greater intensity of red after 
48 h than for 24 h, although green fluorescence was also observed in all images. This 
indicates that with increasing concentration of MDA and time, there were more cells in 
the early stages of apoptosis, compared to the untreated cells. Treatment of both cell 
lines with a positive control, H2O2 (100 µM), gave a similar result to those treated with 
200 µM MDA (data not shown). 
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The same was observed for the green fluorescence, indicating that although the cells 
had begun apoptosis (as indicated by loss of membrane asymmetry), they were still 
viable. Some red fluorescence was observed in the untreated cells for both cell lines and 
time periods. This was possibly due to a background level of apoptosis, whereby a 
number of cell lines exhibited some background level of apoptosis (Sheridan and West, 
2001). This background level of apoptosis may have been due to incubation in FBS-free 
media rather than full media. As BSA (a major component of FBS) interacts with MDA 
(Traverso et al., 2004), as described in Section 3.2, FBS could not be used in the 
treatment of cells. However, as all cells were grown in the same media and conditions, 
other than the two variables of MDA concentration and time, the increase in red 
fluorescence with increased MDA concentration and treatment times for both cell lines 
may be attributed to the effect of MDA on the onset of apoptosis. 
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Figure 20. Apoptosis detection of MRC5 cells treated for 24 h (A-C) and 48 h (D-F) with MDA in FBS-free media: A & D) 0 µM, B & E) 
50 µM and C & F) 100 µM, x20 magnification using confocal microscopy. Red indicates cells stained for apoptosis and green for viable cells.
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Figure 21. Apoptosis detection of MRC5 SV2 cells treated for 24 h (A-C) and 48 h (D-F) with MDA in FBS-free media: A & D) 0 µM, B & E) 
50 µM and C & F) 100 µM, x20 magnification using confocal microscopy. Red indicates cells stained for apoptosis and green for viable cells.
Chapter 3 Cellular Effects of Malondialdehyde 
  122   
The cell number in multicellular organisms and tissues is highly regulated, maintaining 
the balance between cell division and programmed cell death (Alberts et al., 2002). 
Damage to DNA can trigger apoptosis (Ji et al., 1998). DNA damage leads to a rapid 
increase in p53 due to inactivation of the p53/Mdm-2 interaction, which in turn leads 
to reversible cell cycle arrest and induction of DNA repair mechanisms and then to 
apoptosis or senescence (loss of proliferative capacity). p53 transactivates genes that 
induce apoptosis e.g. Fas and Bax and genes that induce cell cycle arrest e.g. CDKN1A 
(Ji et al., 1998; Enge et al., 2009). p53 transcribes Bcl-2 genes, initiating the release of 
cytochrome c into the cytosol. The Bcl-2 gene family regulates procaspase activation, 
some of which inhibit apoptosis, others promoting procaspase activation. The IAP gene 
family act by binding to either procaspases, preventing activation, or to caspases, to 
inhibit activity (Alberts et al., 2002).   
The caspase family of proteases cleave specific proteins in the nucleus and cytoplasm. 
Procaspases, the inactive precursors of caspases, are activated by cleavage by other 
caspases, resulting in a proteolytic caspase cascade. The cascade is activated by an 
intra or extracellular death signal and is self-amplifying and irreversible. Adaptor 
proteins aggregate procaspases. The Fas ligand on the surface of killer lymphocytes is 
an external activation signal which binds to Fas receptor on the cell surface, recruiting 
adaptor proteins and initiating a caspase cascade. The release of cytochrome c from 
mitochondria into the cytosol acts as an internal signal, binding and activating the 
adaptor protein Apaf-1 (Alberts et al., 2002).  
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Apoptotic pathway defects can contribute to a number of diseases such as cancer. For 
example, overexpression of Bcl-2, upregulation of Bcl-xL, inactivation of Bax, and 
mutations in upstream and downstream components of the p53 pathway e.g. Mdm-2, 
ARF and Bax may all lead to tumorigenesis (Lowe and Lin, 2000). p53 is involved in the 
regulation of numerous apoptotic cell functions, and damage to or sequestration of 
the p53 protein can have an effect on p53 dependent DNA binding and pro-apoptotic 
functions. This may explain the reduced red fluorescent intensity observed in MRC5 
SV2 cells compared to MRC5 cells treated with the same concentrations of MDA and 
time. The sequestration of the p53 protein in MRC5 SV2 cells by the binding of the 
integral viral large T antigen (Pipas, 2009) may have reduced the level of apoptosis in 
this cell line due to reduced activation of p53 dependent apoptotic factors. 
Two cell lines were treated with MDA, RKO (human colorectal carcinoma, wild type 
p53) and H1299 (human lung adenocarcinoma, p53-null), and found that there was an 
increase in the M1dG adduct, but also that MDA induced an apoptotic response with 
irreversible cell cycle arrest at G1/S and G2/M and elevation p53 protein levels (Ji et al., 
1998). This increase in apoptotic response due to increased MDA concentration was 
also observed here. 
The effects of MDA on human bone marrow mesenchymal stem cells were assessed 
by flow cytometry and MTT assay. It was found that increasing concentrations of MDA 
(up to 1mM) decreased the cell count, increased the population doubling time, 
decreased cell viability and triggered apoptosis, as also observed here with increased 
apoptosis and decreased cell viability and cell proliferation (Guolin et al, 2006). 
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MDA and H2O2 have been found to induce both apoptotic and necrotic cell death in rat 
cortical neurons, whereby reduced membrane integrity, increased nuclear 
fragmentation were observed. It was suggested that MDA induced apoptosis by 
protein cross-linking (Cheng et al., 2011). This is in keeping with the findings in Sections 
3.4., 3.5., and 3.6., where an increase in irregularity of the cell membrane, cell 
morphology and nuclear morphology were observed with increasing MDA and H2O2 
concentrations, linking these observations to the increase in the early stages of 
apoptosis found here. 
The positive control used in this research was H2O2, which is an intermediate molecule 
formed from dismutation of superoxide anions by superoxide dismutase and is known 
to induce apoptosis and senescence (Ayala et al., 2014). Human primary diploid 
fibroblasts were treated with H2O2, inducing senescence at lower concentrations of 
H2O2 and apoptosis at higher H2O2 concentrations. In the senescent cells, the 
morphology was altered, becoming enlarged, flattened and more rounded, with an 
increase in the size of the nucleus. In apoptotic cells, the cells contracted and detached 
(Bladier et al., 1997). Following treatment of human retinal pigment epithelial cells 
with H2O2, caspase 3 was activated and apoptosis was induced (Kim et al., 2003). H2O2 
induced apoptosis and decreased viability in human gastric carcinoma cells. The pro-
apoptosis factor Bax was up-regulated, the anti-apoptosis factor Bcl-2 was down-
regulated and the cell death receptor Fas expression increased, all of which are 
induced by p53 (Mao et al., 2006). Thus, cellular stress due to H2O2 has been found to 
induce p53 dependent pro-apoptotic pathways, making H2O2 a useful positive control 
for the toxicity studies used here. 
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p53 plays an important role in apoptosis and p53 expression levels have been found to 
increase in response to cellular stress and DNA damage, therefore investigation of the 
levels of expression of p53 in MRC5 and MRC5 SV2 cells in response to treatment with 
MDA would supplement the previous investigations in this section. 
3.8. p53 Expression using Immunoflurescence 
p53 gene expression has been shown to increase in response to DNA damage by 
oxidising agents, irradiation and carcinogenic and cytotoxic compounds, as well as 
other non-DNA damaging cellular stress factors such as hypothermia and hypoxia 
(Hainaut and Hollstein, 2000). Increased p53 expression is part of the apoptotic 
response of cells (Alberts et al., 2002). This assay uses immunofluorescence to detect 
p53 protein levels in MRC5 and MRC5 SV2 cells subject to treatment with MDA for 24 
and 48 h, as a qualitative indicator of oxidative stress and possible DNA damage 
(Section 2.3.10.). p53 protein expression in cells was detected by immunofluorescence 
detection with a p53 specific primary antibody. p53 protein expression gradually 
increased in response to increasing MDA concentrations and treatment time (Figure 
22 and Figure 23). Images for 48 h only are shown as the lower intensity of the red 
fluorescence at 24 h was difficult to view in this format and all images shown are 
representative of a number of images taken for each MDA concentration (n = 6). 
Treatment with the positive control (50 µM H2O2) also showed increased p53 
expression over time compared to the negative control (images not shown), indicating 
that increased p53 expression was due to oxidative stress. Low levels of p53 protein 
were observed in the cytoplasm of both cell lines in the negative control and at 50 µM 
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MDA, whereas following treatment with greater MDA concentrations (100-1000 µM), 
increased levels of p53 protein were observed in the nuclei. p53 is synthesised in the 
cytoplasm and, when subject to cellular stress, p53 re-locates from the cytoplasm of 
the cell to the nucleus, where it is required to inhibit the growth of malignant cells 
(O'Brate and Giannakakou, 2003). 
Low levels of p53 protein were located in the cytoplasm of cells treated with 50 µM 
MDA and the negative control, where it is kept at low levels by interacting with Mdm-2 
in unstressed cells, preventing transport to the nucleus. It would seem that from Figure 
22 and Figure 23, that p53 levels were lower in cells treated with 50 µM MDA than for 
the negative control. Increased levels of p53 protein were observed in the nuclei of 
cells treated with higher concentrations of MDA (100-1000 µM) for both 24 h and 48 h. 
Cleavage of p53-Mdm-2 in response to stress, for example DNA damage, activates p53 
and is transported from the cytoplasm to the nucleus (Hock et al., 2011). 
These observations correlate with previous observations in Section 3.7., whereby 
treatment of cells with increasing MDA and H2O2 concentrations led to increased levels 
of apoptosis, as DNA damage leads to an increase in p53 and induction of apoptosis (Ji 
et al., 1998), as previously described in Section 3.7. There also appears to be a greater 
effect for MRC5 SV2 cells than for MRC5 cells, with greater levels of red fluorescence 
at corresponding MDA treatment concentrations and times. This may be due to the 
sequestration of p53 in MRC5 SV2 cells by binding to the viral large T antigen of SV40, 
which had been used to transform this cell line (Huschtscha and Holliday, 1983), and  
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Figure 22. Confocal image of p53 protein stained red in MRC5 cells treated for 48 h with 
MDA: A) 0 µM, B) 50 µM, C) 100 µM, D) 200 µM, E) 500 µM and F) 1000 µM (x20 
magnification). 
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Figure 23. Confocal image of p53 protein stained red in MRC5 SV2 cells treated for 48 h 
with MDA: A) 0 µM, B) 50 µM, C) 100 µM, D) 200 µM, E) 500 µM and F) 1000 µM (x20 
magnification). 
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thus may instigate an increase in p53 expression to compensate for the bound p53 in 
response to increased oxidative stress. 
This assay shows that an increase in MDA results in increased stress and hence higher 
levels of p53 protein. Quantitative analysis of p53 protein expression levels in response 
to treatment with MDA would confirm this. 
3.9. p53 Expression using Reverse Transcription 
Quantitative Polymerase Chain Reaction  
RT-qPCR is a method used to quantify gene expression using a dual labelled fluorescent 
probe to measure PCR product accumulation (Heid et al., 1996), and is carried out in 
three steps: reverse transcription of mRNA to cDNA followed by amplification of cDNA 
by PCR and real-time detection and quantification of PCR products (Nolan et al., 2006). 
The data may be analysed by absolute quantification, where the transcript copy 
number is determined by using a standard curve, or by relative quantification, where 
the PCR signal of the target transcript is related to that of another sample. The 2ΔΔCt 
method of relative quantification calculates the relative changes in gene expression 
but requires the assumption that the amplification efficiency of the target gene is equal 
to that of the reference gene. The data for the 2ΔΔCt method is usually presented as the 
fold change (fold induction) in gene expression of the target transcript normalised to 
a reference gene and relative to the untreated control (Livak and Schmittgen, 2001). 
In this research, the fold induction was the factor by which p53 increased in response 
to treatment with MDA compared to the untreated control. 
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RT-qPCR is the method of choice for RNA quantification as it is accurate, sensitive and 
specific, there is no post-PCR sample handling preventing contamination and thus 
higher throughput, it allows analysis of small nucleic acid quantities, as low as a single 
cell equivalent, and it is less labour intensive than other methods (Heid et al., 1996). 
However, the data produced depends largely on the quantity and quality of the RNA 
template and the results are subject to biological and technical variation (Nolan et al., 
2006). 
The expression of p53 mRNA of cells following treatment with MDA and H2O2, as a 
positive control (data not shown), was quantified by RT-qPCR, as decribed in Section 
2.3.11. Cycle threshold (Ct) values were measured for both p53 mRNA and GAPDH 
mRNA. The latter is a house-keeping gene, for which expression is assumed to remain 
constant (Barber et al., 2005), and was used as the reference gene to normalize the 
expression data due to give the relative expression of p53 mRNA to GAPDH mRNA . 
This allows for any discrepancies in cell number and RNA extraction. The untreated 
(negative) control was used as a calibrator to which the treated samples were 
compared. The fold induction of p53 mRNA was calculated using the 2ΔΔCt method and 
is shown in Figure 24 for MRC5 and MRC5 SV2 cells treated for 24 and 48 h. Only 
relatively low concentrations of MDA (10 – 100 µM) were used to treat the cells. This 
was because the same amount of RNA was required initially for each sample and cell 
number and viability remained relatively high when treated with these concentrations 
compared with higher concentration (Sections 3.2 and 3.3). 
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Figure 24. Induction of p53 mRNA expression relative to the negative control and 
reference gene GADPH, in cells treated with MDA (0 – 100 μM) for A) 24 h and B) 
48 h, error bars indicate ± 1SD, n = 6. 
After 24 h treatment with MDA, p53 mRNA production was induced in both cell lines 
compared to the negative control. Induction was greater at 10 µM MDA for MRC5 cells 
than MRC5 SV2 cells and gradually decreased up to 100 µM MDA, whereas for 
MRC5 SV2 cells, induction increased at 50 µM MDA and decreased again at 100 µM 
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MDA. After 48 h treatment, p53 mRNA induction was greatly reduced for MRC5 cells 
and slightly reduced for MRC5 SV2 cells, which follow the same pattern as for 24 h 
treatment.  
In order to eliminate background noise due to amplification errors between samples, 
a cut-off point for fold induction should be applied. It has been suggested that the 
minimum fold change for significance is > 2, with some studies suggesting up to 4 fold 
change as the cut-off point (Dalman et al., 2012; Rajeevan et al., 2001). If the minimum 
cut-off point of a 2 fold induction was applied to Figure 24, all results, for both cell lines, 
obtained after 24 h would be significant. No results obtained after 48 h were significant, 
apart from for MRC5 SV2 cells treated with 50 μM. 
The fold induction of p53 in MRC5 and MRC5 SV2 cells was compared with one another 
for each MDA concentration (0-100 µM) and at each time point by Student’s t-test. A 
significant difference was found where P < 0.05. No significant difference was found 
between the two cell lines for any MDA concentration at 24 h. All MDA concentrations 
were significantly different at 48 h (P = 0.0055, 10 µM; P = 0.00009, 50 µM; P = 0.00049, 
100 µM), however, this difference may be due to amplification errors between samples 
as all values (other than for MRC5 SV2 cells treated with 50 μM) were above the 2 fold 
induction threshold. 
Single factor ANOVA was used to compare all MDA concentrations (0-100 µM) for each 
cell line and time point, and a significant difference was found if P < 0.05 and F > Fcrit. 
No significant difference was found between MDA concentrations for MRC5 cells at 
either 24 h or 48 h. However, significant differences were found between MDA 
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concentrations for MRC5 SV2 cells for 24 h (P = 0.012, F = 9.91, Fcrit = 5.14) and for 48 h 
(P = 0.0046, F = 14.98, Fcrit = 5.14), although, the difference seen at 48 h may be due to 
differences in amplification efficiencies between samples, as only the value for 50 μM 
MDA treatment was above the fold induction cut-off point. 
Following treatment with 10 µM MDA, induction of p53 mRNA was increased to a 
greater extent compared to treatment with higher concentrations of MDA, and to a 
greater extent after 24 h than 48 h. This could be due to the increased cell viability at 
lower concentrations, as previously observed in Section 3.3. Conversely, at higher MDA 
concentrations (100 µM), cell number decreased and so did p53 mRNA induction. 
MRC5 SV2 cells survived for longer than MRC5 cells, which may be due to their altered 
p53 response, which would account for their continued induction of p53 mRNA after 
48 h, albeit to a lesser extent than after 24 h. Perhaps due to the sequestration of p53 
in MRC5 SV2 cells by the SV40 large T antigen (Pipas, 2009), inducing the cell to express 
a greater amount of p53 to compensate for the bound p53. 
Although there was a decrease in p53 mRNA induction with increasing concentrations 
of MDA and over time, there appears to be an increase in p53 protein expression when 
viewing cells individually (Figure 22 and Figure 23). This may also be explained by cell 
viability decreasing with increasing MDA concentration, with the collective 
fluorescence decreasing with decreasing cell viability, but expression of p53 increasing 
in individual cells. However, only 0-100 µM MDA concentrations were tested by 
RT-qPCR, whereas, concentrations up to 1000 µM MDA were used for the 
immunofluorescence experiment, and p53 was still induced in both cell lines for both 
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time periods relative to the negative control. Therefore, RT-qPCR studies of the effect 
of higher concentrations (100-1000 µM) MDA on the fold induction of p53 would be 
required for a direct comparison. Levels of p53 expression in non-small cell lung 
carcinoma were found to be high in 90% of tumours (Cherneva et al., 2009). An 
increase in p53 expression in human colon cancer cells treated with inositol 
hexaphosphate was found (Weglarz et al., 2006), although a decline in p53 mRNA 
expression was observed in human bronchial epithelial cells in response to treatment 
with aflatoxin B1 (Van Vleet et al., 2006). Thus, there are differing cellular responses to 
oxidative stress with regards to p53 expression. 
3.10. Summary 
Both cell lines showed reduced proliferation and viability with increasing 
concentrations of MDA, but MRC5 cells to a much greater extent. Cell surface 
morphology was altered, becoming more pitted and irregular in shape, as shown 
initially by light microscopy and then by AFM. A qualitative analysis showed what 
appear to be micronuclei were observed in cells treated with MDA, in a dose-
dependent manner. The nuclear area also appeared to increase and cells appeared to 
express an increased amount of phosphatidyl serine indicating the early stages of 
apoptosis. p53 expression was observed to increase in individual cells, treated with 
increasing amounts of MDA, but the overall p53 fold induction appeared to decrease 
when expression was measured by RT-qPCR, perhaps due to decreased cell viability, 
although p53 induction was still greater than the negative control. 
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Whilst previous studies have utilised the techniques described in this Chapter, the 
novel aspect of this work lies with the use of the combination of these methods to 
study the effects of treating MRC5 and MRC5 SV2 cells with MDA. In particular, the 
effects of MDA on cell surface morphology using AFM, nuclear morphology and p53 
expression studies. 
The above results show that treatment with MDA results in alterations at the cellular 
level. However, these results do not explain whether these alterations would lead to 
mutagenesis, carcinogenesis or other outcomes, hence the need to explain changes at 
the DNA level, which is the focus of the following chapters. 
Chapter 4 Adduct Analysis 
136  
CHAPTER 4  
ADDUCT ANALYSIS 
The development of a method of analysis of M1G adducts in DNA samples by LC-MS-MS 
is detailed in this chapter. A pure M1G standard was synthesised and purified in order to 
proceed with developing a method of quantitative analysis. Initially, the method for 
HPLC separation was optimised using the M1G standard, followed by optimisation of MS 
conditions using LC-MS. The method for M1G analysis was fine-tuned by LC-MS-MS prior 
to analysis of DNA samples.  
A standard C18 - bonded silica column for reverse phase HPLC (Column A) was used 
initially for detection and qualitative analysis of M1G, followed by a narrower column 
(Column B) with the same length, stationary phase and conditions to give increased 
sensitivity for quantitative analysis.  
4.1. Synthesis of M1G Standard 
A pure M1G standard was required in order to develop a method for quantitative 
analysis by LC-MS-MS. The compound was synthesised and purified as described in 
Section 2.3.15., using a procedure adapted from the one described by Singh et al. (2001). 
A number of different conditions for synthesis of the M1G standard were tested, 
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including variation of the ratio of guanine concentration to TMP concentration, the 
temperature and the length of the reaction to determine the reaction condition with 
the greatest yield of M1G crystals. The optimum conditions for synthesis of the standard 
was the reaction of 0.66 mmoles guanine (in 1M HCl) with 2 mmoles TMP at 40°C for 
2 h, yielding 71.3% crude M1G crystals. The temperature was maintained above 40°C for 
the duration of the reaction to prevent guanine precipitation, allowing M1G crystals to 
be collected after 2 h by filtration and dried. 
The solubility of the crude M1G crystals was found to be pH dependent, with greater 
solubility at higher pH. The pH was then decreased to approximately 5 by addition of an 
acid in order to prevent hydrolytic ring-opening of the M1G (Scheme 8). The presence of 
M1G in the solution was detected by HPLC using method C(iv), as described in Section 
2.3.14.1., this method was used throughout the synthesis and purification stages. The 
optimum combination of alkali and acid for dissolving M1G was ammonia with formic 
acid as this gave the largest peak area for M1G (retention times 4.9 min PDA and 5.0 min 
FLD, as shown in Figure 25). The HPLC detectors were sequential resulting in a slight 
delay in retention times from PDA to FLD. The ring-open form of M1G, N2OPdG-, was 
detected by PDA and FLD in basic conditions (pH > 8) with retention times of 4.7 min 
and 4.8 min respectively (data not shown). The N2OPdG- anion eluted earlier as it was 
more polar than the ring-closed M1G. 
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Figure 25. HPLC chromatogram of pure M1G standard, retention time A) 4.995 min 
(PDA) (guanine - 3.905 min) and B) 5.044 min (FLD), using method C4 with column A, 
flow rate 0.5 ml/min, column temperature 25°C. 
The crude M1G was purified twice by SPE, each time collecting pure M1G fractions 
identified by HPLC, as shown in Figure 25, to show that it was a pure compound. A small 
peak was observed at retention time 3.9 min (PDA) in addition to the M1G peak (4.9 min). 
The small peak was guanine, which was identified by HPLC of a pure guanine standard 
(data not shown). The presence of guanine indicated that the purified M1G was not 100 % 
pure, the purity was investigated in Section 2.3.14.1.  
The identity of the compound that eluted at retention time 4.9 min (PDA) was confirmed 
by LC-MS using method C(iii) (Section 2.3.14.1.) as shown in Figure 26. The data acquired 
by a TIC scan of m/z 75 to m/z 190 was processed to produce a RIC of m/z 188, the ion 
of interest, which was further processed to produce a mass spectrum at this m/z. The 
TIC chromatogram shows a peak at retention time 5.1 min, corresponding to the HPLC 
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chromatogram (Figure 26) and the RIC chromatogram of m/z 188 also showed a peak at 
5.1 min. The peak at 5.1 min on the TIC chromatogram appears to be much smaller than 
the RIC peak for m/z 188 due to background noise on the TIC chromatogram. RIC 
processing eliminated the majority of the background noise by only showing m/z 188. 
No guanine was detected at retention time 5.1 min (TIC) when an RIC of m/z 152 was 
produced. A mass spectrum (Figure 27) of the peak at 5.05 min, showed a peak with m/z 
188.2 to confirm that the compound was M1G, which has MR 187.2 g/mol. Again, no 
guanine was detected on the mass spectrum as no peak at m/z 152 was detected. Any 
minor variation in retention time between detectors and instruments could be due to 
differences in tubing lengths between column and detector. The pure fractions were 
combined and freeze-dried to give a 0.3% yield of pure M1G crystals. A greater yield and 
purity of M1G may have been obtained with the use of preparative or semi-preparative 
HPLC rather than solid phase extraction (Singh et al., 2001).  
 
Figure 26. LC-MS mass chromatograms of pure M1G A) RIC of m/z 188 and B) TIC 
scan. 
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Figure 27. LC-MS mass spectrum of M1G at retention time 5.05 min. 
4.2. High Performance Liquid Chromatography Method 
Development 
Using the pure M1G standard, synthesised in Section 2.3.15., the HPLC separation 
method (reverse-phase) C(iv) (Section 2.3.14.1.) was optimised. The mobile phase 
additive that gave the greatest sensitivity with good peak separation was ammonium 
formate (50 mM, pH 5.4) compared to both acetic acid and formic acid which gave 
reduced sensitivity and increased peak overlap on both the PDA and FLD detectors. 
These additives were also chosen as they have suitable volatility for MS. The mobile 
phase combination that gave the optimum peak separation and greatest sensitivity for 
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M1G detection was 75% 50 mM ammonium formate (pH 5.4) and 25% methanol.  A 
20 min isocratic run time with an additional 10 min gradient to 100% methanol and a 
further 10 min equilibration at the starting conditions gave the most consistent results 
with removal of residual analyte from the column.  
The proportion of methanol at 25% gave the optimum sensitivity with sufficient 
retention times for peak separation, whereas lower proportions of methanol showed 
peak broadening and longer retention times and decreased sensitivity. Higher 
proportions of methanol resulted in overlap of guanine and M1G peaks due to reduced 
retention times. Column B gave greater sensitivity than column A, with larger peak areas 
due to the narrower diameter of column B. The peak resolution (Rs) values for the M1G 
and guanine peaks in the M1dG DNA standard were calculated for each column, as 
described in Section 2.3.14.1. Column A had an Rs value of 10.8, compared to column B, 
which had an Rs value of 2.21. Although peak resolution decreased with column B 
compared to column A, there was still baseline resolution (Rs > 1.5) and so column B was 
chosen for use in further analyses. The flow rate that gave the greatest sensitivity with 
Column B was 0.1 ml/min, however, this flow rate caused peak broadening so a higher 
flow rate of 0.2 ml/min was chosen for analysis of M1G.  
M1G was detected using both FLD and PDA detectors. The excitation and emission 
wavelengths for detection by FLD were 360 nm and 500 nm respectively (Singh et al., 
2001). The wavelength chosen for detection by PDA was 254 nm as this is the standard 
wavelength for detection of purines, allowing for detection of guanine and adenine as 
well as M1G (Rong et al., 2015). DNA samples would contain high levels of purine bases 
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in relation to M1G, for example 50 – 120 M1G adducts per 108 nucleotides were detected 
by Chaudhary et al. (1994), of which approximately 50% of the 108 nucleotides would be 
purine bases according to Chargaff’s rule (Elson and Chargaff, 1952). Therefore, it was 
necessary to detect guanine and adenine in order to ascertain whether they caused any 
interference in M1G detection, and also to determine the purity of the M1G standard. 
DNA samples and the M1dG DNA standard were depurinated by acid hydrolyisis, so it 
was unnecessary to detect pyrimidine bases in addition to purines. An M1dG DNA 
standard with M1dG adduct levels of 21 pmol/µg DNA and 3 mg/ml DNA was used to 
determine the accuracy of the optimised methods of M1G detection (Moore et al., 
2010). Chromatograms of guanine, pure M1G standard and the M1dG DNA standard are 
shown in Figure 28, using the optimised HPLC separation method. The data was acquired 
for 30 min, however, as all peaks eluted within the initial 5 min, only 5 min is represented 
on the chromatograms.  
Using the optimised method for HPLC separation, retention times for guanine (A and B) 
were 1.6 min (PDA) and 1.7 min (FLD), and retention times for M1G (C and D) were 
approximately 2.1 min (PDA) and 2.2 min (FLD), as shown in Figure 28. Adenine was 
detected by PDA and had a retention time of 1.8 min, however, it was not detected by 
FLD and would therefore not interfere with M1G detection (data not shown). As the PDA 
peaks for guanine and M1G (1.6 min and 2.1 min respectively) (Figure 28 E) are merged, 
adenine would be included in the peak overlap. Therefore, this PDA method would not 
be suitable for M1G quantification, however, the aim was to use FLD. 
 
Chapter 4 Adduct Analysis 
143  
 
Figure 28. HPLC chromatograms with retention times for - guanine A) 1.553 min 
(PDA) and B) 1.690 min (FLD); pure M1G standard - C) 2.060 min (PDA) and D) 2.207 
min (FLD); and hydrolysed M1dG DNA standard - E) 1.605 min (guanine) and 2.051 min 
(M1G) (PDA) and F) 1.748 min (guanine) and 2.209 min (M1G) (FLD). 
The chromatograms in Figure 28 show minor peaks for guanine (C and D) at 1.6 min (PDA) 
and 1.8 min (FLD) in addition to the main M1G peaks at 2.1 min (PDA) and 2.2 min (FLD), 
indicating that the M1G standard was not 100% pure. The FLD chromatogram (Figure 28 
F) of the M1dG DNA standard showed resolution of guanine and M1G, with a peak which 
corresponds to guanine at retention time 1.8 min in addition to the main peak for M1G 
at 2.2 min. A peak for guanine was also detected by the PDA at 1.6 min alongside a small 
peak for M1G at 2.1 min (Figure 28 E). However, as fluorescence detection is the best 
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method for quantitation of M1G by HPLC compared with PDA, chromatogram F is 
representative of those used for M1dG-DNA quantitation. 
A standard curve was plotted using the mean FLD peak area (Figure 29). The calibration 
curve had a correlation coefficient R2 value of 0.9995 demonstrating good linearity. 
 
Figure 29. Standard curve 0 – 53.4 µM M1G (retention time 2.21 min), analysed by 
HPLC-FLD at 360 nm excitation and 500 nm emission. Error bars (just shown) indicate 
± 1SD from the mean. 
As peaks corresponding to guanine had been detected in Figure 28 (C-F), the purity of 
the M1G standard was assessed. The PDA detector was more sensitive for detection of 
guanine, however, as these peaks were poorly integrated by the software for peak area, 
with a large proportion of the area integrated below the baseline, the peaks were re-
integrated manually and a standard curve of guanine was plotted against mean peak 
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area (Figure 30). The calibration curve had good linearity with a correlation coefficient 
R2 value of 0.9999. 
 
Figure 30. Standard curve of 0 – 66 µM guanine (retention time 1.55 min), 
analysed by HPLC-PDA at 254 nm. Error bars indicate ± 1SD from the mean. 
To determine the purity of the M1G standard with respect to guanine, the peak area of 
the guanine peak, detected by PDA, in the top M1G standards were used to calculate the 
concentration of guanine in each standard using the guanine calibration curve equation 
in Figure 30:  
 y = 21.003x- 1.8306, where x = guanine concentration (µM) and y = peak area 
(mAU*s) 
The mass of guanine in each M1G standard was calculated from the guanine 
concentration (x) and the mass of M1G in each standard was calculated from the M1G 
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concentration. The purity of the M1G standard was then calculated using the following 
equation, using the calculated masses: 
% 𝑃𝑢𝑟𝑖𝑡𝑦 =  
(𝑀𝑎𝑠𝑠 𝑀1𝐺 − 𝑀𝑎𝑠𝑠 𝐺𝑢𝑎𝑛𝑖𝑛𝑒)
𝑀𝑎𝑠𝑠 𝑀1𝐺
 × 100% 
 
The purity of the M1G standard was 75.6% using this method. However, overlap with 
M1G was an issue as the PDA method was not optimised. An alternative method of 
assessing M1G purity is by using the molar absorption coefficients (ε) of M1G and 
guanine. The Beer-Lambert law was used to calculate the molar absorption coefficients: 
𝐴 =  𝜀𝑐𝑙 
Where A is the absorbance, c is the concentration and l is the pathlength. For a graph of 
absorbance (or peak area) versus concentration, where the path length is 1 cm, the 
gradient is the molar absorption coefficient. A graph of the mean PDA peak area (mAU*s) 
versus 5.34 – 21.36 µM M1G is shown in Figure 31 with the mean PDA peak area for 
guanine present in each of the M1G standards. 
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Figure 31. Standard curve of 5.34 – 21.36 µM M1G, shown in orange (retention 
time 2.06 min), guanine impurities (retention time 1.64 min) are shown in blue, 
analysed by HPLC-PDA at 254 nm. Error bars indicate ± 1SD from the mean. 
The gradient of the M1G standard curve in Figure 31 is 41.142 mAU*s/µM and the 
gradient of the guanine impurities curve is 7.1753 mAU*s/µM. The purity of M1G is 
calculated as follows: 
% 𝑃𝑢𝑟𝑖𝑡𝑦 =  [1 −  (
𝜀 𝐺𝑢𝑎𝑛𝑖𝑛𝑒
𝜀 𝑀1𝐺
)] × 100% 
The purity of M1G using the molar absorption coefficient method was calculated to be 
82.6%. However, this method assumes that the gradients are correct and at M1G 
concentrations below 5.34 µM, the gradient of the guanine impurities curve was close 
to zero, meaning that levels of guanine were almost constant for the M1G standards 
below 5.34 µM, despite an increasing M1G concentration. This is unexpected and 
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indicates that guanine formation could be occurring during analysis rather than being 
present in the pure standard. Taking into consideration the purity calculated by both 
methods at higher M1G concentrations (>5.34 µM), it appears that the purity of the M1G 
standard is in the region of 75.6 – 82.6%. Although this value was relatively low for a 
standard, it was anticipated that there would be some degradation of M1G to guanine 
on storage and on the HPLC column and would thus have been of higher purity initially. 
Additionally, some of the M1G would be present in its ring-open form, N2OPdG, which 
eluted earlier then the ring-closed form and was not included in the peak areas for M1G, 
suggesting that the level of guanine impurities calculated could be too high and the 
purity of the M1G standard was greater than the 75.6 – 82.6% range calculated. 
In order to validate the method, the M1dG DNA standard was analysed using the 
optimised HPLC method. The old standard contained 21 pmol M1G/µg DNA and, 
following DNA hydrolysis, was 0.5 mg/ml DNA. So: 
 0.5 mg/ml DNA = 0.5 µg/µl DNA 
 20 µl injection volume = 10 µg DNA 
Therefore there were 210 pmoles M1G/10 µg DNA i.e. total amount injected on to the 
column. 
When analysed, the M1dG DNA standard had a mean peak area of 521 LU*s (FLD), and 
using the calibration equation in Figure 29 to calculate the amount of M1G in the M1dG 
DNA standard: 
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 y = 3.634x + 20.317 
 x = 13.67 µM M1G = 13.67 pmol M1G/µl 
 20 µl injection volume = 273.4 pmoles M1G 
Taking into account the 75.6 – 82.6% purity of the M1G standard, the M1dG DNA 
standard contained between 206.7 and 225.8 pmoles M1G when analysed by this 
method. The M1dG DNA standard had previously been analysed by Moore et al. (2010) 
confirming that there was 21 pmol M1G/µg DNA. The difference in the amount analysed, 
mean 216.3 ± 9.6 pmoles M1G, compared to 210 pmoles M1G in the M1dG DNA standard 
could be because the HPLC method had not been fully optimised for quantitative 
method validation and required further optimization prior to analysis of DNA samples. 
However, it is within acceptable experimental error when the standard deviation is 
taken into account. Additionally, there was some overlap of the M1G peak (retention 
time 2.2 min) and the guanine peak (retention time 1.6 min) as shown in Figure 28 (F) 
and so the peak integration by the software will not have been accurate and the M1G 
peak may have had a smaller peak area resulting in a reduction of the 273.4 pmoles M1G 
to closer to the actual value of 210 pmoles M1G. However, the aim was to produce a 
standard suitable for MS detection and the LC method would require further fine-tuning 
for LC-MS and LC-MS-MS analysis.  
To summarize, following HPLC method development and optimization, the purity of the 
M1G standard had been assessed and used to quantify an M1dG DNA standard that had 
been made and analysed independently on different instruments. The results agree 
within 130% without taking the new M1G standard purity into account. However, when 
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adjusting for a purity of 76 – 83%, then the standard values agree within 98 – 108%, 
which is within acceptable limits. 
4.3. Mass Spectrometry Method Development 
Following development of the HPLC method for M1G analysis, the next step was to 
optimise the MS method, initially by LC-MS and then by LC-MS-MS prior to quantitative 
analysis of DNA samples. 
The LC-MS method, described in Section 2.3.14.2., was further optimised by direct 
infusion of the M1G standard on to the MS to determine the optimum cone voltage that 
gave the greatest peak intensities for the ions of interest. The optimum cone voltage 
was 50 V for ES+ mode m/z 152 for guanine and m/z 188 for M1G, as at lower cone 
voltages, not enough ions were generated and higher cone voltages produced too much 
fragmentation with loss of the ions of interest. The data acquisition time was reduced 
from 30 min to 20 min as all of the eluents eluted in the initial 5 min (column A) or 
2.5 min (column B). Greater MS peak intensities were achieved with the narrower 
column B than column A, thus column B was chosen for further analysis. A flow rate of 
0.2 ml/min was used with this column as determined in Section 4.2. 
Both guanine and the M1G standard were analysed by LC-MS during LC-MS method 
optimisation, as shown in Figure 32. Guanine is shown in A – C, with a UV absorbance 
peak at 1.5 min and a RIC of m/z 152 a0074 1.8 min retention times. The mass spectrum  
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Figure 32. LC-MS chromatograms and mass spectra of guanine – A) RIC of m/z 152 
for guanine, B) UV absorbance and C) mass spectrum of A; and M1G standard – D) RIC 
of m/z 188 for M1G, E) RIC of m/z 152 for guanine, F) UV absorbance retention times 
1.51 min (guanine) and 2.00 min (M1G) and G) mass spectrum of D for M1G. 
at 1.8 min shows an m/z of 152.2228, corresponding to guanine MR 151.13 g/mol, with 
the addition of ~+1 by protonation of the parent ion (M) to give MH+ as the MS was 
operated in ES+ mode. The difference in retention times between UV and MS detectors 
was due to different lengths of tubing carrying the sample from the column to the 
detectors. The M1G standard is shown in D-G, with UV absorbance peaks at retention 
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times 1.5 min for guanine and 2.0 min for M1G. SIM of m/z 188 at retention time 2.3 min 
for M1G and RIC of m/z 152 for guanine at retention time 1.9 min. The mass spectrum 
at 2.3 min shows an m/z of 188.2701, corresponding to M1G (MR 1.87.1582 g/mol). The 
relative intensities of the RIC of M1G standard for m/z 152 (guanine) to m/z 188 (M1G) 
(Figure 32, D-E) had a ratio of 0.208, which gives the M1G standard a purity of 79.2% 
which is within the range previously calculated in Section 4.2., although assumes the 
same response per mass of analyte. 
The final stage of HPLC and MS method development was LC-MS-MS, which involved 
fine-tuning of the methods previously optimised for M1G analysis. The cone voltage 
optimised by LC-MS (50 V) was found to also be optimum for LC-MS-MS. The optimum 
collision energy required to fragment the precursor ion of M1G into product ions was 
found to be 28 eV. The M1G molecular (precursor) ion in ES+ mode was m/z 188 and this 
fragmented into product ions m/z 79, 106, 133 and 160, as shown in Scheme 13. Szekely 
et al. (2008) used multi-stage MS/MS analysis of M1dG in ES+ mode with 26 eV collision 
energy by direct infusion. M1dG has an m/z of 304 and neutral loss of the deoxyribose 
unit (116 Da) by collision induced dissociation occurred to give m/z 188 (M1G), followed 
by loss of CO (28 Da) to m/z 160, followed by further loss of HCN (27 Da) to m/z 133. The 
two product fragments of m/z 188, m/z 160 and 133 were also detected by this research, 
as shown in Scheme 13. This research also produced two further product fragments, m/z 
106 and m/z 79. Further loss of HCN (27 Da) from m/z 133 fragment gives the m/z 106 
product fragment and subsequent loss of another HCN (27 Da) from m/z 106 leaves 
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product fragment m/z 79, which corresponds to a 6-membered ring and therefore the 
more stable of the product fragments. 
 
Scheme 13. LC-MS-MS fragmentation of M1G in ES+ mode (m/z 188) to product ions 
A) m/z 79 (plus 109 fragment), B) m/z 106 (plus 82 fragment), C) m/z 133 (plus 55 
fragment), and D) m/z 160 (plus 28 fragment).  
At 20 V collision energy, high levels of the molecular ion (MH+) and low levels of product 
ions were achieved, indicating low fragmentation. However, the opposite occurred with 
30 V collision energy with much lower MH+ and higher levels of product ions. This 
collision energy was fine-tuned to 28 V. Next, the HPLC method was fine-tuned with a 
reduced run time of 10 minutes, as all eluents eluted within the initial 5 min. A blank 
sample (mobile phase only) was run in between samples to flush any remaining sample 
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from the column. The flow rate was also altered as there was some peak overlap 
between M1G and guanine peaks by UV detection. Flow rates of 0.075 ml/min – 
0.2 ml/min were tested and 0.15 m/min was found to be the optimum. Lower flow rates 
gave better peak separation, however, there was also reduced sensitivity. Although 
0.2 ml/min gave the greatest sensitivity, a lower flow rate of 0.15 ml/min gave better 
peak separation with only a slight loss in sensitivity compared to lower flow rates. 
Two scans were run concurrently by LC-MS-MS, a products of m/z 188 scan and an MRM 
scan. The products of m/z 188 scan, scanned for all product ions of MH+ (m/z 188) 
resulting in a TIC chromatogram. The TIC data could then be processed using RIC to look 
for product ions of MH+, such as m/z 79. The TIC or RIC data could be further analysed 
to look at the mass spectra of peaks of interest at any retention time. The four main 
product ions detected for M1G were m/z 79, 106, 133 and 160, of these m/z 79 and 106 
were chosen to analyse as they gave the greatest peak intensities. An MRM scan was 
also run of two reactions, scanning for m/z 188 to 79 and m/z 188 to 106 only.  
M1G standard (5.34 µM), guanine (66 µM) and adenine (66 µM) were analysed by the 
optimised LC-MS-MS method. The UV, MRM, TIC and RIC of product ions of M1G are 
shown in Figure 33, along with the mass spectrum of product ions at retention time 
2.9 min. An additional peak was seen on the UV chromatogram at 2.0 min which was 
also the only peak present when a blank containing mobile phase (50 mM ammonium 
formate (pH 5.4)) was run, and was absent when water only was run. This peak was 
therefore due to the mobile phase. A small peak corresponding to guanine (m/z 152)  
Chapter 4 Adduct Analysis 
155  
 
Figure 33. LC-MS-MS chromatograms and mass spectrum of 53.4 µM M1G 
standard - A) UV chromatogram, retention times 2.03 min (mobile phase) and 2.96 min 
(M1G), B) MRM chromatogram, retention time 2.85 min (M1G), C) products of m/z 188 
TIC chromatogram, retention time 2.86 min (M1G) and 2.30 min (guanine), D) product 
ion (RIC) chromatogram from TIC, all the same for m/z 79, 106, 133, 160 and 188, 
retention time 2.86 min (M1G), and E) Mass spectrum of product ion peak at 2.86 min, 
m/z peaks 79.01, 105.86, 132.85, 159.96 and 187.89. 
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was detected at 2.3 min on the TIC chromatogram Figure 33 C, the relative intensities of 
the guanine peak to the M1G peak at 2.9 min gave a ratio of 0.0146, which corresponds 
to a purity of 98.6%, although this would assume the same response per mass of analyte. 
This is a greater value for purity for the M1G standard than previously calculated (Section 
4.2), the M1G peak in Figure 33 C was quite broad and may encompass the ring-open 
form of M1G, N2OPdG, which had previously not been included. The MS (Figure 33 E) 
shows the 4 main product ions and the molecular ion (m/z 188). The two ions with the 
greatest peak intensities were m/z 79 and 106 and were the ions chosen for further 
analysis of M1G. 
Guanine and adenine were also analysed by LC-MS-MS to determine if they caused any 
interference with M1G detection by this method. In addition to the products of m/z 188  
and MRM scans, a full scan by LC-MS was also carried out, which scans for all m/z within 
a specified range, m/z 70 – 1000 in this case. Figure 34 shows the products of m/z 188 
scan UV chromatogram (A) and full scan (B-C) for guanine. Guanine eluted at 2.3 min 
and 2.3 min on the UV chromatograms for both the products of m/z 188 and full scans 
respectively. Guanine was not detected by the products of m/z 188 TIC scan or the MRM 
scan (not shown), but was detected by the full scan at 2.1 min (Figure 33 C). The MS 
(Figure 33 D) shows that the peak at 2.1 min had an m/z of 151.86, which corresponds 
to guanine. Adenine was not detected by MS for either LC-MS (full scan) or by LC-MS-
MS, only by the UV detector for both scans, with a retention time of 2.7 min (data not 
shown). This peak was quite close to that of M1G with regards to retention time, 
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however, as adenine was not detected by MS under these conditions, there would be 
no interference with M1G detection.  
 
Figure 34. Products of m/z 188 and MRM (A) and full scan (B-C) chromatograms 
and mass spectrum (D) of 66 µM guanine – A) UV chromatogram, retention time 
2.28 min, B) UV chromatogram, retention time 2.25 min, C) TIC scan, retention time 
2.10 min, and D) mass spectrum of (C) at retention time 2.10 min, peak at m/z 151.86. 
As guanine could be detected by LC-MS, but not LC-MS-MS, a M1G standard was spiked 
with different amounts of guanine to determine if there was any interference with M1G 
detection. Small differences could be seen in the peak intensities of the M1G peak 
between the standards spiked with guanine and those not spiked, but not between 
those spiked with different amounts of guanine. The differences were < ±5% from the 
non-spiked M1G standards and could be attributed to experimental and instrumental 
error. 
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A standard curve of M1G, analysed by LC-MS-MS, was plotted of peak intensity (AU) 
versus M1G concentration for product ions m/z 79 and 106 and MRM, as shown in Figure 
35. All standard curves had good R2 values (< 0.9833), with the MRM showing the best 
linear fit (0.9955). However, the curve for m/z 79 showed the steepest gradient. The 
MRM and m/z 106 curves were very similar. 
 
Figure 35. LC-MS-MS standard curves of 0 – 53.4 µM M1G standard (retention time 
2.85 min) product ions m/z 79 and 106 and MRM scan. 
The M1dG DNA standard was also analysed by LC-MS-MS, in order to validate the 
method. The UV, TIC, MRM and products of m/z 188 ion chromatograms are shown in 
Figure 36, as well at the MS of the M1G peak at retention time 2.9 min on the TIC 
chromatogram (C), which shows the product ions of M1G. The UV chromatogram (Figure 
36 A) shows 3 peaks at 2.0 min for the mobile phase, 2.3 min for guanine and 2.8 min 
for M1G. The MRM and TIC (Figure 36 B and C) chromatograms show peaks at 2.8 min  
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Figure 36. Products of m/z 188 and MRM LC-MS-MS chromatograms and mass 
spectrum of M1dG DNA standard - A) UV chromatogram, retention times 2.03 min 
(mobile phase), 2.30 min (guanine) and 2.80 min (M1G), B) MRM chromatogram, 
retention time 2.87 min (M1G), C) TIC chromatogram, retention time 2.88 min (M1G), 
D) product ion (RIC) chromatogram from TIC, all the same for m/z 79, 106, 133, 160 
and 188, retention time 2.86 min (M1G), and E) mass spectrum of product ion peak at 
2.86 min, m/z peaks 78.95, 105.93, 132.85, 160.15 and 188.02. 
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and 2.9 min respectively for M1G. The product ion (RIC) chromatogram (Figure 36 D) 
processed from the peak at 2.88 min on the TIC chromatogram was the same for all 
product ions of M1G: m/z 79, 106, 133 and 160 as well at the molecular ion m/z 188. 
The levels of M1G adduct in the M1dG DNA standard were calculated using the 
calibration equations of product ions m/z 79 and 106 and the MRM scan, as shown in 
Figure 35, in order to validate the detection method. The DNA standard contained 
21 pmol M1G/µg DNA and 3 mg/ml DNA, of which 30 µg DNA was used for analysis 
following acid hydrolysis, to quantify M1G for method validation: 
 10 µl injection volume = 3 µg DNA 
 Therefore there are 63 pmoles M1G/3 µg DNA i.e. total amount on the column 
When analysed, the M1dG DNA standard had a peak intensity for product ion m/z 79 of 
1.2 x105, and using the calibration equation in Figure 35 to calculate the amount of M1G 
in the M1dG DNA standard: 
 y = 20802x – 3230.1 
 x = 5.924 µM M1G = 5.924 pmol M1G/µl 
 10 µl injection volume = 59.24 pmoles M1G 
 1 µg DNA = 19.75 pmoles M1G = 94.03% of the DNA standard 
The M1dG DNA standard had a peak intensity for product ion m/z 106 of 6.41 x104, and 
using the calibration equation in Figure 35 to calculate the amount of M1G in the M1dG 
DNA standard: 
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 y = 10580x + 1045.2 
 x = 5.959 µM M1G = 5.959 pmol M1G/µl 
 10 µl injection volume = 59.59 pmoles M1G 
 1 µg DNA = 19.86 pmoles M1G = 94.59% of the DNA standard 
The M1dG DNA standard had a peak intensity for the MRM scan of 3.94 x104, and using 
the calibration equation in Figure 35 to calculate the amount of M1G in the M1dG DNA 
standard: 
 y = 7757.7x + 3328.2 
 x = 4.649 µM M1G = 4.649 pmol M1G/µl 
 10 µl injection volume = 46.49 pmoles M1G 
 1 µg DNA = 15.50 pmoles M1G = 73.79% of the DNA standard 
The amount of M1G in the M1dG DNA standard was comparable for both product ions 
m/z 79 and 106, however, the MRM scan gave a much lower amount due to reduced ion 
intensity. 
LC-MS-MS had greater sensitivity for detection of the M1dG DNA standard than HPLC 
(Section 4.2). Of the products of m/z 188 scan, the two product fragments that gave the 
greatest M1G peak intensities were m/z 79 and m/z 106. Extraction of RIC data from the 
TIC for these two product fragments, gave the greatest sensitivity for detection of the 
M1dG DNA standard, 94.03% and 94.59% of the M1dG DNA standard respectively, which 
shows good reproducibility and is within the acceptable range of the true value. The 
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MRM scan of m/z 188 to 79 and m/z 188 to 106 gave a lower sensitivity than the two 
product fragments individually at 73.79% despite the combined ion intensities of the 
MRM scan, however the calibration curve for this scan of M1G standard had a poor 
gradient. These scans were duplicated and gave similar results. The methods had been 
optimised further for the LC-MS-MS scans than for the HPLC in Section 4.2, which, along 
with the greater sensitivity, selectivity and accuracy of the instrumentation, may explain 
the differences in sample accuracy between the two instruments.  
The LOQ of M1G standard by LC-MS-MS was calculated by using the calibration line 
method, as described in Section 2.3.17.1., and shown in Table 14. The lowest LOQ was 
for m/z 79, and the closest peak on the calibration line to this was the peak at 0.267 µM 
M1G. This peak had a % RSD value of 0.15%, which showed good peak precision. 
Table 14. The LOD and LOQ of the M1G standard by LC-MS-MS 
Calibration 
Line 
 
LOD 
 
LOQ 
 
M1G (µM) 
M1G (pg) in 10 µl 
injection 
M1G (µM) 
M1G (pg) in 
10 µl injection 
m/z 79 0.09 169 0.273 511 
m/z 106 0.278 520 0.841 1575 
MRM 0.101 189 0.307 574 
 
The LOD of M1G standard by LC-MS-MS was calculated by using the calibration line 
method, as described in Section 2.3.17.1., and shown in Table 14. The lowest LOD was 
for m/z 79, with the closest peak on the calibration line corresponding to 0.089 µM M1G 
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(164 pg M1G in 10 µl injection volume). The lowest peak integrated on each calibration 
line was for 0.0356 µM M1G, which corresponds to 67 pg M1G in 10 µl injection volume. 
4.4. Analysis of M1G Adducts in DNA 
DNA extracted from MRC5 and MRC5 SV2 cells and CT-DNA were treated with MDA and 
then precipitated and hydrolysed prior to analysis by LC-MS-MS. MRC5 and MRC5 SV2 
cells were also treated with MDA and DNA was then extracted, precipitated and 
hydrolysed for analysis.  
M1G adducts in the DNA from the MRC5 and MRC5 SV2 cells treated and the DNA 
extracted and then treated were undetectable by this LC-MS-MS method and 
instrumentation. This may possibly be due to the low concentrations of DNA extracted 
from the cells and thus any M1G present may have been below the LOD. Alternatively, 
cellular DNA repair mechanisms may have removed any adducts present in the DNA, 
possibly resulting in the formation of mutations. The elution buffer used in the DNA 
extraction protocol was pH 9.0, which would indicate the presence on the ring-open 
form of M1dG, N2OPdG (as previously described in Section 1.9.) (Knutson and Marnett, 
2010). However, subsequent procedures, such as acid hydrolysis, would convert the 
ring-open form back to the ring-closed form, and hence should have been detected 
provided that the adduct concentration was above the LOD of the method. Other studies 
have used similar DNA extraction protocols for M1dG adduct analysis (Leuratti et al., 
1998; Gottschalg, 2002), and is thus not thought to affect adduct levels. 
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The MRC5 and MRC5 SV2 DNA samples were also analysed independently by Lieslot 
Hemeryck and Dr Lynn Vanhaecke of Ghent University, Belgium. No M1G was observed 
in the MRC5 and MRC5 SV2 DNA treated post-extraction from the cells (data not shown). 
However, they were able to observe very low levels of M1G in DNA samples from cells 
treated with MDA. The levels detected were around the LOD and were therefore not 
quantifiable and were inconsistent, and it was not clear if these were method artefacts 
at this low level.  
M1G adducts were detected in the CT-DNA samples, the UV, TIC, MRM and products of 
m/z 188 chromatograms are shown in Figure 37, with the MS of the TIC (C) peak at 
2.9 min retention time, which shows the 4 product ions of M1G (m/z 79, 106, 133 and 
160) and the molecular ion m/z 188. The UV chromatogram (Figure 37, A) shows a broad 
peak at 2.4 min for guanine, with a shoulder to the left, merging with the peak for the 
mobile phase (2.0 min previously). A peak at 2.8 min corresponds to M1G. The MRM 
peak (Figure 37, B) at 2.9 min also indicates M1G and the product ion (RIC) 
chromatogram (Figure 37, D) is representative of all of the chromatograms for the 
product ions of M1G, m/z 79, 106, 133 and 160. This data is very similar to that of the 
M1G standard, as shown in Figure 33, and the M1dG DNA standard, as shown in Figure 
36. 
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Figure 37. Products of m/z 188 and MRM LC-MS-MS chromatograms and mass 
spectrum of CT-DNA treated with 50 mM MDA - A) UV chromatogram, retention time 
2.35 min (guanine) and 2.84 min (M1G), B) MRM chromatogram, retention time 
2.92 min (M1G), C) TIC chromatogram, retention time 2.92 min (M1G), D) product ion 
chromatogram from TIC, all the same for m/z 79, 106, 133, 160 and 188, retention time 
2.91 min (M1G), and E) mass spectrum of product ion peak at 2.86 min, m/z peaks 
78.89, 106.05, 132.85, 159.70 and 188.02. 
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The peak intensities of product ions of M1G m/z 79 and 106 (chosen as they gave the 
greater peak intensities) were measured for CT-DNA treated with MDA and the M1G 
concentration in each sample was calculated using the equations from the calibration 
curves in Figure 35. A chart of M1G concentration versus the MDA concentration was 
plotted using both product ions and is shown in Figure 38. For both product ions, the 
concentration of M1G increases with the concentration of MDA, although the 
concentration is slightly lower for m/z 106 than m/z 79. For m/z 79, there was a low 
concentration (0.16 µM) M1G adducts in untreated DNA, which is also often found for 
many adducts, however this is below the LOQ and just above the LOD, as shown in Table 
14. For m/z 106, the untreated DNA and the DNA treated with 0.01 mM MDA have low 
negative values, -0.09 and -0.06 µM M1G. The levels of M1G detected for m/z 79 were 
below the LOQ for < 1 mM MDA, but all MDA concentrations were greater than the LOD. 
For m/z 106, the levels of M1G detected were below the LOD for < 1 mM MDA, and 
above the LOQ for > 10 mM MDA. This means that the levels of M1G detected at the 
lower MDA concentrations were less reliable than for higher concentration, particularly 
for m/z 106, however, a clear pattern can be seen whereby levels of M1G increased with 
increasing MDA concentration. 
Treatment with the highest concentration of MDA (50 mM) results in 1.95 µM and 
1.74 µM M1G adducts for m/z 79 and 106 respectively, which corresponds to 
0.39 pmol/µg DNA and 0.35 pmol/µg DNA respectively (or 1205 adducts per 107 
nucleotides and 1077 adducts per 107 nucleotides, respectively). However, the MDA 
solution used here was only verified, in Section 3.1., up to 10 mM by HPLC with DNP 
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derivatisation, where at this concentration, an additional small peak was observed, 
indicating potential polymerization of MDA (Gutteridge et al., 1977) which would reduce 
the effective dose of MDA. Thus, it only appears to be possible to detect any effect from 
~ 0.1 mM MDA upwards, although this does appear to be a dose-response relationship. 
 
Figure 38. M1G concentration in CT-DNA treated with 0 – 50 mM MDA for product 
ions of M1G - m/z 79 and 106. Error bars show ±1 SD from the mean. 
ISB was carried out as previously described Moore et al. (2010) (data not shown). 
Adducts were not detectable by ISB for the cell samples, which corroborates with the 
LC-MS-MS data here, indicating that cellular responses, such as DNA repair mechanisms, 
could be occurring. Treatment with MDA alone resulted in a dose-response relationship 
as expected for the CT-DNA samples, however, only DNA was involved and no cellular 
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responses could have repaired these adducts. Similar effects have been seen in previous 
studies with HT29 cell, which also showed that there was no correlation between MDA 
concentration and adduct levels (unpublished data) (Gottschalg, 2002). 
4.5.  Summary 
A method of M1G adduct detection has been developed and validated using a M1dG DNA 
standard that had been made previously Moore et al. (2010). The standard had been 
analysed by independent methods and the value obtained by LC-MS-MS here was 
94.03% of that expected, showing that the standard was of a high purity and this method 
has given good accuracy. 
M1G adducts in DNA from the MRC5 and MRC5 SV2 cells treated and the DNA extracted 
and then treated were undetectable by this LC-MS-MS method and instrumentation. 
However, the DNA concentrations were very low for the DNA from treated cells, and for 
MRC5 and MRC5 SV2 DNA treated post-extraction. Increasing the yield of DNA from the 
cells may allow for detection of M1G adducts by this method and instrumentation, 
however, there would be cell culture issues with increasing the yield sufficiently as large 
numbers of cells would have to be cultured. Analysis elsewhere and by the ISB, which 
uses a lot less DNA (1 μg), also showed no quantifiable adducts. Instrumentation with 
much greater sensitivity may aid future quantification of adducts in cellular DNA. M1G 
adducts have been quantified in CT-DNA, although with a relatively high concentration 
of DNA compared to MRC5 and MRC5 SV2 DNA.  
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MDA has been found to have an effect on MRC5 and MRC5 SV2 cells at the cellular level, 
as previously described in Chapter 3, with reduced cell proliferation and viability, 
alteration to cell and nuclear morphology, increased apoptosis and p53 expression. 
However, M1dG adducts were undetectable in these cells by LC-MS-MS. Other than the 
possible reasons mentioned above, DNA repair mechanisms in the cell, such as NER 
(Marnett, 1999), may act to remove M1dG adducts from DNA, and the M1dG adduct is 
subsequently metabolised to 6-oxo-M1dG and 2,6-oxo-M1dG (Knutson et al., 2007) for 
excretion. MDA has also been found to form protein adducts (Agarwal and Draper, 1992), 
and must encounter an array of proteins, such as actin, in the cell cytosol and nucleus 
prior to reaching the DNA, and thus may be sequestered as protein-MDA adducts, 
reducing the effective dose of MDA reacting with DNA. MDA also reacts with its own 
degradation product, acetaldehyde, and the amino group of proteins to form MDA-
acetaldehyde-protein adducts (Tuma et al., 2001). This may explain why M1dG adducts 
were detected in CT-DNA and not DNA extracted from cells treated with MDA. 
While analysis and quantification of M1G adducts by LC-MS is useful as it can relate the 
treatment of samples of cells or DNA with a particular substance to the effect on the 
levels of adducts, it does not give any indication as to the effects at the DNA level due 
to adduct formation. It also requires very costly instrumentation for analysis, particularly 
for the levels of sensitivity required if biological samples were to be analysed, whereas 
other methods of adduct detection can be much less expensive, for example, analysis of 
DNA by mutation sequencing which shows the long-term effects upon DNA rather than 
just adducts which may be repaired or of no consequence to the cell. 
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CHAPTER 5 
EFFECT OF MALONDIALDEHYDE ON 
DNA 
This chapter details the effect of treatment with MDA on DNA. DNA extracted from 
MRC5 and MRC5 SV2 cells, treated in vitro with MDA, was subject to imaging by AFM 
and mutation sequencing of residues 4640-5328 (encompassing exon 1) of the human 
TP53 gene (GenBank accession NG_017013.2). The effects of MDA on DNA topography 
and on DNA sequence are presented here. 
5.1. Imaging of DNA by Atomic Force Microscopy 
To image the effect that treatment of cells with MDA on DNA topography, AFM was 
utilized following immobilization of DNA on mica discs, as described in Section 2. 3.13.2. 
Initially, as negative controls, images were taken of the mica only and of the TE buffer 
that the DNA samples were diluted in, shown in Figure 39, to demonstrate the 
appearance of the mica without DNA attached. In Figure 39, the mica in A was 
approximately 0.4 nm in height, whereas the small round ‘blobs’ in B were most likely 
formed from crystals of TE buffer and were approximately 4 nm in height. The two 
images show that there was no DNA contamination on either the mica or in the TE buffer 
used. 
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Figure 39. AFM images of A) mica only and B) TE buffer. 
5.1.1. Effect of MDA on DNA Topography 
The effect of treatment of cells with MDA can be seen in Figure 40 where the DNA from 
untreated cells was adsorbed on to the mica surface in long, double-stranded networks, 
and was similar for both the MRC5 and MRC5 SV2 cell lines, although the images differ 
in size. Whereas following treatment of cells with MDA (100-1000 µM), the DNA 
networks were more fragmented with increasing MDA concentration and treatment 
time, indicating DNA damage due to MDA treatment. The images shown in Figure 40 are 
representative of those from a number of samples (n = 3). The untreated controls and 
treatment with low concentrations of MDA (10 – 100 µM) gave similar images 
repeatedly, however with further increases in MDA concentration, images were difficult 
to obtain due to increased fragmentation and/or the clumping together of DNA making 
it difficult to locate areas of damaged DNA. Although images were taken for both 24 and 
48 h, only images for 48 h MDA treatment are shown. 
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Figure 40. AFM images of DNA extracted from MRC5 (A-C) and MRC5 SV2 (D-F) cells treated for 48 h: A&D untreated, B&E) 100 µM MDA 
and C&F) 1000 µM MDA, immobilized on mica.
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This increased DNA fragmentation due to treatment with genotoxic compounds has 
been observed previously. Liu et al. (2010) looked at DNA-cisplatin interactions by AFM 
and found that the appearance of DNA changed with increasing cisplatin concentration, 
from extended chains to bending structures, worm-like structures and flat particles, with 
longer DNA fragments (~48 kbp) forming loop structures. BPDE has been shown to 
induce the formation of DNA adducts. When using AFM in tapping mode to image the 
treated DNA, 30° bends were observed at the adduct sites (Pietrasanta et al., 2000). It 
has been recently suggested that DNA dynamics rather than static DNA structure is 
important in gene expression control. Using high speed AFM in tapping mode, RNA 
polymerase has been shown moving along DNA strands by time-lapse AFM (Lyubchenko, 
2011). Thus, AFM enables visualisation of DNA in an environment that may reveal its 
biological conformation.  
The height along the length of the DNA molecules was measured, shown in Figure 41. 
The height varied along the length of the DNA molecule in peaks and troughs. For MRC5, 
the height decreased from 1.6 nm to 0.6 nm, over a 140 nm length. For MRC5 SV2, over 
the same distance, the height alternated between 1.0 nm and 0.4 nm with many more 
peaks and troughs than MRC5 DNA, although this difference may be due to differences 
in image size. The height profiles were representatives of a number taken for each cell 
line (n = 3), however, as the images are not the same size, comparison of DNA height 
profiles between the two cell lines cannot be quantified. The differences in height (peaks 
and troughs) along the length of the DNA strands maybe due to the major and minor 
grooves of DNA. The average diameter of double stranded DNA (B-form) is 2 nm, the 
height of the DNA measured in Figure 41 is less than this which could be due to the DNA 
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becoming flattened due to adsorption on to the mica, and no hydrogen bonds due to 
dehydration, meaning that the tertiary structure of the DNA molecule collapses and is 
therefore not the same as in vivo (Klinov et al., 2003). 
Figure 41. AFM images of DNA extracted from untreated A) MRC5 cells and B) MRC5 
SV2 cells, immobilized on mica. The height along the DNA molecule is shown beneath 
each image. 
The heights along the DNA strands, as shown in Figure 41, were measured in order to 
show what the height profile looked like before the addition of M1dG primary antibodies 
in the following section. This was to determine whether the antibody-DNA could be 
detected using AFM and also whether the DNA fragments clumped together. 
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5.1.2. Use of M1dG Antibodies to Locate MDA-Induced Mutations 
As a feasibility study, M1dG primary antibodies were used to see if M1dG adducts could 
be located on the DNA strands using AFM, as described in Section 2.3.13.3. As the lowest 
concentration of M1dG adduct that has been detected in cellular DNA is 1 per fmol DNA 
i.e. 1 in 107 bp or 0.5 in 107 bases (Moore et al., 2010), and as 1 bp is 3.4 Å in length, or 
0.34 nm (Watson and Crick, 1953), and assuming that the M1dG adducts are evenly 
spaced, an adduct would be present every 3.4 mm, and therefore a large number of 
images may be required to detect M1dG adducts by this method. It may therefore only 
be possible to see adduct-antibody binding at high MDA concentrations. 
The M1dG antibody and MRC5 and MRC5 SV2 DNA, from cells treated with MDA 
(0-1000 µM), incubated with the antibody were both imaged by AFM. The antibody and 
the antibody incubated with MRC5 SV2 DNA treated with 100 µM MDA are shown in 
Figure 42. Similar observations were shown with MRC5 DNA and other concentrations 
of MDA, although increasing DNA fragmentation with increasing MDA concentration 
was observed, as in the previous section, thus locating areas of damaged DNA was more 
difficult at higher concentrations. Antibodies imaged by AFM have been found to have 
greater heights then DNA, for example the anti-interleukin 10 antibody was found to be 
4.2 ± 0.3 nm (Ierardi et al., 2013). The height of the antibody adsorbed to mica (Figure 
42 A) was 2.8 nm, smaller than the anti-interleukin 10 antibody, and the peak shown in 
Figure 42 B was 1.4 nm, indicative of DNA only, as seen in the previous section. The 
antibody can be clearly seen on mica, however, in conjunction with MDA-treated DNA, 
and although the image appears to have ‘blobs’ attached to the DNA fragments, which 
may possibly be the antibody, the height profile of the DNA fragment with the ‘blob’ 
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indicates that it is DNA only. This correlates with the adduct results in Section 4.4., where 
no adducts could be detected by any methods including the ISB which utilises the M1dG 
antibody. Hence, if no adducts had formed then there could be no DNA-antibody binding 
and thus no adducts detected in the DNA samples by AFM. This may be due to the large 
number of AFM images that would be required to detect any M1dG adducts, as discussed 
above, or alternatively, a rapid turnover occurred and it was not possible to find them 
in cell samples due to DNA repair mechanisms. 
 
Figure 42.  AFM images of A) M1dG antibody only and B) DNA extracted from 
MRC5 SV2 cells treated with 100 µM MDA plus M1dG antibody for 48 h, immobilized 
on mica. The height is shown below each image. 
5.2. Mutation Sequencing 
Missense mutations in the TP53 gene are present in about half of all cancer cases 
(Martin et al., 2002), with inactivation of the TP53 gene by viral or cellular oncogenes 
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being associated with further cases. Most of the mutations are found in the central 200 
amino acid section of the p53 protein. The functional wild-type p53 protein exhibits an 
anti-tumour response inhibiting neoplastic transformation, for example cell growth is 
arrested when p53 induces the expression of Cip1 cell cycle inhibitor. Mutations in exons 
5-9 of p53 lead to inactivation of the gene in many human cancers. A major target in p53 
is the DNA binding domain (Hainaut and Hollstein, 2000) which contains many of the 
mutation hotspots, six of which stand out: arginine residues 248, 273 (both in direct 
contact with DNA), 175, 249 and 282, and glycine 245 (Cho et al., 1994).  
The main TP53 transcript is 2586 bases in length (Xu-Monette et al., 2012) and most 
mutations have been found in the central DNA binding domain (Kruse and Gu, 2009). 
The main transcript includes a 5’ UTR which covers exon 1, a large intron between exons 
1 and 2, and the coding sequence from exons 2 to 11 (Xu-Monette et al., 2012). A bias 
has been observed in the mutation screening of the human TP53 gene, with the majority 
of studies focusing on the main coding regions (exons 2-11) and overlooking the 5’UTR 
exon 1 (Liu and Bodmer, 2006), perhaps as it is a non-coding sequence and therefore 
dismissed as non-functional.  
Protein-coding DNA sequences make up only a small fraction of the human genome, and 
some non-coding sequences transcribing regulatory promoters, enhancers and silencers, 
RNA molecules such as tRNAs, origins of replication and telomeres and centromeres. 
However, the majority of the human genome has long been referred to as ‘junk DNA’, 
DNA sequences that have no biological function. However, current research suggests 
that much of this ‘junk’ DNA has been found to have, or has the potential to have, some 
biological functionality (Palazzo and Gregory, 2014), including regions involved in gene 
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regulation and control of gene expression at the post-transcriptional level (Blattner, 
2008). An example of this is the 5’ UTR of the human TP53 gene, which encompasses 
exon 1. 
Recent studies have found that regulatory elements are located in exon 1, and can 
regulate the translation and the stability of p53 mRNA (Pouladi et al., 2013). A regulator 
of p53 was discovered recently, which is an antisense transcript of p53, called Wrap53. 
Wrap53 overlaps exon 1 in the antisense direction and encodes the Wrap53α transcript 
that hybridises with p53 mRNA, which prevents degradation of the p53 mRNA, and is 
thus a form of post-transcriptional p53 control (Mahmoudi et al., 2009). It has been 
suggested that the Wrap53-p53 interaction is required to maintain basal p53 levels in 
cells, as overexpression of Wrap53 leads to increased p53 mRNA levels resulting in 
translation to p53 protein, whereas knockdown of Wrap53 leads to reduced levels of 
p53 mRNA (Farnebo, 2009). This section of the TP53 gene, previously overlooked in 
mutation studies as it is not part of the main p53 coding sequence, therefore has a role 
in p53 regulation in both the sense and antisense sequences.  
In order to locate MDA-induced mutations and map M1dG adduction sites, mutation 
sequencing was carried out. A 689 bp section of the human TP53 gene, covering the 
5’UTR and exon 1, was amplified by PCR from DNA extracted from MRC5 and MRC5 SV2 
cells treated with MDA and H2O2 for 48 h. The DNA sequence analysed included residues 
4640-5328 of the 32,772 bp TP53 gene, located on chromosome 17 (GenBank accession 
NG_017013.2). The PCR products were then sequenced to look for mutations that could 
be attributed to treatment with MDA. 
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5.2.1.  Agarose Gel Electrophoresis 
The sizes of the PCR products were checked by agarose gel electrophoresis as shown in 
Figure 43. All PCR products had single bands at approximately 700 bp in size, 
corresponding to the PCR product length of 689 bp. The negative control, containing no 
DNA, had no band (lane 2), whilst the positive control (H2O2) produced a single band 
corresponding to 689 bp (lane 10). 
 
Figure 43. Agarose electrophoresis gel of MRC5 TP53 (residues 4640-5328) PCR 
products. Lane 1: Hyperladder II, Lane 2: no DNA, Lanes 3 – 9: 0-1000 µM MDA, Lane 
10: 100 µM H2O2.  
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5.2.2.  Mutation Sequencing of the p53 Gene Segment 
The DNA sequencing of the PCR products was carried out by double stranded primer 
walking Sanger DNA sequencing. The mutations and the type of mutations detected in 
MRC5 and MRC5 SV2 DNA from cells treated with MDA and H2O2 are shown in Appendix 
1 and were compared to the same sequence from the TP53 gene (NCBI, 2014). Conflicts 
were highlighted to indicate mutations in the sequences and are summarized in Table 
15. 
In general, more mutations were observed in MRC5 DNA (n=21 MDA, n=20 H2O2) than 
for MRC5 SV2 DNA (n=11 MDA, n=12 H2O2). This may be due to the altered p53 response 
and p53 stabilisation by the viral large T antigen in MRC5 SV2 cells compared to the wild-
type MRC5 p53, as described in Section 1.11. This large T antigen - p53 binding blocks 
p53 dependent gene expression and may therefore have an effect upon the cellular 
response to DNA damage. 
No mutations occurred in the negative control DNA (untreated), nor in DNA where cells 
had been treated with 10 µM MDA, which may be due to very low levels of mutations 
and DNA repair mechanisms reversing any mutations that may have formed, or no 
mutations were produced in this relatively short section of DNA sequence.  
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Table 15. Mutation type and residue number of mutations in DNA from MRC5 and 
MRC5 SV2 cells treated with MDA and H2O2. Residue numbers with repeat mutations 
are highlighted in bold with different, corresponding colours. 
 
Residue Number Mutation Type Residue Number Mutation Type
0
10 MDA
4821 C to T transition 4724 G insertion
5149 G insertion
5152 G insertion
4738 A to G transition 5253 T insertion
4823 T insertion
4832 C to A transversion
5188 T insertion
5216 G insertion
5238 T insertion
5245 G insertion
5254 C insertion
5255 T insertion
4724 G insertion 4724 G insertion
5216 G insertion 5216 G insertion
5256 T insertion 5256 T insertion
5263 C insertion 5263 C insertion
4714 A to G transition 5222 A insertion
4724 G insertion
5255 T insertion
4724 G insertion 4724 G insertion
5254 C insertion 4725 A insertion
5155 G insertion
5253 A insertion
4714 A to G transition 5215 G insertion
4724 G insertion
5253 T insertion
5263 C insertion
4738 A to G transition 4738 A to G transition
4819 A to G transition 4788 T insertion
4828 T to A transversion 4791 G insertion
4830 A insertion 4819 A to G transition
5150 G to C transversion 4820 G to T transversion
5209 A insertion 4821 C to T transition
5214 G insertion 4831 C to A transversion
5219 G to C transversion 5046 A insertion
5224 A insertion 5154 G insertion
5226 G to A transition 5171 G insertion
5242 G to T transversion 5287 G to A transition
5260 G to T transversion
5266 G to T transversion
5281 G to T transversion
5287 G to A transition
5311 G to T transversion
500 MDA
1000 MDA
50 H2O2
100 H2O2
Cell Treatment (µM)
MRC5 Mutations MRC5 SV2 Mutations
50 MDA
100 MDA
200 MDA
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For the DNA from MRC5 cells treated with MDA, the majority (43%) of mutations 
occurred in DNA from cells treated with 100 µM. Normal biological levels of MDA are 
< 50 µM, so these mutations may be representative of those occurring in human tissue 
subjected to oxidative stress. This was followed by a decrease in the number of 
mutations as MDA concentration was increased further, up to 1000 µM. This may be 
due to more cells being damaged due to higher MDA concentrations, resulting in 
increased apoptosis and decreased cell viability as previously observed in Sections 3.3 
and 3.7, with increasing MDA levels. Mutations occurring in cells that have undergone 
apoptosis would not be detected, as only DNA from live cells, including those in the early 
stages of apoptosis, which remained attached to the flask wall was collected for analysis.  
In both cell lines treated with the positive control, H2O2, the number of mutations 
increased with increasing H2O2 concentration, suggesting that the higher H2O2 
concentration (100 µM) was enough to cause mutations in the DNA whilst retaining cell 
viability.   For the DNA from MRC5 SV2 cells treated with MDA, the greater numbers of 
mutations occurred at concentrations of 200 µM and 1000 µM MDA, but were much 
lower in number than the respective MRC5 DNA, perhaps due to the altered p53 
response of MRC5 SV2 cells. 
A number of mutations observed, were repeated, as highlighted in Table 15 in different 
colours. These were an A to G transition appearing twice at residue 4714 in MRC5 DNA; 
a G insertion appearing seven times at residue 4724 in both cell lines; and A to G 
transition appearing three times at residue 4738 in both cell lines; a C to T transition 
appearing twice in both cell lines at residue 4821; a G insertion appearing three times at 
residue 5216 in both cell lines; a T insertion appearing twice and an A insertion appearing 
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once at residue 5253 in both cell lines; a C insertion appearing twice at residue 5254 in 
MRC5 DNA; a T insertion appearing twice in MRC5 DNA at residue 5255; a T insertion 
appearing twice at residue 5256 in both cell lines; and a C insertion appearing three 
times at residue 5263 in both cell lines. The most prominent mutation was the G 
insertion at residue 4724, indicating a potential mutation hotspot in this DNA sequence. 
Exon 1 is 224 bp in length and is located between residues 4953 and 5176 of the TP53 
gene sequence, within the 689 bp region sequenced here. Mutations found in this region 
were at residues 5149, 5152 and 5155 due to treatment with MDA, and residues 5046, 
5150, 5154 and 5171 due to treatment with H2O2. The 689 bp sequence examined also 
aligns to residues 1841 to 1153 of the 17432 bp Wrap53 gene sequence (GenBank 
reference NG_028245.1) in the antisense direction.  
The type and percentage of mutations found in the DNA of both cell lines following 
treatment with MDA and H2O2 is summarised in Figure 44. In the DNA from MRC5 cells 
treated with MDA, the majority of mutations were insertions, of which were mainly G, 
T and C (81% in total) but no A insertions. The remainder were transitions, of which were 
A to G and C to T, and transversions, of which were C to A. All of the mutations that 
occurred in the DNA from MRC5 SV2 cells treated with MDA were insertions, of which 
the majority were G, but also A, which did not occur in MRC5 cells, and no transistions 
or transversions. This difference in mutation type between the two cell lines maybe due 
to the sequestration of the p53 protein in MRC5 SV2 cells by the viral large T antigen 
compared to the wild type p53 in MRC5 cells (Huschtscha and Holliday, 1983; Pipas, 
2009), which may have an effect on downstream p53 dependent gene expression and 
subsequent alteration to DNA repair response mechanisms.  
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Figure 44. Type of mutations (%) in DNA from MRC5 cells treated with A) MDA and B) 
H2O2 and MRC5 SV2 cells treated with C) MDA and D) H2O2. 
TP53 is the most commonly mutated tumour suppressor gene in lung cancer (Hecht, 
2008), with mutations present in around 60% of human lung cancers. The majority of 
the mutations are G to T transversions, which are infrequent in other tumours except 
hepatocellular carcinoma. In other cancers, almost all mutations are G to A transitions 
(Hainaut and Hollstein, 2000; Hecht, 2008). The mutations in smoking associated lung 
cancers occur at a number of mutational hotspots along the TP53 gene, particularly at 
codons 157 (specific for lung cancer), 249 and 273 which are found in the DNA binding 
domain of the p53 protein (Denissenko et al., 1996). Previous studies have described 
DNA mutations due to MDA and M1dG adduct formation. MDA has been shown to 
induce frameshift mutations and base pair substitutions (Niedernhofer et al., 2003; del 
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Rio et al., 2005). Benamira et al. (1995) found that the majority of mutations in 
Escherichia coli DNA were transversions consisting mainly of G to T and transitions 
consisting of A to G and C to T substitutions, and the remaining sequence changes were 
single base insertions. Whereas the data here found that the majority of mutations were 
insertions. M1dG is also mutagenic in mammalian cells, with the majority of mutations 
occurring as base substitutions at dT and dA and the remaining as frameshift mutations 
(insertions or deletions) (Stafford et al., 2009).  
In the TP53 gene of lung cancer cells, the majority of mutations were G:C to T:A 
transversions, of which there was a strong link between these types of mutation and 
cigarette smoking (Soussi et al., 2000), whereas there was an increase in G:C to A:T 
transitions in TP53 lung cancer mutation spectra in non-smokers (Kim et al., 2012).  An 
increase in frameshift mutations was observed in former or non-smokers who were 
exposed to passive smoking (Vahakangas et al., 2001). The majority of mutations 
observed here, in both cell lines, were insertions i.e. frameshift, as previously observed 
in passive smokers, whereas in the smoking-associated lung cancer studies, the majority 
were transversions. Although both types occurred in MRC5 and only insertions in MRC5 
SV2 cells. Some transition mutations were observed in MRC5 DNA, which holds some 
similarity with non-smoking-associated lung cancer studies. Additionally, the majority of 
mutations seen here, occurred at guanine bases, which had also been observed 
previously, and is in keeping with the greater reactivity of MDA with guanine to produce 
M1dG adducts, compared to the other DNA bases (Marnett, 1999). The mutation 
hotspots for G:C to T:A transversions occurring in lung cancers of smokers were at 
codons 157, 158, 245, 248 and 273, which have been identified as strong binding sites 
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for PAHs, suggesting direct DNA damage from cigarette smoke carcinogens at these sites, 
rather than from endogenous sources (Hainaut and Pfeifer, 2001), as would be expected 
here as MDA is a product of endogenous lipid peroxidation (Chaudhary et al., 1994). All 
of the studies above looked at the main coding regions of TP53 (exons 2-11), whereas 
the 5’ UTR was studied here as little mutational analysis has been carried out on this 
region previously (Liu and Bodmer, 2006), hence, no direct comparison may be carried 
out. However, mutational analysis of this region of TP53 as a result of exposure to MDA 
provides a novel contribution to research. 
Of the mutations that occurred in the DNA from MRC5 cells treated with H2O2, the 
majority of mutations were transversions, of which were G to T, G to C and T to A. The 
remainder were transitions, of which were A to G and G to A, and insertions, of which 
the majority were A and G. In the DNA from MRC5 SV2 cells treated with H2O2, half of 
the mutations were insertions, of which the majority were G with no C insertions. The 
remainder were transitions, of which were A to G, C to T and G to A, and transversions, 
of which were G to T and C to A. The mutation profiles for MDA and the positive control, 
H2O2, differ for both cell lines, which may be due to the different modes of action of 
MDA and H2O2, enabling the assumption that the mutations seen here were a direct 
effect of MDA treatment. H2O2 is an intermediate molecule formed by dismutation of 
superoxide ions by superoxide dismutase (Ayala et al., 2014), and is involved in the 
production of hydroxyl radicals in the Fenton reaction (see Section 1.5). The hydroxyl 
radicals react with DNA bases resulting in DNA damage, mainly DNA strand breaks and 
base substitutions, mainly transversions at guanine (Termini, 2000), the majority of 
mutations were G to T transversions or C to T transitions (Lee et al., 2002). The mutations 
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in MRC5 DNA due to H2O2 are in line with the findings in these previous studies, however, 
those in MRC5 SV2 DNA do not, which, again, may be due to the sequestration of MRC5 
SV2 p53 by the SV40 virus (Huschtscha and Holliday, 1983).  
5.2.3.  Secondary Structure of the p53 Protein Sequences 
The mutations were examined to determine their influence upon secondary structure 
of residues 4640-5328 of the wild-type p53 protein shown in Figure 45. The primary and 
secondary structures of MRC5 and MRC5 SV2 DNA from cells treated with MDA and H2O2, 
compared to residues 4640-5328 of the wild-type p53 protein, are shown in Appendix 2. 
The predicted effect of the mutations in Table 15, in the previous Section, are shown in 
the primary structure, where there are alterations in amino acid sequence, and 
consequently the secondary structure of how the pattern of hydrogen bonds between 
the amino and carboxyl groups of the peptide backbone of the protein is altered 
resulting in changes to how the protein folds into α-helices and β-strands. 
 
Figure 45. Primary structure of residues 4640-5328 of GenBank TP53 sequence. 
Secondary structures are illustrated with arrows in pink (β –strand) or blue (α-helix). 
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No change in the secondary structure was predicted in either cell line for untreated cells 
and those treated with 10 µM MDA, due to no observed mutations in these section of 
DNA sequence, compared to the wild type p53 sequence. Changes in secondary 
structure were predicted in cells treated with increasing concentrations of MDA and 
H2O2 above 10 µM MDA, with increasing irregularity. Different numbers and lengths of 
α helices and β strands were predicted with increasing MDA and H2O2 concentrations, 
with increasing irregularity the further along the DNA sequence, from 1 to 689 bases. 
This effect was predicted to be more so for MRC5 SV2 DNA than for MRC5 DNA, possibly 
due to the greater number of insertion mutations found in MRC5 SV2 DNA than MRC5 
DNA, as described in the previous Section. 
Insertion (and deletion) mutations are frame-shift mutations which alter the reading 
frame of the DNA sequence resulting in changes where the mutation is inserted (or 
deleted), but also for downstream sequences. This effect is predicted here, where there 
is an increased number of insertions, resulting in an increased number of changes to the 
secondary structure. MRC5 DNA, which had fewer insertion mutations, had an increased 
number of short β strands with increased MDA and H2O2 concentrations, and apart from 
the final ~60 amino acids, the stretches of amino acids were similar with similar 
secondary folding, compared to MRC5 SV2 DNA which had increased irregularity of 
secondary folding after the initial ~80 amino acids. 
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Table 16. Repeat mutations in residues 4640-5328 of the TP53 gene sequence in 
MRC5 and MRC5 SV2 DNA form cells treated with MDA and H2O2. 
Residue 
Number 
Mutation Type 
Amino Acid 
Wild Type Mutated 
4714 
A to G 
Transition 
Lysine Arginine 
4724 G Insertion Serine Glutamic Acid 
4738 
A to G 
Transition 
Threonine Alanine 
4821 G to T Transition Glutamine Stop Codon 
5216 G Insertion Histidine Alanine 
5253 T Insertion Lysine Isoleucine 
5254 C Insertion Lysine Asparagine 
5255 T Insertion Serine Phenylalanine 
5256 T Insertion Serine Phenylalanine 
5263 C Insertion Glycine Glycine 
 
The repeated mutations described in the previous section, all apart from one (residue 
5263), was predicted to result in changes to the amino acid sequence, assuming that the 
reading frame began at residue 1 of the 689 bp sequence (residue 4640 of the TP53 
sequence), and are summarised in Table 16. 
Changes to the secondary structure also results in alteration of protein charge and the 
hydrophobicity of the sequence. The net charge of a protein alters with pH and is 
determined by the pK values of the ionisable carboxyl and amino groups of the amino 
acids that make up the protein. The isoelectric point (PI) is the pH at which the net 
charge is zero and solubility of the protein is minimal. An excess of acidic residues (e.g. 
aspartic acid and glutamic acid) gives a low PI and an excess of basic residues (e.g. 
arginine, histidine and lysine) gives a high PI (Shaw et al., 2001). The PI is also important 
in determining the cellular localization of proteins, for example, nuclear proteins have a 
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neutral to basic PI (pH 7.4 to 8.1), whereas cytoplasmic proteins often have more acidic 
PI’s (pH < 7.4) (Khaldi and Shields, 2011). The protein charge versus pH plots of the 
predicted amino acid sequences of MRC5 and MRC5 SV2 DNA treated with MDA and 
H2O2 are shown in Figure 46. The PI’s of each sequence are shown in Figure 47 and were 
calculated from the protein versus charge plots. The PI of the predicted amino acid 
sequences of MRC5 DNA treated with MDA increased from pH 9.3 for the untreated 
control and 10 µM MDA, which was the same as the wild type p53 sequence, to pH 11.1 
for 200 µM MDA and then decreased again to pH 10.5 for 1000 µM MDA. The PI’s for 
MRC5 SV2 followed the same trend, however fluctuated between 50 and 1000 µM MDA. 
For cells treated with H2O2 (data not shown), the PI’s increased with increasing H2O2 
concentration, but to a greater extent for MRC5 than for MRC5 SV2 cells. The overall 
increase in PI for both cell lines indicated an overall increase in the number of basic 
amino acids (e.g. lysine) incorporated into the sequences due to mutations, compared 
to the wild type p53 sequence, which follows previous observations that PI can vary with 
sequence mutations, mainly insertions and deletions (Khaldi and Shields, 2011). When 
acidic residues were replaced with lysine residues in the Ribonuclease Sa protein 
sequence, the PI increased with increasing number of lysine residues added (Shaw et al., 
2001). The repeated mutations, described in the previous Section, were predicted to 
result in the alteration of mainly basic and polar amino acids being replaced with mostly 
non-polar amino acids. However, as these were mainly insertions which affect the 
downstream amino acid sequence, the effect on the overall amino acid sequence of this 
section of the TP53 gene may have been an overall increase in basic residues resulting 
in increased PI’s. 
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Figure 46. Protein charge vs pH plots of predicted amino acid sequences of residues 
4640-5328 of the TP53 gene extracted from A) MRC5 cells and B) MRC5 SV2 cells 
treated with MDA (0-1000 µM) and H2O2 (50-100 µM) for 48 h, compared to amino 
acid sequences of residues 4640-5328 of the GenBank TP53 gene (p53).  
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Figure 47. Isolelectric points of predicted amino acid sequences of residues 4640-5328 
of the TP53 gene extracted from MRC5 and MRC5 SV2 cells treated with MDA 
(0-1000 µM) and H2O2 (50-100 µM) for 48 h. 
Mutations may also have an effect on the hydrophobicity of a protein sequence, which 
in turn affects the secondary and tertiary structure of the protein. The structure of a 
protein defines its function. The hydrophobicity of an amino acid sequence determines 
where each amino acid will be located in the final structure of the protein. Hydrophobic 
amino acids such as isoleucine and valine are non-polar and are located on the inside on 
globular proteins, away from the water-containing cytosol, or span the hydrophobic lipid 
bilayer of membranes in transmembrane proteins. Whereas hydrophilic amino acid 
residues such as arginine and lysine, are located on the exterior of globular proteins and 
on either side of the membrane of transmembrane proteins, where they interact with 
the water in the cytosol by hydrogen bonding (Kyte and Doolittle, 1982).  
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A hydrophobicity plot is a method of displaying the hydrophobic and hydrophilic regions 
of an amino acid sequence and can be used to predict the protein structure, potentially 
indicating transmembrane regions. Each amino acid is allocated a hydrophobicity score 
from 4.6 for the most hydrophobic (isoleucine) to -4.6 for the most hydrophilic (arginine). 
Hydrophobic regions are identified as peaks above the midline and hydrophilic regions 
as peaks below (Kyte and Doolittle, 1982). Predicted hydrophobicity plots for untreated 
and MDA (1000 µM) treated MRC5 and MRC5 SV2 cells are shown in Figure 48. The plots 
for the untreated control for each cell line are identical, and match the plot for the same 
section of the wild type p53 sequence (data not shown). A greater proportion of the 
untreated control sequences (A and C) are hydrophilic, with five main hydrophobic 
regions – two small regions at the beginning of the sequence, a large region in the middle 
which is the most hydrophobic, and two large regions towards the end of the sequence. 
For the MRC5 sequence from cells treated with 1000 µM MDA, there are more regions 
of predicted hydrophobicity (seven), with greater hydrophobicity, denoted by the 
increased peak size, than for the untreated control. These hydrophobic regions can be 
seen at the beginning of the sequence, with a main hydrophobic region spanning 
positions 100 to 150 of the amino acid sequence. The two hydrophobic sequences seen 
in the untreated control towards the end of the sequence were smaller in the treated 
sequence. For the MRC5 SV2 sequence from cells treated with 1000 µM MDA, the two 
hydrophobic regions seen at the start of the untreated sequence were much smaller in 
the treated sequence, with a wider region of hydrophobicity in the centre of the 
sequence than the untreated control. There were also more regions of hydrophobicity 
at the end of the treated   
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Figure 48. Kyte-Doolittle hydrophobicity plot of amino acid sequence of residues 4640-5328 of TP53 gene from MRC5 cells A) 
untreated and B) treated with 1000 µM MDA and MRC5 SV2 cells C) untreated and D) treated with 1000 µM MDA for 48 h.
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sequence than compared to the untreated control and also the treated MRC5 sequence. 
These alterations in the predicted hydrophobic regions of sequences from cells treated 
with MDA compared to the untreated controls, demonstrate the effect of mutations on 
the hydrophobicity of the protein sequences and as a result, the potential for alteration 
of the proteins’ secondary and tertiary structure, which may impact on the functionality 
of the protein molecule. 
5.3. Summary 
Genomic DNA, extracted and purified from MRC5 and MRC5 SV2 cells which had been 
treated with MDA, showed increasing fragmentation with increasing MDA 
concentration, when imaged by AFM. A feasibility study was also carried out to see if 
M1dG antibodies could be used to locate M1dG adducts on the same DNA strands. It was 
not possible to locate any adducts in this study, perhaps due to cellular DNA repair 
mechanisms or low concentrations of adducts making location and detection of them 
difficult by this method. Mutation sequencing was then carried out to see if MDA had 
an effect on the DNA sequence. 
For the first time, the 5’ UTR region of the human TP53 gene was amplified by PCR and 
sequenced from MRC5 and MRC5 SV2 DNA extracted from cells treated with MDA and 
H2O2. This sequence encodes exon 1 and also Wrap53 in the antisense direction, a 
transcript that hybridises with p53 preventing post-transcriptional degradation. In 
general, a greater number of mutations were found in MRC5 DNA than in MRC5 SV2 
DNA, perhaps due to the altered p53 response of MRC5 SV2 cells. No mutations were 
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found in either the negative control or in DNA from cells treated with 10 µM MDA for 
both cell lines, perhaps due to low level mutation rates and/or DNA repair mechanisms. 
DNA from both cell lines had an increased number of mutations with increasing 
concentration of H2O2, the positive control. 
For MRC5 DNA, the highest number of mutations occurred in DNA from cells treated 
with 100 µM MDA, followed by a decreasing number up to 1000 µM, of which the 
majority were G insertion mutations, with some transitions (A to G and C to T) and 
transversions (C to A). For MRC5 SV2 DNA from cells treated with MDA, the greater 
number of mutations were found for 200 µM MDA and then 1000 µM MDA, of which all 
of the mutations were insertions, mainly G. A number of repeated mutations were 
identified, the majority of which resulted in an amino acid change to this sequence. For 
the positive control, H2O2, the majority of mutations in MRC5 DNA were transversions 
(Mostly G to T or C), and half of the mutations in MRC5 SV2 cells were insertions (mainly 
G) and the remainder were transitions and transversions. Thus, a clear difference was 
observed in mutations occurring due to MDA and H2O2, so eliminating radical attack, but 
also between the two cell lines which was due to the difference in p53 response. 
An increase in changes to the amino acid sequence of this section of DNA was predicted, 
with increasing concentrations of MDA and H2O2, which resulted in an increased number 
of predicted changes to the secondary structure of this sequence, and an overall 
increase to the isoelectric points of the amino acid sequences, and an increase to the 
number of predicted hydrophobic regions.  
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CHAPTER 6 
CONCLUSIONS & FUTURE WORK 
6.1. Conclusions 
Overall, low concentrations of MDA appeared to induce cell proliferation in both cell 
lines, whereas higher concentrations of MDA appeared to inhibit proliferation and 
viability with a dose-dependent response, but MRC5 cells to a much greater extent, 
perhaps due to the sequestration of p53 in MRC5 SV2 cells by the viral large T antigen. 
Cell surface morphology was altered, becoming more pitted and irregular in shape with 
increasing MDA concentration. A qualitative analysis showed what appear to be 
micronuclei were observed in cells treated with MDA, in a dose-dependent manner. The 
nuclear area also appeared to increase and cells appeared to express an increased 
amount of phosphatidyl serine indicating the early stages of apoptosis. p53 expression 
was observed to increase in individual cells, treated with increasing amounts of MDA, 
but overall p53 fold induction appeared to decrease when expression was measured by 
RT-qPCR, perhaps due to decreased cell viability, although p53 induction was still greater 
than the negative control. Thus, treatment with MDA results in alterations at the cellular 
level. Whilst previous studies have utilised these techniques, the novelty of this work is 
the combination of these methods to study the effects of treating MRC5 and MRC5 SV2 
cells with MDA. In particular, the effects of MDA on cell surface morphology using AFM, 
nuclear morphology and p53 expression studies. 
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A sensitive method of M1dG adduct detection has been developed using LC-MS-MS, 
however, M1dG adducts were undetectable in these cell lines. Insufficient DNA may have 
been extracted for detection, or DNA repair mechanisms in the cell may act to remove 
M1dG adducts from DNA. MDA may have been sequestered as protein-MDA adducts, 
reducing the effective dose of MDA reacting with DNA. M1dG adducts have been 
quantified in CT-DNA treated with MDA, showing a dose-response relationship, 
although with a relatively high concentration of DNA compared to MRC5 and MRC5 SV2 
DNA. Thus DNA-MDA reactions occur in the absence of biological events, however, 
cellular processes may interfere with DNA-MDA interactions. 
Genomic DNA, extracted and purified from MRC5 and MRC5 SV2 cells which had been 
treated with MDA, showed increasing fragmentation with increasing MDA 
concentration, when imaged by AFM. This indicates that MDA is able to reach the 
nucleus and interact with DNA and cause alterations at the DNA level, although cellular 
responses to the presence of MDA may cause the fragmentation of DNA. 
For the first time, the 5’ UTR region of the human TP53 gene was amplified by PCR and 
sequenced from MRC5 and MRC5 SV2 DNA extracted from cells treated with MDA. 
Mutations were found in this segment of DNA, generally increasing with increasing MDA 
concentration, and to a greater extent in MRC5 DNA than MRC5 SV2 DNA. Thus MDA 
has an effect on DNA but it is not known as to whether this is directly via M1dG adducts 
(which were not detected), or by other cellular processes. The mutation pattern does 
not match that found in smoking-related lung cancer cells, which might be expected as 
the cell lines used were lung fibroblasts, however, insertion i.e. frameshift mutations 
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and transition mutations were observed which have been associated with passive 
smoking related and non-smoking related lung cancers respectively. Additionally, the 
majority of mutations found were at guanine residues, which would be expected as MDA 
has a greater reactivity with guanine than any of the other nucleotide bases. No direct 
comparison can be made between the mutations found here and the TP53 mutation 
database, as the section of the TP53 gene sequenced was the 5’ UTR which includes 
exon 1, whereas the data held in the database covers the protein coding exons 2-11. 
Additionally, the majority of mutation data for TP53 and lung cancer is for tobacco 
smoke, which contains a complex mix of carcinogenic compounds, such as PAHs, where 
the effects of these compounds may differ from or have a greater effect than MDA and 
the contribution of MDA to the mutations seen may have been masked by the impact of 
these other compounds. 
6.2. Future Work 
A number of different assays were carried out to determine the effects of MDA at the 
cellular level in human lung fibroblast MRC5 and MRC SV2 cell lines. A clear effect was 
found, however, further work may be carried out to complement and improve upon 
these findings.  
Due to the potential reaction of proteins in FBS with MDA, the effect of FBS on cell 
proliferation was analysed in Section 3.2. After 48 h incubation in serum-free media, 
both cell lines appeared to no longer proliferate when compared to those grown in 
complete media, although they still remained viable which allowed their use in further 
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analyses. The use of a protein-free FBS-substitute, which are now readily available, could 
be used as an alternative to serum-free media, to allow both cell lines to continue 
proliferating up to 48 h, and beyond. The effect of MDA on MRC5 and MRC5 SV2 cells 
could be assessed over longer periods of exposure. 
The culturing of the two cell lines may be scaled-up in order to produce sufficient 
amounts of mRNA for RT-qPCR p53 expression analysis, with the addition of higher 
concentrations of MDA to treat the cells (100-1000 µM), so that these results may be 
compared directly to the immunofluorescence assay for p53 expression. In addition to 
this, further expression studies could be carried out using RT-qPCR, for example 
apoptosis-related proteins such as Bcl-2, Bax, JNK and ERK (Cheng et al., 2011). Any 
potential differences in expression may reveal the effects of MDA on these proteins and 
thus give further information as to the effects of MDA on apoptosis, they may also reveal 
the effects of p53 sequestration on the mechanisms of apoptosis. As it has been 
suggested that the use of a single housekeeping gene, such as GAPDH, is no longer the 
preferred method of normalising the target gene expression due to variations in 
expression due to experimental factors (Kozera and Rapacz, 2013). Multiple 
housekeeping genes should be used instead, for example glucose-6-phosphate 
isomerase, proteasome subunits PSMB2 and PSMB4, and RAS oncogene family member 
RAB7A have been suggested (Eisenberg and Levanon, 2013), which could be used to 
improve the robustness of the RT-qPCR analysis. 
MDA was observed to have an effect upon the nuclear morphology of MRC5 and MRC5 
SV2 cells, with the nuclear area increasing and the number of what appeared to be 
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micronuclei increasing with increasing MDA concentration. The alteration in nuclear 
area may have been due to the flattening and spreading of the cell due to cytoskeletal 
changes, therefore 3-D imaging of the cells would be required to confirm this by 
measuring nuclear volume rather than area. Additionally, a full micronucleus assay could 
be carried out, as described in Section 3.6., in order to quantify the number of 
micronuclei formed in response to treatment with MDA. 
MDA was observed to have a clear effect upon cell morphology, observed by both LM, 
where live cells were imaged in vitro, and AFM, where the cell surface of air-dried cells 
were also imaged. Work may be continued here to assess the effect of MDA on cell 
morphology and topography by carrying out force-measurements using AFM to look at 
the mechanical properties of the cell. The effect of MDA upon the cell cytoskeleton could 
also be assessed by immunofluorescence with confocal microscopy. Monoclonal 
antibodies against actin and β tubulin may be used to stain these cytoskeletal 
components following exposure of cells to different concentrations of MDA, to 
determine its effect on the cytoskeleton and thus cell morphology.  
AFM was also used to image DNA from MRC5 and MRC5 SV2 cells treated with MDA, 
and found that there was increased DNA fragmentation with increasing MDA 
concentrations. A feasibility study was carried out to see if M1dG antibodies could be 
used to locate M1dG adducts on the same DNA strands, however, it was not possible to 
locate any adducts in this study. Immunoaffinity purification of the DNA samples could 
be carried out to isolate M1dG adduct-containing DNA strands (Hochleitner et al., 1991) 
prior to AFM analysis to increase the likelihood of locating antibodies bound to M1dG 
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DNA adducts. This could also be used in conjunction with chemical force microscopy 
(CFM), an ultra-sensitive method using a chemically functionalised AFM tip 
(Hinterdorfer et al., 1996). M1dG antibodies could be attached to an AFM tip and used 
to locate M1dG adducts on DNA strands. Additionally, isolation of specific regions of DNA, 
such as the TP53 gene, for AFM and CFM analysis could be carried out. 
A LC-MS-MS method was developed for the detection and quantification of M1dG 
adducts in DNA samples. The method was successful in that M1dG adducts were 
detected in CT-DNA samples that had been treated with MDA, in a dose-dependent 
manner. However, DNA extracted from MRC5 and MRC5 SV2 cells that had been treated 
with MDA was insufficient in concentration for adduct detection by this method and the 
LC-MS-MS instrumentation available. In order to produce sufficient data for publication 
of this method, and the effect of MDA on M1dG adduct levels in these cell lines, 
additional work is being undertaken. Initially, the method of DNA extraction is being 
examined using the M1dG-DNA standard to determine whether there was any loss of 
adduct via this method. If any loss of adduct is detected, an alternative method of DNA 
extraction will need to be used for further analysis. The culturing of the cell lines may 
need to be scaled-up significantly in order to produce sufficient DNA to be used to detect 
M1dG adducts. The use of more sensitive instrumentation may also be required for 
M1dG adduct detection, as the LOD and LOQ of the instrumentation used here were 
relatively high. Immunoaffinity purification of the DNA samples could be carried out to 
isolate M1dG adduct-containing DNA prior to analysis and thus improve adduct 
detection levels. 
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Finally, a section of the TP53 gene from DNA extracted from MRC5 and MRC5 SV2 cells 
treated with MDA was sequenced and mutations were found. However, the mutation 
pattern did not match the mutations found in the TP53 gene in smoking-related lung 
cancer cells, which might be expected as the cell lines were human lung fibroblasts. This 
may be due to the section of the TP53 gene differing from those used previously in the 
p53 database, the 5’ UTR in this study and the protein coding exons 2-11 in previous 
studies. However, differences were identified in the mutation patterns of MRC5 and 
MRC5 SV2 in response to MDA, which can be attributed to the differing p53 responses 
of the two cell lines. There is thus sufficient novel mutation data to present for 
publication, however a number of further analyses could be carried out to enhance the 
work. PCR amplification and mutation sequencing of the same sequences of the TP53 
gene as used in previous studies could be carried out and compared. Additionally, it may 
be possible that cellular DNA repair mechanisms could repair some of the mutations 
found here, and/or mutations occurring prior to DNA extraction may have already been 
repaired. A series of different MDA treatment times could therefore be used to monitor 
this effect, along with returning the treated cells to complete media for a set period of 
time post-treatment.  
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APPENDIX 1 
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Figure 49. Nucleotide sequence of residues 4640-5328 of TP53 gene, sequenced from DNA of MRC5 cells treated with MDA (0-1000 µM) 
and H2O2 (50-100 µM) for 48 h, aligned to the TP53 GenBank sequence. Mutations in the sequence are highlighted as conflicts. 
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Figure 50. Nucleotide sequence of residues 4640-5328 of TP53 gene, sequenced from DNA of MRC5 SV2 cells treated with MDA 
(0-1000 µM) and H2O2 (50-100 µM) for 48 h, aligned to the TP53 GenBank sequence. Mutations in the sequence are highlighted as conflicts.
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Figure 51. Primary structure of residues 4640-5328 of the TP53 gene extracted from MRC5 cells treated with MDA (0-1000 µM) and H2O2 
(50-100 µM) for 48 h. Secondary structures are illustrated with arrows in pink (β –strand) or blue (α- helix). 
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Figure 52. Primary structure of residues 4640-5328 of the TP53 gene extracted from MRC5 SV2 cells treated with MDA (0-1000 µM) and 
H2O2 (50-100 µM) for 48 h. Secondary structures are illustrated with arrows in pink (β –strand) or blue (α- helix).  
